<SEC-DOCUMENT>0001193125-15-013397.txt : 20150116
<SEC-HEADER>0001193125-15-013397.hdr.sgml : 20150116
<ACCEPTANCE-DATETIME>20150116170938
ACCESSION NUMBER:		0001193125-15-013397
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		10
FILED AS OF DATE:		20150116
DATE AS OF CHANGE:		20150116
EFFECTIVENESS DATE:		20150116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OMEROS CORP
		CENTRAL INDEX KEY:			0001285819
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911663741
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-201581
		FILM NUMBER:		15533308

	BUSINESS ADDRESS:	
		STREET 1:		201 ELLIOTT AVENUE WEST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98119
		BUSINESS PHONE:		206-676-5000

	MAIL ADDRESS:	
		STREET 1:		201 ELLIOTT AVENUE WEST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98119
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>d825446ds3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
<HTML><HEAD>
<TITLE>S-3ASR</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on January 16, 2015 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration
No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM S-3
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933</I></B><B><I> </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>OMEROS
CORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Washington</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>91-1663741</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>201 Elliott Avenue West </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Seattle, Washington 98119 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(206) 676-5000 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address,
including zip code, and telephone number, including area code, of registrant&#146;s principal executive offices) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Gregory A.
Demopulos, M.D. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>President, Chief Executive Officer and </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chairman of the Board of Directors </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Omeros Corporation </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>201
Elliott Avenue West </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Seattle, Washington 98119 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(206) 676-5000 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name,
address, including zip code, and telephone number, including area code, of agent for service) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to:
</I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Marcia S. Kelbon</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Vice President, Patent and General Counsel</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and Secretary</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Omeros
Corporation</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>201 Elliott Avenue West</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Seattle, Washington 98119</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(206) 676-5000</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>David B. H. Martin</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Kerry Shannon Burke</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Covington&nbsp;&amp; Burling LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One CityCenter</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>850 Tenth
Street, N.W.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20001</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(202) 662-6000</B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public</B>: From time to time after the effective date of this registration
statement. </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans,
please check the following box.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of the securities being registered on
this Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following
box.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering
pursuant to Rule&nbsp;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the
Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective
amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&nbsp;462(e) under the Securities Act, check the following box.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional
securities or additional classes of securities pursuant to Rule&nbsp;413(b) under the Securities Act, check the following box.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the Exchange Act. (Check one): </P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title&nbsp;of Each Class of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities to be Registered</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registered<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed Maximum</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering&nbsp;Price</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>per&nbsp;Unit<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed Maximum</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering&nbsp;Price<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registration&nbsp;Fee<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Common Stock, par value $0.01 per share</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Preferred Stock, par value $0.01 per share</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Debt Securities</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Depositary Shares<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Subscription Rights</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Units<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">An indeterminate number and aggregate initial offering price of securities of each identified class are being registered as may from time to time be offered at indeterminate prices, including an indeterminate number or
amount of securities that may be issued upon the exercise, settlement, exchange or conversion of securities offered hereunder. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for,
or upon exercise of, convertible or exchangeable securities. </TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The registrant is deferring payment of all of the registration fee and omitting information from the Calculation of Registration Fee table in accordance with Rules&nbsp;456(b) and 457(r) under the Securities Act.
</TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Each depositary share will be issued under a depositary agreement and will be evidenced by a depositary receipt. </TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Each unit will represent an interest in two or more other securities registered hereunder, which may or may not be separable from one another. </TD></TR></TABLE>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g825446g53m01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By this prospectus, Omeros Corporation may from time to time offer and sell: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preferred
Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Depositary Shares </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Subscription
Rights </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to
time, we may offer and sell the securities described in this prospectus separately or together in any combination, in one or more classes or series, in amounts, at prices and on terms that we will determine at the time of the offering. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus may not be used to sell securities unless accompanied by a prospectus supplement, which will describe the method and specific
terms of the offering, including the amount, price and terms of the applicable offered securities. You should carefully read this prospectus, the information incorporated by reference in this prospectus, the prospectus supplement, including any
information incorporated by reference in such prospectus supplement, and any free writing prospectus before you purchase any of the securities offered hereby. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These securities may be offered and sold in the same offering or in separate offerings, to or through underwriters, dealers or agents or
directly to purchasers. The names of any underwriters, dealers or agents involved in the sale of our securities, their compensation and any over-allotment options held by them will be described in the applicable prospectus supplement. See &#147;Plan
of Distribution.&#148; </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The NASDAQ Global Market under the symbol &#147;OMER.&#148; On January&nbsp;15,
2015, the closing price of our common stock was $22.64 per share. </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in
our securities involves significant risks. Before buying our securities, you should carefully consider the risks described under the caption &#147;<A HREF="#rom825446_6">Risk Factors</A>&#148; beginning on page 4 of this prospectus, in the documents
incorporated by reference into this prospectus, and in the applicable prospectus supplement. </B></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is January 16, 2015. </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_1">About this Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_2">Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">iii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_3">About Omeros</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_4">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_5">Incorporation by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_6">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_7">Ratio of Earnings to Fixed Charges</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_8">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_9">Description of Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_10">Description of Preferred Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_11">Description of Debt Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_12">Description of Depositary Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_13">Description of Warrants</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_14">Description of Subscription Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_15">Description of Units</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_16">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_17">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom825446_18">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on Form S-3 that we filed with the United States Securities and Exchange Commission, or
SEC, using an automatic shelf registration procedure. The company elected to file this Form S-3 shelf registration statement following its recently achieved eligibility as a &#147;well-known seasoned issuer&#148;, or WKSI, under SEC regulations
regarding public float and other requirements. Under this shelf process, we may, from time to time, offer or sell any combination of the securities described in this prospectus in one or more offerings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus only provides you with a general description of the securities that we may offer. Each time we sell securities pursuant to
this prospectus, we will describe in a prospectus supplement, which will be delivered with this prospectus, specific information about the offering and the terms of the particular securities offered. The prospectus supplement may also add, update or
change the information contained in this prospectus. Before purchasing any securities, you should carefully read both this prospectus and the accompanying prospectus supplement and any free writing prospectus prepared by or on behalf of us, together
with the additional information described under &#147;Where You Can Find More Information.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus does not contain all of
the information included in the registration statement. For a more complete understanding of the offering of the securities, you should refer to the registration statement, including its exhibits. Those exhibits may be filed with the registration
statement or may be incorporated by reference to earlier SEC filings listed in the registration statement or in subsequent filings that we may make under the Securities Exchange Act of 1934, or Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information contained or incorporated by reference in this prospectus, the accompanying prospectus supplement
or any free writing prospectus that we have prepared which relates to a particular offering. We have not authorized anyone else to provide you with different or additional information. If anyone provides you with different or additional information,
you should not rely on it. We are not making an offer to sell or soliciting an offer to buy these securities under any circumstance in any jurisdiction where the offer or solicitation is not permitted. You should assume that the information
contained in this prospectus, any prospectus supplement or any free writing prospectus that we have prepared is accurate only as of the date of the respective document in which the information appears, and that any information in documents that we
have incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus or any prospectus supplement or any sale of a security. Our business, financial
condition, results of operations and prospects may have changed since those dates. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, any prospectus supplement and the
information incorporated herein and therein by reference includes trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included or incorporated by reference into this prospectus
supplement or the accompanying prospectus are the property of their respective owners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context indicates otherwise, in this
prospectus supplement and the accompanying prospectus the terms &#147;Company,&#148; &#147;Omeros,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148; refer to Omeros Corporation, a Washington corporation, and its subsidiaries on a
consolidated basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_2"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, each prospectus supplement and the information incorporated by reference in this prospectus and each prospectus supplement
contain certain statements that constitute &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, or Securities Act, and Section&nbsp;21E of the Exchange Act, which are subject to the safe harbor
created by those sections for such statements. Forward-looking statements are based on our management&#146;s beliefs and assumptions and on information currently available to our management. All statements other than statements of historical fact
are forward-looking statements. Terms such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;goal,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148;
&#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would&#148; and similar expressions and variations thereof are intended to identify forward-looking statements, but these terms are not the exclusive means of
identifying such statements. Those statements appear in this prospectus, any accompanying prospectus supplement and the documents incorporated herein and therein by reference, particularly in the sections entitled &#147;Prospectus Summary&#148; and
&#147;Risk Factors,&#148; and include statements regarding the intent, belief or current expectations of us and our management that are subject to known and unknown risks, uncertainties and assumptions. Examples of forward-looking statements
include, but are not limited to, statements regarding: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our anticipation that we will begin U.S. commercial sales of Omidria&#153; in early 2015; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to receive regulatory approval for our Marketing Authorisation Application, or MAA, for OMS302, or Omidria, in the European Union, or EU; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our expectation of receiving an opinion on the MAA from the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, in 2015; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to partner in Europe and our anticipation that we will initiate marketing and sales of Omidria in the EU in 2015, assuming approval of our MAA for Omidria and partnering in Europe; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our plans for sales, marketing and distribution of Omidria in the U.S. and for partnering, sales, marketing and distribution in the EU and other international territories; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our expectation that additional sales representatives will be hired, trained and in the field by the end of January 2015; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to successfully complete our Phase 2 clinical trials for OMS824 and OMS721; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to recommence active enrollment in our Phase 2 clinical trial of OMS824 in Huntington&#146;s disease or initiate further clinical studies in either our OMS824 Huntington&#146;s or schizophrenia programs;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to initiate post-marketing studies for Omidria and additional clinical trials for OMS103, should they be necessary; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">whether there may be an opportunity to have OMS103 produced and commercialized by a registered outsourcing facility; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our expectations regarding the clinical, therapeutic and competitive benefits of Omidria and our product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our anticipated future sales from Omidria and our estimate regarding how long our existing cash, cash equivalents and short-term investments will be sufficient to fund our anticipated operating expenses, capital
expenditures and interest and principal payments on our outstanding notes; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to raise additional capital through the capital markets or through one or more corporate partnerships, equity offerings, debt financings, collaborations, licensing arrangements or asset sales;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our anticipation that we will rely on contract manufacturers to develop and manufacture our product candidates and to manufacture Omidria for commercial sale; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to enter into acceptable arrangements with potential corporate partners; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">whether pediatric studies may afford Omidria an additional six months of exclusivity; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our expectations about the commercial competition that Omidria and our product candidates may face; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our expected financial position, performance, growth, expenses, magnitude of net losses and availability of resources; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the extent of protection that our patents provide and that our pending patent applications will provide, if patents issue from such applications, for our technologies, programs, products and product candidates;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our estimates regarding our future net losses, revenues, research and development expenses and selling, general and administrative expenses.</TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you
should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in
the forward-looking statements. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking
statements, even if new information becomes available in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_3"></A>ABOUT OMEROS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for
large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. Derived from our proprietary PharmacoSurgery<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> platform, Omidria<SUP
STYLE="font-size:85%; vertical-align:top">&#153; </SUP>(phenylephrine and ketorolac injection) 1%/0.3%, our first drug product, was approved by the&nbsp;U.S. Food and Drug Administration, or FDA,&nbsp;on May&nbsp;30, 2014 for use during cataract
surgery or intraocular lens replacement, or ILR, to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative ocular pain. Our PharmacoSurgery platform, designed to improve clinical outcomes of patients
undergoing ophthalmological, arthroscopic, urological and other surgical procedures, is based on low-dose combinations of FDA-approved therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to inhibit
preemptively inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
our pipeline we have a series of development programs targeting pain, inflammation, coagulopathies and disorders of the central nervous system, including the following six clinical-stage programs: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our lead <FONT STYLE="white-space:nowrap">MASP-2</FONT> antibody OMS721, which is in a Phase 2 clinical program in patients with thrombotic microangiopathies; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Phase 2 program evaluating our lead phosphodiesterase 10, or PDE10, inhibitor OMS824 for the treatment of Huntington&#146;s disease, which is in a Phase 2 clinical trial that is currently suspended pending further
evaluation of an observation from a nonclinical study in rats; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Phase&nbsp;2 program evaluating OMS824 for the treatment of schizophrenia, which is not in an active clinical trial; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our PharmacoSurgery product candidate OMS103 for reducing inflammatory pain following arthroscopic partial meniscectomy, which has completed one Phase 3 trial in patients undergoing this procedure; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our PPAR<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT> program, in which three Phase 2 clinical trials are being conducted by our collaborators to evaluate a PPAR<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT> agonist,
alone or in combination with other agents, for their effects on smoking, as well as in the abuse liability of oxycodone or heroin; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our PharmacoSurgery product candidate OMS201 for use during urological procedures, including uroendoscopic procedures, which completed a Phase 1/Phase 2 clinical trial in 2010 and is not currently in active clinical
trials. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have a diverse group of preclinical programs, which include our PDE7 program, in which we are
developing proprietary compounds to treat addiction and compulsive disorders as well as movement disorders, and our Plasmin program, in which we are advancing novel antifibrinolytic agents for the control of blood loss during surgery or resulting
from trauma as well as for other hyperfibrinolytic states (<I>e.g.</I>, liver disease). We also have two additional platforms: one used to generate antibodies and the other capable of unlocking new G protein-coupled receptor, or GPCR, drug targets.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For Omidria and each of our product candidates and programs, we have retained all manufacturing, marketing and distribution rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated in the State of Washington in 1994. Our principal executive offices are located at 201 Elliott Avenue West, Seattle,
Washington 98119, and our telephone number is (206)&nbsp;676-5000. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_4"></A>WHERE YOU CAN FIND MORE INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to
the public over the Internet at the SEC&#146;s website at www.sec.gov. You may also read </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and copy any document we file at the SEC&#146;s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the Public
Reference Room. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, including any amendments to those reports, and other information that we file with or furnish to the SEC pursuant to Section&nbsp;13(a)
or 15(d) of the Exchange Act can also be accessed free of charge by linking directly from our website at www.omeros.com under &#147;Investor &#151; Financial Information &#151; SEC Filings.&#148; These filings will be available as soon as reasonably
practicable after we electronically file such material with, or furnish it to, the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration
statement under the Securities Act relating to the offering of these securities. The registration statement, including the attached exhibits, contains additional relevant information about us and the securities. This prospectus does not contain all
of the information set forth in the registration statement. You can obtain a copy of the registration statement, at prescribed rates, from the SEC at the address listed above. The registration statement and the documents referred to below under
&#147;Incorporation by Reference&#148; are also available on our Internet website, www.omeros.com. We have not incorporated by reference into this prospectus the information on, or that can be accessed through, our website, and you should not
consider it to be a part of this prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_5"></A>INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; the information we file with it, which means that we can disclose important
information to you by referring you to those documents. The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC will automatically update and supersede this information. The
following documents that we have previously filed with the SEC (File No.&nbsp;001-34475) are incorporated by reference herein: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Annual Report on Form 10-K for the year ended December&nbsp;31, 2013 filed with the SEC on March&nbsp;13, 2014; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Quarterly Reports on Form 10-Q for the quarterly periods ended March&nbsp;31, 2014, June&nbsp;30, 2014 and September&nbsp;30, 2014 filed with the SEC on May&nbsp;12, 2014, August&nbsp;11, 2014 and November&nbsp;10,
2014, respectively; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Current Reports on Form 8-K filed with the SEC on March&nbsp;7, 2014,&nbsp;March&nbsp;18, 2014,&nbsp;April&nbsp;3, 2014,&nbsp;May&nbsp;22, 2014,&nbsp;May&nbsp;29, 2014,&nbsp;June&nbsp;2,
2014,&nbsp;September&nbsp;29, 2014 and October&nbsp;7, 2014 (excluding all information furnished in such reports under Item&nbsp;2.02, Item&nbsp;7.01 or Item&nbsp;9.01); and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the description of our common stock contained in Exhibit 99.1 to our Annual Report on Form 10-K for the year ended December&nbsp;31, 2013, filed with the SEC on March&nbsp;13, 2014. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All reports and other documents that we subsequently file pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the
completion of the sales of the securities offered hereby but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date
of the filing of such reports and documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, as supplemented, may contain information that updates, modifies or is
contrary to information in one or more of the documents incorporated by reference in this prospectus. You should rely only on the information incorporated by reference or provided in this prospectus, the accompanying prospectus supplement or any
free writing prospectus that we have prepared that relates to a particular offering. We have not authorized anyone else to provide you with different or additional information. You should not assume that the information in this prospectus is
accurate as of any date other than the date of this prospectus or the date of the documents incorporated by reference in this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide without charge to each person, including any beneficial owner, to whom this
prospectus is delivered, upon written or oral request, a copy of any or all documents that are incorporated by reference into this prospectus, but not delivered with the prospectus, other than exhibits to such documents unless such exhibits are
specifically incorporated by reference into the documents that this prospectus incorporates. You should direct written requests to: Omeros Corporation, Attn: Legal Department, 201 Elliott Avenue West, Seattle, Washington 98119, or you may call us at
(206)&nbsp;676-5000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in our securities involves a high degree of risk. The prospectus supplement applicable to each offering of our securities will
contain a discussion of the risks applicable to an investment in our securities. Before deciding whether to invest in our securities, you should consider carefully the risks described under the heading &#147;Risk Factors&#148; in the applicable
prospectus supplement and in any of our filings with the SEC that are incorporated by reference therein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_7"></A>RATIO OF EARNINGS TO FIXED CHARGES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, the amount of our fixed charges has exceeded our earnings. The following table sets forth our deficiency of earnings available to
cover fixed charges for the nine months ended September&nbsp;30, 2014, and for each year in the five-year period ended December&nbsp;31, 2013. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2012</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2011</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2010</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2009</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deficiency of earnings available to cover fixed charges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">52,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">38,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,089</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The deficiency of earnings available to cover fixed charges has been computed on a consolidated basis.
&#147;Earnings&#148; consist of loss from continuing operations before income taxes, plus fixed charges and amortization of capitalized interest. Fixed charges consist of interest expensed and capitalized, amortization of premiums, discounts and
capitalized expenses related to debt and an estimate of the interest component of rent expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this prospectus, we
have no&nbsp;shares of preferred stock outstanding and, consequently, our ratio of combined fixed charges and preference dividends to earnings is the same as our deficiency of earnings available to cover fixed charges as disclosed above. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_8"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the prospectus supplement, we intend to use the net proceeds from the sale of securities offered under this
prospectus for general corporate purposes, including expenses related to the commercialization of Omidria, as well as for research and development expenses, such as funding clinical trials, pre-clinical studies and otherwise advancing potential drug
candidates toward commercialization, including marketing and selling product candidates that receive regulatory approval. We may also use the net proceeds for working capital, the repayment of debt obligations, acquisitions or investments in
businesses, products or technologies that are complementary to our own, and other capital expenditures. We will set forth in the prospectus supplement our intended use for the net proceeds received from the sale of any securities. Pending the use of
such proceeds, we intend to invest the net proceeds in short-term, investment grade, interest-bearing instruments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_9"></A>DESCRIPTION OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue, separately or together with, or upon conversion, exercise or exchange of other securities, common stock, par value $0.01 per
share, as set forth in the applicable prospectus supplement. The following summary of our common stock does not purport to be complete and is subject to, and is qualified in its entirety by reference to, our Amended and Restated Articles of
Incorporation, or Articles of Incorporation, Amended and Restated Bylaws, or Bylaws, and applicable provisions of the Washington Business Corporation Act, or WBCA. Therefore, you should carefully consider the actual provisions of our Articles of
Incorporation and Bylaws as well as relevant portions of the WBCA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized and Outstanding Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of (i)&nbsp;150,000,000&nbsp;shares of common stock, par value $0.01 per share, and
(ii)&nbsp;20,000,000&nbsp;shares of preferred stock, par value $0.01 per share. As of December 31, 2014, 34,181,332&nbsp;shares of common stock were outstanding and no&nbsp;shares of preferred stock were outstanding. All outstanding shares of common
stock are fully paid and nonassessable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividend Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to preferences that may be applicable to any outstanding&nbsp;shares of preferred stock, holders of common stock are entitled to
receive ratably such dividends as may be declared by the board of directors out of funds legally available therefor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights and Cumulative
Voting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of our common stock are entitled to one vote per share on all matters to be voted on by the shareholders. Our
Articles of Incorporation provide that shareholders are not entitled to cumulate votes in the election of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preemptive Rights; Redemption or
Sinking Fund </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of common stock have no preemptive, conversion or subscription rights. There are no redemption or sinking fund
provisions applicable to our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidation Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we liquidate, dissolve or wind up, holders of our common stock are entitled to share ratably in all assets remaining after payment of
liabilities and the liquidation preferences of any outstanding&nbsp;shares of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing; Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The NASDAQ Global Market under the symbol &#147;OMER.&#148; The transfer agent and registrar for our common stock
is Computershare Inc. Its address is P.O. Box 43006, Providence, Rhode Island 02940-3006 and its telephone number is 1-866-282-4938. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2014, we had warrants outstanding to purchase an aggregate of 551,435&nbsp;shares of our common stock, as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A warrant that we assumed in connection with our acquisition of nura, inc. on August&nbsp;11, 2006 to purchase 11,539&nbsp;shares of our common stock with an exercise price of $9.13 per share. This warrant will
terminate upon the earlier of (a)&nbsp;April&nbsp;26, 2015 and (b)&nbsp;certain acquisitions of us as described in the warrant. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Warrants issued on March&nbsp;29, 2007 to purchase an aggregate of 139,897&nbsp;shares of our common stock with an exercise price of $12.25 per share. Unless we extend the termination date of these warrants, they will
terminate on the earlier of (a)&nbsp;a change of control as defined in the warrants and (b)&nbsp;March 29, 2015. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Three warrants issued on October&nbsp;21, 2010, each to purchase up to 133,333&nbsp;shares of our common stock, with exercise prices of $20.00, $30.00 and $40.00 per share, respectively. These warrants will terminate on
October&nbsp;21, 2015. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Washington Law and our Articles of Incorporation and Bylaws </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of Washington law, our Articles of Incorporation and our Bylaws contain provisions that may delay, defer or discourage
another party from acquiring control of us. These provisions, which are summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed, in part, to encourage persons seeking
to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquiror outweigh the disadvantages of discouraging
a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Washington Anti-Takeover Statute
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Washington law imposes restrictions on some transactions between a corporation and significant shareholders. Chapter&nbsp;23B.19 of
the WBCA generally prohibits a target corporation from engaging in specified &#147;significant business transactions&#148; with an &#147;acquiring person.&#148; This statute could prohibit or delay the accomplishment of mergers or other takeover or
change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us. An acquiring person is defined as a person or group of persons that beneficially owns 10% or more of the voting securities of the target
corporation. With limited exceptions, the target corporation may not engage in significant business transactions for a period of five years after the share acquisition by an acquiring person, unless (a)&nbsp;the significant business transaction or
the acquiring person&#146;s purchase of shares was approved by a majority of the members of the target corporation&#146;s board of directors prior to the acquiring person&#146;s share acquisition or (b)&nbsp;the significant business transaction was
both approved by the majority of the members of the target corporation&#146;s board and authorized at a shareholder meeting by at least two-thirds of the outstanding voting shares (excluding the acquiring person&#146;s shares or shares over which
the acquiring person has voting control at or subsequent to the acquiring person&#146;s share acquisition). Significant business transactions include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a merger or share exchange with, disposition of assets to, or issuance or redemption of stock to or from, the acquiring person; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a termination of five percent or more of the employees of the target corporation as a result of the acquiring person&#146;s acquisition of 10% or more of the&nbsp;shares of the target corporation; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a transaction in which the acquiring person is allowed to receive a disproportionate benefit as a shareholder. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the five-year period, a significant business transaction may occur, as long as it complies with fair price provisions specified in
Chapter&nbsp;23B.19 or is approved at a meeting of shareholders by a majority of the votes entitled to be counted within each voting group entitled to vote separately on the transaction, not counting the votes of&nbsp;shares as to which the
acquiring person has beneficial ownership or voting control. A corporation may not &#147;opt out&#148; of this statute. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Board Classification </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors is divided into three classes. The directors in each class will serve for a three-year term, with one class being
elected each year by our shareholders. This system of electing directors may tend to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discourage a third party from making a tender offer or otherwise attempting to obtain control of us, because it generally makes it more difficult for shareholders to replace a majority of the
directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Directors May&nbsp;be Removed Only for Cause </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our directors may be removed only for cause by the affirmative vote of the holders of our voting stock at a meeting of shareholders called for
such purpose. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Board Vacancies Filled Only by Directors Then in Office </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only our board of directors may determine the number of directors on our board and fix such number by resolution from time to time. Our
Articles of Incorporation provide that vacancies and newly created seats on our board of directors may only be filled by the majority vote of the remaining members of our board of directors. The inability of our shareholders to determine the number
of directors or to fill vacancies or newly created seats on our board of directors makes it more difficult to change the composition of our board of directors, but these provisions may promote a continuity of existing management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>No Cumulative Voting </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Articles of
Incorporation provide that shareholders are not entitled to cumulate votes in the election of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limits on Ability of Shareholders to Act by
Written Consent or Call a Special Meeting </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Washington law limits the ability of shareholders of public companies from acting by written
consent by requiring unanimous written consent for a shareholder action to be effective. This limit on the ability of our shareholders to act by less than unanimous written consent may lengthen the amount of time required to take shareholder
actions. As a result, a holder controlling a majority of our capital stock who is unable to obtain unanimous written consent from all of our shareholders would not be able to amend our Bylaws or remove directors without holding a shareholders
meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our Articles of Incorporation provide that, unless otherwise required by law, special meetings of the shareholders
may be called only by the chairman of the board, the chief executive officer, the president, or the board of directors acting pursuant to a resolution adopted by a majority of the board members. A shareholder may not call a special meeting, which
may delay the ability of our shareholders to force consideration of a proposal or for holders controlling a majority of our capital stock to take any action, including the removal of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Requirements for Advance Notification of Shareholder Nominations and Proposals </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Bylaws establish advance notice procedures with respect to shareholder proposals and the nomination of candidates for election as
directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. The Bylaws do not give the board of directors the power to approve or disapprove shareholder nominations of candidates
or proposals regarding business to be conducted at a special or annual meeting of the shareholders. However, our Bylaws may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed. These
provisions may also discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#146;s own slate of directors or otherwise attempting to obtain control of our company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Amendment of Bylaws </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Articles of
Incorporation and Bylaws provide that shareholders can amend or repeal our Bylaws only upon the affirmative vote of the holders of our voting stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Undesignated Preferred Stock </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed below, our board of directors has the ability to issue preferred stock with voting or other rights or preferences that could
impede the success of any attempt to effect a change of control. These and other provisions may have the effect of deferring hostile takeovers or delaying changes in control or management. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_10"></A>DESCRIPTION OF PREFERRED STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue, separately or together with, or upon conversion, exercise or exchange of other securities, preferred stock, par value $0.01 per
share, as set forth in the applicable prospectus supplement. The following summary does not purport to be complete and subject to, and is qualified in its entirety by reference to, our Articles of Incorporation, Bylaws and applicable provisions of
the WBCA. Therefore, you should carefully consider the actual provisions of our Articles of Incorporation and Bylaws as well as relevant portions of the WBCA. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of our Articles
of Incorporation, our board of directors is authorized, from time to time and without further shareholder action, to issue of up to 20,000,000&nbsp;shares of preferred stock in one or more series, and to fix the designations, powers, preferences and
rights, and the qualifications, limitations or restrictions applicable to the preferred stock. As of the date of this prospectus, no&nbsp;shares of preferred stock were outstanding and our board of directors has made no provision for the issuance of
any series of preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights, preferences, privileges and restrictions of the preferred stock of each series will be fixed
by the Articles of Amendment to the Articles of Incorporation relating to that series and will be described in the applicable prospectus supplement. Our board of directors has the discretion to fix the number of&nbsp;shares of any such series and
the designation thereof, and to fix and amend the powers, preferences and rights, and the limitations or restrictions granted to or imposed upon any wholly unissued series of preferred stock, including the voting rights, dividend rights, dividend
rate, conversion rights, rights and terms of redemption (including sinking fund provisions), redemption prices and liquidation preferences of any such series. Our board of directors has authority to decrease the number of&nbsp;shares of any series
of preferred stock that is outstanding, but not below the number of&nbsp;shares of any such series then outstanding. In addition, any such reduction is subject to the powers, preferences and rights, and the qualifications, limitations and
restrictions thereof stated in the Articles of Incorporation or the board resolution originally fixing the number of&nbsp;shares of such series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issuance of preferred stock will affect, and may adversely affect, the rights of holders of common stock. It is not possible to state the
actual effect of the issuance of any&nbsp;shares of preferred stock on the rights of holders of common stock until our board of directors determines the specific rights, preferences and privileges attached to that series of preferred stock. The
effects of issuing preferred stock could include one or more of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">restricting dividends on the common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">diluting the voting power of the common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">impairing the liquidation rights of the common stock; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delaying or preventing changes in control or management of our company. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable
prospectus supplement will specify the terms of the series of preferred stock being offered, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number of&nbsp;shares of preferred stock being offered; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the designation of the series of preferred stock; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the per share purchase price of the preferred stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the dividend rate or method of determining the dividend rate, if any, including whether the dividend rate is fixed or variable; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the date or dates on which dividends will accrue and the dividend payment dates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">whether dividends will be cumulative or non-cumulative and, if cumulative, the dates from which dividends will accrue; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the price and the terms and conditions for redemption, if any, including redemption at our option or at the option of the holders, the time period for redemption, and any accumulated dividends or premiums;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the liquidation preference, if any, and any accumulated dividends upon the liquidation, dissolution or winding up of our affairs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any sinking fund or similar provision, and, if so, the terms and provisions relating to the purpose and operation of the fund; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the terms and conditions, if any, for conversion or exchange of preferred stock for any other class or classes of our securities, including the price or the rate of conversion or exchange and the method, if any, of
adjustment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the voting rights of the preferred stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any exchange on which the preferred stock will be listed; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any or all other preferences and relative, participating, optional or other special rights, privileges or qualifications, limitations or restrictions; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the material United States federal income tax consequences relating to the purchase and ownership of the series of preferred stock that is described in the prospectus supplement. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have no present plans to issue any&nbsp;shares of preferred stock nor are any&nbsp;shares of our preferred stock presently outstanding.
Preferred stock will be fully paid and nonassessable upon issuance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rank </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable prospectus supplement, the preferred stock will, with respect to distribution rights and rights
upon liquidation, dissolution or winding up of the company, rank (i)&nbsp;senior to our common stock and to any series of preferred stock which specifically provides that it will rank junior to the preferred stock being offered, (ii)&nbsp;junior to
any series of preferred stock which specifically provides that it will rank senior to the preferred stock being offered and (iii)&nbsp;on parity with any other series of preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issuance of preferred stock will affect, and may adversely affect, the rights of holders of common stock. It is not possible to state the
actual effect of the issuance of any&nbsp;shares of preferred stock on the rights of holders of common stock until our board of directors determines the specific rights attached to that preferred stock. The effects of issuing preferred stock could
include one or more of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">restricting dividends on the common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">diluting the voting power of the common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">impairing the liquidation rights of the common stock;&nbsp;or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delaying or preventing changes in control or management of our company. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividend Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of preferred stock will have the dividend rights set forth in the applicable prospectus supplement. Dividends on any series of
preferred stock, if cumulative, will be cumulative from and after the date set forth in the applicable prospectus supplement. Any restriction on the repurchase or redemption of&nbsp;shares of preferred stock while dividends on such&nbsp;shares are
in arrears shall be set forth in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will appoint a transfer agent and registrar for the preferred stock that will be set forth in the applicable prospectus supplement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Anti-Takeover Matters </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Refer to
&#147;Description of Common Stock &#151; Anti-Takeover Effects of Washington Law and our Articles of Incorporation and Bylaws&#148; for a discussion of provisions of the WBCA and our Articles of Incorporation and Bylaws that may have the effect of
delaying, deferring or preventing a change of control. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_11"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue, separately or together with, or upon conversion, exercise or exchange of other securities, debt securities, including
debentures, notes, bonds and other evidences of indebtedness as set forth in the applicable prospectus supplement. The debt securities may be either secured or unsecured and will either be senior debt securities or subordinated debt securities. The
debt securities will be issued under one or more separate indentures between us and a trustee to be specified in an accompanying prospectus supplement. Senior debt securities will be issued under a senior indenture and subordinated debt securities
will be issued under a subordinated indenture. Together, the senior indenture and the subordinated indenture are called indentures in this description. This prospectus, together with the applicable prospectus supplement, will describe the terms of a
particular series of debt securities that we may offer from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary of the material provisions of the
indentures and the debt securities does not purport to be complete and is subject to, and is qualified in its&nbsp;entirety by reference to, the provisions of the applicable indenture and certificates evidencing the applicable debt securities.
Therefore, you should carefully consider the applicable indenture and the certificate evidencing the applicable debt security that is filed as an exhibit to the registration statement that includes this prospectus. Other specific terms of the
applicable indenture and debt securities will be described in the applicable prospectus supplement. If any particular terms of the indenture or debt securities described in a prospectus supplement differ from any of the terms described below, then
the terms described below will be deemed to have been superseded by that prospectus supplement. In this description of the debt securities, the words &#147;Omeros Corporation,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148; refer only to
Omeros Corporation and not to our subsidiary, unless we otherwise expressly state or the context otherwise requires. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Debt securities may be issued in separate series without limitation as to aggregate principal amount. We may specify a maximum aggregate
principal amount for the debt securities of any series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not limited as to the amount of debt securities that we may issue under
the indentures. Unless otherwise provided in a prospectus supplement, a series of debt securities may be reopened to issue additional debt securities of such series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement relating to a particular series of debt securities will set forth the material terms of the debt securities being
offered, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the title of the debt securities and whether they are senior debt securities or subordinated debt securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the offering price; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the person who shall be entitled to receive interest, if other than the record holder on the record date; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the maturity date or dates; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the interest rate or rates, if any, which may be fixed or variable, at which the debt securities will bear interest, or the method of determining such rate or rates; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the date from which interest will accrue, the interest payment dates and the regular record dates, or the method for calculating the dates and rates; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the place or places where payments of principal and interest may be made; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any mandatory or optional redemption provisions or sinking fund provisions and any applicable redemption or purchase prices associated with these provisions; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if issued other than in denominations of U.S. $1,000 or any multiple of U.S. $1,000, the denominations in which the debt securities shall be issuable; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if applicable, the method for determining how the principal, premium, if any, or interest will be calculated by reference to an index or formula; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if other than U.S. currency, the currency or currency units in which principal, premium, if any, or interest will be payable, whether we or a holder may elect payment to be made in a different currency and the
designation of the original currency determination agent; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the portion of the principal amount that will be payable upon acceleration of maturity, if other than the entire principal amount; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if the principal amount payable at stated maturity will not be determinable as of any date prior to stated maturity, the amount or method for determining the amount which will be deemed to be the principal amount;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if applicable, whether the debt securities shall be subject to the defeasance provisions described below under &#147;Satisfaction and Discharge; Defeasance&#148; or such other defeasance provisions specified in the
applicable prospectus supplement for the debt securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any conversion or exchange provisions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">whether the debt securities will be issuable in the form of a global security; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any subordination provisions applicable to the subordinated debt securities if different from those described below under &#147;Subordinated Debt Securities&#148;; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any paying agents, authenticating agents, security registrars or other agents for the debt securities, if other than the trustee; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any provisions relating to any security provided for the debt securities, including any provisions regarding the circumstances under which collateral may be released or substituted; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any deletions of, or changes or additions to, the events of default, acceleration provisions or covenants; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any provisions relating to guaranties for the securities and any circumstances under which there may be additional obligors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any other specific terms of such debt securities. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we denominate the purchase price of any
of the debt securities in a foreign currency or currencies, or if the principal of or premium, if any, or interest on any series of debt securities is payable in a foreign currency or currencies, we will include in the applicable prospectus
supplement information on the restrictions, elections, material federal income tax considerations, specific terms and other information with respect to that issue of debt securities and the foreign currency or currencies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the prospectus supplement, the debt securities will be registered debt securities. Debt securities may be sold
at a substantial discount below their stated principal amount, bearing no interest or interest at a rate which at the time of issuance is below market rates. The U.S. federal income tax considerations applicable to debt securities sold at a discount
will be described in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exchange and Transfer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Debt securities may be transferred or exchanged at the office of the security registrar or at the office of any transfer agent designated by
us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not impose a service charge for any transfer or exchange, but we may require holders to pay any tax or other governmental
charges associated with any transfer or exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any partial redemption of debt securities of any series, we will not be
required to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">issue, register the transfer of or exchange any debt security of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption and ending at the close of
business on the day of the mailing; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">register the transfer of or exchange any debt security of that series selected for redemption, in whole or in part, except the unredeemed portion being redeemed in part. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, we will appoint the trustee as the security registrar. Any transfer agent, in addition to the security registrar initially
designated by us, will be named in the prospectus supplement. We may designate additional transfer agents or change transfer agents or change the office of the transfer agent. However, we will be required to maintain a transfer agent in each place
of payment for the debt securities of each series. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conversion or Exchange </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any debt securities being offered are convertible into or exchangeable for common stock or other securities of the company, the relevant
prospectus supplement will set forth the terms of conversion or exchange. Those terms will include whether conversion or exchange is mandatory, at the option of the holder or at our option, and the number of shares of common stock or other
securities, or the method of determining the number of shares of common stock or other securities, to be received by the holder upon conversion or exchange. These provisions may allow or require the number of shares of our common stock or other
securities to be received by the holders of such series of debt securities to be adjusted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt securities of any series may be represented, in whole or in part, by one or more global securities. Each global security will: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">be registered in the name of a depositary, or its nominee, that we will identify in a prospectus supplement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">be deposited with the depositary or nominee or custodian; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">bear any required legends. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No global security may be exchanged in whole or in part for debt
securities registered in the name of any person other than the depositary or any nominee unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the depositary has notified us that it is unwilling or unable to continue as depositary or has ceased to be qualified to act as depositary; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an event of default has occurred and is continuing with respect to the debt securities of the applicable series; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any other circumstance described in a prospectus supplement has occurred permitting or requiring the issuance of any such security. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As long as the depositary, or its nominee, is the registered owner of a global security, the
depositary or nominee will be considered the sole owner and holder of the debt securities represented by the global security for all purposes under the indentures. Except in the above limited circumstances, owners of beneficial interests in a global
security will not be: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">entitled to have the debt securities registered in their names; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">entitled to physical delivery of certificated debt securities; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">considered to be holders of those debt securities under the indenture. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments on a global
security will be made to the depositary or its nominee as the holder of the global security. Some jurisdictions have laws that require that certain purchasers of securities take physical delivery of such securities in definitive form. These laws may
impair the ability to transfer beneficial interests in a global security. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Institutions that have accounts with the depositary or its
nominee are referred to as &#147;participants.&#148; Ownership of beneficial interests in a global security will be limited to participants and to persons that may hold beneficial interests through participants. The depositary will credit, on its
book-entry registration and transfer system, the respective principal amounts of debt securities represented by the global security to the accounts of its participants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ownership of beneficial interests in a global security will be shown on and effected through records maintained by the depositary, with
respect to participants&#146; interests, or any participant, with respect to interests of persons held by participants on their behalf. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments, transfers and exchanges relating to beneficial interests in a global security will be subject to policies and procedures of the
depositary. The depositary policies and procedures may change from time to time. Neither any trustee nor we will have any responsibility or liability for the depositary&#146;s or any participant&#146;s records with respect to beneficial interests in
a global security. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Payment and Paying Agents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in a prospectus supplement, the provisions described in this paragraph will apply to the debt securities. Payment of
interest on a debt security on any interest payment date will be made to the person in whose name the debt security is registered at the close of business on the regular record date. Payment on debt securities of a particular series will be payable
at the office of a paying agent or paying agents designated by us. However, at our option, we may pay interest by mailing a check to the record holder. The trustee will be designated as our initial paying agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also name any other paying agents in a prospectus supplement. We may designate additional paying agents, change paying agents or change
the office of any paying agent. However, we will be required to maintain a paying agent in each place of payment for the debt securities of a particular series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All moneys paid by us to a paying agent for payment on any debt security that remain unclaimed for a period ending the earlier of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">10 business days prior to the date the money would be turned over to the applicable state; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at the end of two years after such payment was due, </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">will be repaid to us thereafter. The holder may look only
to us for such payment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Protection in the Event of a Change of Control </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in a prospectus supplement with respect to a particular series of debt securities, the debt securities will not
contain any provisions that may afford holders of the debt securities protection in the event we have a change in control or in the event of a highly leveraged transaction, whether or not such transaction results in a change in control. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Covenants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in
a prospectus supplement with respect to a particular series of debt securities, the debt securities will not contain any financial or restrictive covenants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger and Sale of Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in a prospectus supplement with respect to a particular series of debt securities, we may not consolidate with or
merge into any other person, in a transaction in which we are not the surviving corporation, or convey, transfer or lease our properties and assets substantially as an entirety to, any entity, unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the successor entity, if any, is a corporation, limited liability company, partnership, trust or other business entity existing under the laws of the United States, any State within the United States or the District of
Columbia; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the successor entity assumes our obligations on the debt securities and under the applicable indenture; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">immediately after giving effect to the transaction, no default or event of default shall have occurred and be continuing; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">certain other conditions specified in the indenture are met. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we indicate otherwise in a prospectus supplement with respect to a particular series of debt securities, the following will be events of
default for any series of debt securities under the indentures: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">we fail to pay any interest on any debt security of that series when it becomes due and we subsequently fail to pay such interest for 30 days; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">we fail to pay principal of or any premium on any debt security of that series when due; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">we fail to deposit any sinking fund payment when due; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">we fail to perform any other covenant in the applicable indenture and such failure continues for 90 days after we are given the notice required in the indentures; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">certain events including our bankruptcy, insolvency or reorganization. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional or
different events of default applicable to a series of debt securities may be described in a prospectus supplement. An event of default of one series of debt securities is not necessarily an event of default for any other series of debt securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trustee may withhold notice to the holders of any default, except defaults in the payment of principal, premium, if any, interest,
any sinking fund installment on, or with respect to any conversion right of, the debt securities of such series. However, the trustee must consider it to be in the interest of the holders of the debt securities of such series to withhold this
notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we indicate otherwise in a prospectus supplement, if an event of default, other than an event of default described in
clause (5)&nbsp;above, shall occur and be continuing with respect to any series of debt securities, either the trustee or the holders of at least 25% in aggregate principal amount of the outstanding securities of that
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
series may declare the principal amount and premium, if any, of the debt securities of that series, or if any debt securities of that series are original issue discount securities, such other
amount as may be specified in the applicable prospectus supplement, in each case together with accrued and unpaid interest, if any, thereon, to be due and payable immediately. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an event of default described in clause (5)&nbsp;above shall occur, the principal amount and premium, if any, of all the debt securities of
that series, or if any debt securities of that series are original issue discount securities, such other amount as may be specified in the applicable prospectus supplement, in each case together with accrued and unpaid interest, if any, thereon,
will automatically become immediately due and payable without any declaration or other action on the part of the trustee or any holder. Any payment by us on the subordinated debt securities following any such acceleration will be subject to the
subordination provisions described below under &#147;Subordinated Debt Securities.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After acceleration, the holders of a majority in
aggregate principal amount of the outstanding securities of that series may, under certain circumstances, rescind and annul such acceleration if all events of default, other than the non-payment of accelerated principal, or other specified amounts
or interest, have been cured or waived. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the duty to act with the required care during an event of default, the trustee will
not be obligated to exercise any of its rights or powers at the request of the holders unless the holders shall have offered to the trustee reasonable indemnity. Generally, the holders of a majority in aggregate principal amount of the outstanding
debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A holder of debt securities of any series will not have any right to institute any proceeding under the indentures, or for the appointment of
a receiver or a trustee, or for any other remedy under the indentures, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">the holder has previously given to the trustee written notice of a continuing event of default with respect to the debt securities of that series; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">the holders of at least a majority in aggregate principal amount of the outstanding debt securities of that series have made a written request and have offered reasonable indemnity to the trustee to institute the
proceeding; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">the trustee has failed to institute the proceeding and has not received direction inconsistent with the original request from the holders of a majority in aggregate principal amount of the outstanding debt securities of
that series within 60 days after the original request. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders may, however, sue to enforce the payment of principal,
premium or interest on any debt security on or after the due date or to enforce the right, if any, to convert any debt security (if the debt security is convertible) without following the procedures listed in clauses (1)&nbsp;through (3)&nbsp;above.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will furnish the trustee an annual statement by our officers as to whether or not we are in default in the performance of the
conditions and covenants under the indenture and, if so, specifying all known defaults. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we indicate otherwise in a prospectus supplement, we and the applicable trustee may make modifications and amendments to an indenture
with the consent of the holders of a majority in aggregate principal amount of the outstanding securities of each series affected by the modification or amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also make modifications and amendments to the indentures for the benefit of holders without their consent, for certain purposes
including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">providing for our successor to assume the covenants under the indenture; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">adding covenants or events of default; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">making certain changes to facilitate the issuance of the securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">securing the securities, including provisions relating to the release or substitution of collateral; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">providing for guaranties of, or additional obligors on, the securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">providing for a successor trustee or additional trustees; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">curing any ambiguities or inconsistencies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">permitting or facilitating the defeasance and discharge of the securities; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">other changes specified in the indenture. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, neither we nor the trustee may make any
modification or amendment without the consent of the holder of each outstanding security of that series affected by the modification or amendment if such modification or amendment would: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">change the stated maturity of any debt security; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduce the principal, premium, if any, or interest on any debt security or any amount payable upon redemption or repurchase, whether at our option or the option of any holder, or reduce the amount of any sinking fund
payments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduce the principal of an original issue discount security or any other debt security payable on acceleration of maturity; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">change the place of payment or the currency in which any debt security is payable; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">impair the right to enforce any payment after the stated maturity or redemption date; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if subordinated debt securities, modify the subordination provisions in a materially adverse manner to the holders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">adversely affect the right to convert any debt security if the debt security is a convertible debt security; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">change the provisions in the indenture that relate to modifying or amending the indenture. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Satisfaction
and Discharge; Defeasance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be discharged from our obligations on the debt securities, subject to limited exceptions, of any
series that have matured or will mature or be redeemed within one year if we deposit enough money with the trustee to pay all of the principal, interest and any premium due to the stated maturity date or redemption date of the debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each indenture contains a provision that permits us to elect either or both of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We may elect to be discharged from all of our obligations, subject to limited exceptions, with respect to any series of debt securities then outstanding. If we make this election, the holders of the debt securities of
the series will not be entitled to the benefits of the indenture, except for the rights of holders to receive payments on debt securities or the registration of transfer and exchange of debt securities and replacement of lost, stolen or mutilated
debt securities. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We may elect to be released from our obligations under some or all of any financial or restrictive covenants applicable to the series of debt securities to which the election relates and from the consequences of an
event of default resulting from a breach of those covenants. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To make either of the above elections, we must irrevocably
deposit in trust with the trustee enough money to pay in full the principal, interest and premium on the debt securities. This amount may be made in cash and/or U.S. government obligations or, in the case of debt securities denominated in a currency
other than U.S. dollars, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cash in the currency in which such series of securities is denominated and/or foreign government obligations. As a condition to either of the above elections, for debt securities denominated in
U.S. dollars we must deliver to the trustee an opinion of counsel that the holders of the debt securities will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Foreign government obligations&#148; means, with respect to debt securities of any series that are denominated in a currency other than
United States dollars: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">direct obligations of the government that issued or caused to be issued the currency in which such securities are denominated and for the payment of which obligations its full faith and credit is pledged, or, with
respect to debt securities of any series which are denominated in euros, direct obligations of certain members of the European Union for the payment of which obligations the full faith and credit of such members is pledged, which in each case are
not callable or redeemable at the option of the issuer thereof; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obligations of a person controlled or supervised by or acting as an agency or instrumentality of a government described in the bullet above, the timely payment of which is unconditionally guaranteed as a full faith and
credit obligation by such government, which are not callable or redeemable at the option of the issuer thereof; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any depository receipt issued by a bank as custodian with respect to any obligation specified in the first two bullet points and held by such bank for the account of the holder of such deposit any receipt, or with
respect to any such obligation which is so specified and held. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notices </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices to holders will be given by mail to the addresses of the holders in the security register. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indentures and the
debt securities will be governed by, and construed under, the laws of the State of New York. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Personal Liability of Directors, Officers, Employees
and Shareholders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No incorporator, shareholder, employee, agent, officer, director or subsidiary of ours will have any liability for
any obligations of ours, or because of the creation of any indebtedness under the debt securities, the indentures or supplemental indentures. The indentures provide that all such liability is expressly waived and released as a condition of, and as a
consideration for, the execution of such indentures and the issuance of the debt securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regarding the Trustee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indentures limit the right of the trustee, should it become our creditor, to obtain payment of claims or secure its claims. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trustee is permitted to engage in certain other transactions with us. However, if the trustee acquires any conflicting interest, and there
is a default under the debt securities of any series for which it is trustee, the trustee must eliminate the conflict or resign. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
accompanying prospectus supplement will specify the trustee for the particular series of debt securities to be issued under the indentures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subordinated Debt Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following provisions will be applicable with respect to each series of subordinated debt securities, unless otherwise stated in the prospectus supplement relating to that series of subordinated debt securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indebtedness evidenced by the subordinated debt securities of any series is subordinated, to
the extent provided in the subordinated indenture and the applicable prospectus supplement, to the prior payment in full, of all senior debt, including any senior debt securities, in cash or other payment satisfactory to the holders of senior debt.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any distribution of our assets upon any dissolution, winding up, liquidation or reorganization, whether voluntary or involuntary,
marshalling of assets, assignment for the benefit of creditors, or in bankruptcy, insolvency, receivership or other similar proceedings, payments on the subordinated debt securities will be subordinated in right of payment to the prior payment in
full in cash or other payment satisfactory to holders of senior debt of all senior debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any acceleration of the
subordinated debt securities of any series because of an event of default with respect to the subordinated debt securities of that series, holders of any senior debt would be entitled to payment in full in cash or other payment satisfactory to
holders of senior debt of all senior debt before the holders of subordinated debt securities are entitled to receive any payment or distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the subordinated debt securities will be structurally subordinated to all indebtedness and other liabilities of our subsidiaries,
including trade payables and lease obligations. This occurs because our right to receive any assets of our subsidiaries upon their liquidation or reorganization, and your right to participate in those assets, will be effectively subordinated to the
claims of that subsidiary&#146;s creditors, including trade creditors, except to the extent that we are recognized as a creditor of such subsidiary. If we are recognized as a creditor of that subsidiary, our claims would still be subordinate to any
security interest in the assets of the subsidiary and any indebtedness of the subsidiary senior to us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to promptly notify
holders of senior debt or their representatives under the subordinated indenture if payment of the subordinated debt securities is accelerated because of an event of default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the subordinated indenture, we may also not make payment on the subordinated debt securities if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a default in our obligations to pay principal, premium, if any, interest or other amounts on our senior debt occurs and the default continues beyond any applicable grace period, which we refer to as a payment default;
or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a nonpayment default occurs and is continuing with respect to designated senior debt that permits holders of designated senior debt to accelerate its maturity, and the trustee receives a payment blockage notice from us
or some other person permitted to give the notice under the subordinated indenture, which we refer to as a non-payment default. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may and shall resume payments on the subordinated debt securities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in case of a payment default, when the default is cured or waived or ceases to exist; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in case of a nonpayment default, the earlier of when the default is cured or waived or ceases to exist or 179 days after the receipt of the payment blockage notice. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No new payment blockage period may start on the basis of a nonpayment default unless at least 365 days have elapsed from the initial
effectiveness of the immediately prior payment blockage notice. No nonpayment default that existed or was continuing on the date of delivery of any payment blockage notice to the trustee shall be the basis for a subsequent payment blockage notice.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of these subordination provisions, in the event of our bankruptcy, dissolution or reorganization, holders of senior debt may
receive more, ratably, and holders of the subordinated debt securities may receive less, ratably, than our other creditors. The subordination provisions will not prevent the occurrence of any event of default under the subordinated indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The subordination provisions will not apply to payments from money or government obligations held
in trust by the trustee for the payment of principal, interest and premium, if any, on subordinated debt securities pursuant to the provisions described under &#147;Satisfaction and Discharge; Defeasance,&#148; if the subordination provisions were
not violated at the time the money or government obligations were deposited into trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the trustee or any holder receives any payment
that should not have been made to them in contravention of subordination provisions before all senior debt is paid in full in cash or other payment satisfactory to holders of senior debt, then such payment will be held in trust for the holders of
senior debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Senior debt securities will constitute senior debt under the subordinated indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional or different subordination provisions may be described in a prospectus supplement relating to a particular series of debt
securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Definitions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Designated senior debt</I>&#148; means our obligations under any particular senior debt in which the instrument creating or evidencing
the same or the assumption or guarantee thereof, or related agreements or documents to which we are a party, expressly provides that such indebtedness shall be designated senior debt for purposes of the subordinated indenture. The instrument,
agreement or other document evidencing any designated senior debt may place limitations and conditions on the right of such senior debt to exercise the rights of designated senior debt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Indebtedness</I>&#148; means the following, whether absolute or contingent, secured or unsecured, due or to become due, outstanding
on the date of the indenture for such series of securities or thereafter created, incurred or assumed: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our indebtedness evidenced by a credit or loan agreement, note, bond, debenture or other written obligation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all of our obligations for money borrowed; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all of our obligations evidenced by a note or similar instrument given in connection with the acquisition of any businesses, properties or assets of any kind, </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our obligations: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>as lessee under leases required to be capitalized on the balance sheet of the lessee under generally accepted accounting principles, or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>as lessee under other leases for facilities, capital equipment or related assets, whether or not capitalized, entered into or leased for financing purposes;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all of our obligations under interest rate and currency swaps, caps, floors, collars, hedge agreements, forward contracts or similar agreements or arrangements; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all of our obligations with respect to letters of credit, bankers&#146; acceptances and similar facilities, including reimbursement obligations with respect to the foregoing; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all of our obligations issued or assumed as the deferred purchase price of property or services, but excluding trade accounts payable and accrued liabilities arising in the ordinary course of business;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all obligations of the type referred to in the above clauses of another person and all dividends of another person, the payment of which, in either case, we have assumed or guaranteed, for which we are responsible or
liable, directly or indirectly, jointly or severally, as obligor, guarantor or otherwise, or which are secured by a lien on our property; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">renewals, extensions, modifications, replacements, restatements and refundings of, or any indebtedness or obligation issued in exchange for, any such indebtedness or obligation described in the above clauses of this
definition. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Senior debt</I>&#148; means the principal of, premium, if any, and interest, including
all interest accruing subsequent to the commencement of any bankruptcy or similar proceeding, whether or not a claim for post-petition interest is allowable as a claim in any such proceeding, on, and all fees and other amounts payable in connection
with, our indebtedness. Senior debt shall not include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any debt or obligation if its terms or the terms of the instrument under which or pursuant to which it is issued expressly provide it shall not be senior in right of payment to the subordinated debt securities or
expressly provide that such indebtedness is on the same basis or &#147;junior&#148; to the subordinated debt securities; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">debt to any of our subsidiaries. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Subsidiary&#148; </I>means an entity more than 50%
of the outstanding voting stock of which is owned, directly or indirectly, by us or by one or more of our other subsidiaries or by a combination of us and our other subsidiaries. For purposes of this definition, &#147;voting stock&#148; means stock
or other similar interests to us which ordinarily has or have voting power for the election of directors, or persons performing similar functions, whether at all times or only so long as no senior class of stock or other interests has or have such
voting power by reason of any contingency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_12"></A>DESCRIPTION OF DEPOSITARY SHARES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may elect to offer fractional interests in&nbsp;shares of preferred stock, in which case we will issue to the public receipts for
depositary&nbsp;shares and each of these depositary&nbsp;shares will represent a fraction of a share of the applicable series of preferred stock, as set forth in the applicable prospectus supplement. The following summary of the terms of the
depositary&nbsp;shares does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the terms of the depositary&nbsp;shares and preferred stock, as well as the form of the deposit agreement, our Articles of
Incorporation and the Articles of Amendment relating to the applicable series of preferred stock that are, or will be, filed with the SEC. Therefore, you should carefully consider the actual provisions of these documents. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each owner of a depositary share
will be entitled, in proportion to the applicable fractional interest in&nbsp;shares of preferred stock underlying that depositary share, to all rights and preferences of the preferred stock underlying that depositary share. These rights may include
dividend, voting, redemption and liquidation rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The&nbsp;shares of preferred stock underlying the depositary&nbsp;shares will be
deposited with a bank or trust company selected by us to act as depositary, under a deposit agreement between us, the depositary and the holders of the depositary receipts. The depositary will be the transfer agent, registrar and dividend disbursing
agent for the depositary&nbsp;shares. The name and address of the principal executive office of the depositary will be included in the prospectus supplement relating to the issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary&nbsp;shares will be evidenced by depositary receipts issued pursuant to the depositary agreement. Holders of depositary
receipts agree to be bound by the deposit agreement, which requires holders to take certain actions such as filing proof of residence and paying certain charges. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends and Other Distributions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
depositary will distribute cash dividends or other cash distributions, if any, received in respect of the series of preferred stock underlying the depositary&nbsp;shares to the record holders of depositary receipts in proportion to the number of
depositary&nbsp;shares owned by those holders on the relevant record date. The relevant record date for depositary&nbsp;shares will be the same date as the record date for the preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a distribution other than in cash, the depositary will distribute property received by it to the record holders of depositary
receipts that are entitled to receive the distribution, unless the depositary determines that it is not feasible to make the distribution. If this occurs, the depositary, with our approval, may adopt another method for the distribution, including
selling the property and distributing the net proceeds to the holders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidation Preference </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a series of preferred stock underlying the depositary&nbsp;shares has a liquidation preference, in the event of our voluntary or involuntary
liquidation, dissolution or winding up, holders of depositary&nbsp;shares will be entitled to receive the fraction of the liquidation preference accorded each share of the applicable series of preferred stock, as set forth in the applicable
prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a series of preferred stock underlying the depositary&nbsp;shares is subject to redemption, the depositary&nbsp;shares will be redeemed from
the proceeds received by the depositary resulting from the redemption, in whole or in part, of the preferred stock held by the depositary. Whenever we redeem any preferred stock held by the depositary, the depositary will redeem, as of the same
redemption date, the number of depositary&nbsp;shares representing the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
preferred stock so redeemed. The depositary will mail the notice of redemption to the record holders of the depositary receipts promptly upon receiving the notice from us and no fewer than 20 nor
more than 60 days, unless otherwise provided in the applicable prospectus supplement, prior to the date fixed for redemption of the preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the date fixed for redemption, the depositary&nbsp;shares called for redemption will no longer be outstanding. When the
depositary&nbsp;shares are no longer outstanding, all rights of the holders will end, except the right to receive money, securities or other property payable upon redemption. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon receipt of notice of any
meeting at which the holders of preferred stock are entitled to vote, the depositary will mail the information contained in the notice of meeting to the record holders of the depositary receipts underlying the preferred stock. Each record holder of
those depositary receipts on the record date will be entitled to instruct the depositary as to the exercise of the voting rights pertaining to the amount of preferred stock underlying that holder&#146;s depositary&nbsp;shares. The record date for
the depositary will be the same date as the record date for the preferred stock. The depositary will try, as far as practicable, to vote the preferred stock underlying the depositary&nbsp;shares in accordance with these instructions. We will agree
to take all action that may be deemed necessary by the depositary in order to enable the depositary to vote the preferred stock in accordance with these instructions. The depositary will not vote the preferred stock to the extent that it does not
receive specific instructions from the holders of depositary receipts. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Withdrawal of Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Owners of depositary&nbsp;shares will be entitled to receive upon surrender of depositary receipts at the principal office of the depositary
and payment of any unpaid amount due to the depositary, the number of whole&nbsp;shares of preferred stock underlying their depositary&nbsp;shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Partial&nbsp;shares of preferred stock will not be issued. Holders of preferred stock will not be entitled to deposit the&nbsp;shares under
the deposit agreement or to receive depositary receipts evidencing depositary&nbsp;shares for the preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment and Termination of the
Deposit Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The form of depositary receipt evidencing the depositary&nbsp;shares and any provision of the deposit agreement may
be amended by agreement between the depositary and us. However, any amendment which materially and adversely alters the rights of the holders of depositary&nbsp;shares, other than fee changes, will not be effective unless the amendment has been
approved by at least a majority of the outstanding depositary&nbsp;shares. The deposit agreement may be terminated by the depositary or us only if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all outstanding depositary&nbsp;shares have been redeemed; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">there has been a final distribution of the preferred stock in connection with our dissolution and such distribution has been made to all the holders of depositary&nbsp;shares. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Charges of Depositary </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay all
transfer and other taxes and governmental charges arising solely from the existence of the depositary arrangement. We will also pay charges of the depositary in connection with: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the initial deposit of the preferred stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the initial issuance of the depositary&nbsp;shares; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any redemption of the preferred stock; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all withdrawals of preferred stock by owners of depositary&nbsp;shares. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of depositary receipts will pay transfer, income and other taxes and governmental charges
and other specified charges as provided in the deposit agreement for their accounts. If these charges have not been paid, the depositary may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refuse to transfer depositary&nbsp;shares; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">withhold dividends and distributions; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">sell the depositary&nbsp;shares evidenced by the depositary receipt. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Miscellaneous </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary will forward to the holders of depositary receipts all reports and communications we deliver to the depositary that we are
required to furnish to the holders of the preferred stock. In addition, the depositary will make available for inspection by holders of depositary receipts at the principal office of the depositary, and at such other places as it may from time to
time deem advisable, any reports and communications we deliver to the depositary as the holder of preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor the
depositary will be liable if either we or the depositary are prevented or delayed by law or any circumstance beyond the control of either the depositary or us in performing our respective obligations under the deposit agreement. Our obligations and
the depositary&#146;s obligations will be limited to the performance in good faith of our or the depositary&#146;s respective duties under the deposit agreement. Neither we nor the depositary will be obligated to prosecute or defend any legal
proceeding in respect of any depositary&nbsp;shares or preferred stock unless satisfactory indemnity is furnished. The depositary and we may rely on: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">written advice of counsel or accountants; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">information provided by holders of depositary receipts or other persons believed in good faith to be competent to give such information; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">documents believed to be genuine and to have been signed or presented by the proper party or parties. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Resignation and Removal of Depositary </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary may resign at any time by delivering a notice to us. We may remove the depositary at any time. Any such resignation or removal
will take effect upon the appointment of a successor depositary and its acceptance of such appointment. The successor depositary must be appointed within 60 days after delivery of the notice for resignation or removal. The successor depositary must
be a bank and trust company having its principal office in the United States of America and having a combined capital and surplus of at least $50,000,000. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_13"></A>DESCRIPTION OF WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue warrants for the purchase of common stock, preferred stock, debt securities or any combination thereof. Warrants may be issued
independently or together with common stock, preferred stock or debt securities and may be attached to or separate from any offered securities. Each series of warrants will be issued under a separate warrant agreement, the terms of which will be
described in the applicable prospectus supplement. The following summary of the terms of the warrants does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the terms of the warrants as well as the form
of warrant agreement and the terms of the applicable underlying securities. Therefore, you should carefully consider the actual provisions of these documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The particular terms of any issue of warrants will be described in the prospectus supplement relating to the issue. Those terms may include:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number of&nbsp;shares of common stock or preferred stock purchasable upon the exercise of warrants to purchase such&nbsp;shares and the price at which such number of&nbsp;shares may be purchased upon such exercise;
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the designation, stated value and terms (including, without limitation, liquidation, dividend, conversion and voting rights) of the series of preferred stock purchasable upon exercise of warrants to purchase preferred
stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the principal amount of debt securities that may be purchased upon exercise of a debt warrant and the exercise price for the warrants, which may be payable in cash, securities or other property; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the date(s) on which the right to exercise the warrants will commence and the date(s) on which the right will expire; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">United States federal income tax consequences applicable to the warrants; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provision for changes to or adjustments in the exercise price; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the terms of any anti-dilution or other adjustment provisions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the terms of any mandatory or optional call provisions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if applicable, the date on and after which the warrants and the common stock, preferred stock or debt securities underlying the warrants will be separately transferable; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">information with respect to book entry procedures; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the identity of the warrant agent; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any additional terms of the warrants, including terms, procedures, and limitations relating to the exchange, exercise and settlement of the warrants. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of equity warrants will not be entitled to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">vote, consent or receive dividends; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">receive notice as shareholders with respect to any meeting of shareholders for the election of our directors or any other matter; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">exercise any rights as shareholders of Omeros Corporation. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Debt warrant certificates will be
exchangeable for new debt warrant certificates of different denominations. Debt warrants may be exercised at the corporate trust office of the warrant agent or any other office indicated in the prospectus supplement. Prior to the exercise of their
debt warrants, holders of debt warrants will not have any of the rights of holders of the debt securities purchasable upon exercise and will not be entitled to payment of principal or premium, if any, or interest on the debt securities purchasable
upon exercise. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_14"></A>DESCRIPTION OF SUBSCRIPTION RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue subscription rights to purchase&nbsp;shares of our common stock or preferred stock. These subscription rights may be issued
independently or together with any other security offered hereby and may or may not be transferable by the shareholder receiving the subscription rights in such offering. In connection with any offering of subscription rights, we may enter into a
standby arrangement with one or more underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement relating to any offering of subscription rights will include specific terms relating to the offering, including:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the price, if any, for the subscription rights; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the exercise price payable for each share of common stock or preferred stock upon the exercise of the subscription rights; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number of subscription rights to be offered to each shareholder; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number and terms of the&nbsp;shares of common stock or preferred stock which may be purchased per each subscription right; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the extent to which the subscription rights are transferable; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any other terms of the subscription rights, including the procedures and limitations relating to the exchange and exercise of the subscription rights; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the dates on which the right to exercise the subscription rights shall commence and expire; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the extent to which the subscription rights may include an over-subscription privilege with respect to unsubscribed securities or an over-allotment privilege to the extent the securities are fully subscribed; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if applicable, the material terms of any standby underwriting or purchase arrangement that we may enter into in connection with the offering of subscription rights. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preceding summary of the terms of the subscription rights does not purport to be complete and is subject to, and is qualified in its
entirety by reference to, the terms of the subscription rights being offered, as well as any applicable subscription rights certificate and the terms of the securities to which the subscription rights relate. Therefore, you should carefully consider
the actual provisions of the subscription right, and subscription agreement and the applicable securities. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_15"></A>DESCRIPTION OF UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue units comprised of one or more of the other securities described in this prospectus or any prospectus supplement in any
combination. Each unit will be issued so that the holder of the unit is also the holder, with the rights and obligations of a holder, of each security included in the unit. The units may be issued under unit agreements to be entered into between us
and a unit agent, which may provide that the securities included in the unit may not be held or transferred separately, at any time or times before a specified date or upon the occurrence of a specified event or occurrence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable prospectus supplement will describe: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances the securities comprising the units may be held or transferred separately;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a description of the terms of any unit agreement governing the units; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a description of the provisions for the payment, settlement, transfer or exchange of the units; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a discussion of material federal income tax considerations, if applicable;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">whether the units if issued as a separate security will be issued in fully registered or global form. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preceding summary of the terms of the units does not purport to be complete and is subject to, and is qualified in its entirety by
reference to, the terms of the units being offered, as well as any applicable unit agreement and the terms of the applicable classes of securities comprising the unit. Therefore, you should carefully consider the actual provisions of the unit, any
unit agreement and the applicable securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_16"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell the securities offered under this prospectus from time to time pursuant to underwritten public offerings, negotiated transactions,
block trades or a combination of these methods or through underwriters, dealers or agents or directly to one or more purchasers. The securities may be distributed from time to time in one or more transactions at: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a fixed price or prices, which may be changed; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">market prices prevailing at the time of sale; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">prices related to the prevailing market price; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">negotiated prices. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each time that we sell securities pursuant to this prospectus, we will
provide a prospectus supplement or supplements that will describe the method of distribution and set forth the terms and conditions of the offering of such securities, including the following information: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the terms of the offering; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the names of any underwriters, dealers or agents; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the name or names of any managing underwriter or underwriters; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the purchase price of the securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the net proceeds from the sale of the securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any underwriting discounts, concessions, commissions or agency fees and other items constituting underwriters&#146;, dealers&#146; or agents&#146; compensation; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any delayed delivery arrangements; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">estimated offering expenses. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may grant to the underwriters options to purchase additional
securities to cover over-allotments, if any, at the public offering price, with additional underwriting commissions or discounts, as applicable, set forth in the prospectus supplement. The terms of any over-allotment option will be set forth in the
prospectus supplement for those securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may engage in at-the-market offerings into an existing trading market in accordance with
Rule&nbsp;415(a)(4) under the Securities Act. Any at-the-market offering will be through an underwriter or underwriters acting as principal or agent for us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue to our existing security holders, through a dividend or similar distribution, subscription rights to purchase&nbsp;shares of our
common stock or preferred stock, which may or may not be transferable. In any distribution of subscription rights to our existing security holders, if all of the underlying securities are not subscribed for, we may then sell the unsubscribed
securities directly to third parties or may engage the services of one or more underwriters, dealers or agents, including standby underwriters, to sell the unsubscribed securities to third parties. The applicable prospectus supplement will describe
the specific terms of any offering of our common stock or preferred stock through the issuance of subscription rights, including, if applicable, the material terms of any standby underwriting or purchase arrangement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sale Through Underwriters or Dealers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
underwriters are used in the sale, the underwriters will acquire the securities for their own account, including through underwriting, purchase, security lending or repurchase agreements with us. The underwriters may resell the securities from time
to time in one or more transactions, including negotiated transactions. Underwriters may sell the securities in order to facilitate transactions in any of our other securities (described in this prospectus or otherwise), including other public or
private transactions and short sales. Underwriters may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
offer securities to the public either through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting as underwriters. Unless otherwise
indicated in the prospectus supplement, the obligations of the underwriters to purchase the securities will be subject to certain conditions, and the underwriters will be obligated to purchase all the offered securities if they purchase any of them.
The underwriters may change from time to time any initial public offering price and any discounts or concessions allowed or reallowed or paid to dealers. The prospectus supplement will include the names of the underwriters and the terms of the
transaction, including any underwriting discounts or commissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If dealers are used in the sale of securities offered through this
prospectus, we will sell the securities to them as principals. They may then resell those securities to the public at varying prices determined by the dealers at the time of resale. The prospectus supplement will include the names of the dealers and
the terms of the transaction, including any discounts or commissions received. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Direct Sales and Sales Through Agents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell the securities offered through this prospectus directly. In this case, no underwriters, dealers or agents would be involved. Such
securities may also be sold through agents designated from time to time. The prospectus supplement will name any agent involved in the offer or sale of the offered securities and will describe any commissions payable to the agent. Unless otherwise
indicated in the prospectus supplement, any agent will agree to use its reasonable best efforts to solicit purchases for the period of its appointment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell the securities directly to institutional investors or others who may be deemed to be underwriters within the meaning of the
Securities Act with respect to any sale of those securities. The terms of any such sales will be described in the prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delayed
Delivery Contracts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the prospectus supplement indicates, we may authorize underwriters, dealers or agents to solicit offers from
certain types of institutions to purchase securities at the public offering price under delayed delivery contracts. These contracts would provide for payment and delivery on a specified date in the future. The contracts would be subject only to
those conditions described in the prospectus supplement. The applicable prospectus supplement will describe the commission payable for solicitation of those contracts. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Making, Stabilization and Other Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the applicable prospectus supplement states otherwise, all preferred stock, debt securities, depositary&nbsp;shares, warrants,
subscription rights and units will be new issues of securities with no established trading market. Unless indicated in the applicable prospectus supplement, we do not expect to list the offered securities on a securities exchange, except for our
common stock, which is listed on The NASDAQ Global Market. Any underwriters that we use in the sale of offered securities may make a market in such securities, but may discontinue such market making at any time without notice. Therefore, we cannot
assure you that the securities will have a liquid trading market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any underwriter may also engage in stabilizing transactions, syndicate
covering transactions and penalty bids in accordance with Rule&nbsp;104 of Regulation M under the Exchange Act. Stabilizing transactions involve bids to purchase the underlying security in the open market for the purpose of preventing or retarding a
decline in the price of the securities. Syndicate covering transactions involve purchases of the securities in the open market after the distribution has been completed in order to cover syndicate short positions. Penalty bids permit the
underwriters to reclaim a selling concession from a syndicate member when the securities originally sold by the syndicate member are purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price of
our securities or preventing or retarding a decline in the market price of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities. As a result, the price of the securities in the open market may be higher than it would otherwise be in the absence of these transactions. The underwriters may, if they commence these
transactions, discontinue them at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Derivative Transactions and Hedging </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, the underwriters or other agents may engage in derivative transactions involving the securities. These derivatives may consist of short
sale transactions and other hedging activities. The underwriters or agents may acquire a long or short position in the securities, hold or resell securities acquired and purchase options or futures on the securities and other derivative instruments
with returns linked to or related to changes in the price of the securities. In order to facilitate these derivative transactions, we may enter into security lending or repurchase agreements with the underwriters or agents. The underwriters or
agents may effect the derivative transactions through sales of the securities to the public, including short sales, or by lending the securities in order to facilitate short sale transactions by others. The underwriters or agents may also use the
securities purchased or borrowed from us or others (or, in the case of derivatives, securities received from us in settlement of those derivatives) to directly or indirectly settle sales of the securities or close out any related open borrowings of
the securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Auctions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also make sales through the Internet or through other electronic means. Since we may from time to time elect to offer securities
directly to the public, with or without the involvement of agents, underwriters or dealers, utilizing the Internet or other forms of electronic bidding or ordering systems for the pricing and allocation of such securities, you will want to pay
particular attention to the description of that system, which we will provide in a prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such electronic system may
allow bidders to directly participate, through electronic access to an auction site, by submitting conditional offers to buy that are subject to acceptance by us, and which may directly affect the price or other terms and conditions at which such
securities are sold. These bidding or ordering systems may present to each bidder, on a so-called &#147;real-time&#148; basis, relevant information to assist in making a bid, such as the clearing spread at which the offering would be sold, based on
the bids submitted, and whether a bidder&#146;s individual bids would be accepted, prorated or rejected. For example, in the case of debt security, the clearing spread could be indicated as a number of &#147;basis points&#148; above an index
treasury note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon completion of such an electronic auction process, securities will be allocated based on prices bid, terms of bid or
other factors. The final offering price at which securities would be sold and the allocation of securities among bidders would be based in whole or in part on the results of the Internet or other electronic bidding process or auction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The specific terms
of any lock-up provisions in respect of any given offering will be described in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters,
dealers and agents may be entitled, under agreements entered into with us, to indemnification by us against certain liabilities, including liabilities under the Securities Act. Our underwriters, dealers and agents, or their affiliates, may be
customers of, engage in transactions with or perform services for us, in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In compliance with guidelines
of the Financial Industry Regulatory Authority, Inc., or FINRA, and unless otherwise disclosed in the applicable prospectus supplement, we do not intend for the maximum consideration or discount to be received by any FINRA member or independent
broker dealer to exceed 8.0% of the aggregate amount of the securities offered pursuant to this prospectus and any applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which
they receive customary compensation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_17"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of any offered securities will be passed upon by Mark A. Metcalf, our Associate General Counsel, Corporate Finance and Governance
and Assistant Secretary, and Covington&nbsp;&amp; Burling LLP, Washington, D.C., and for any underwriters, dealers or agents by counsel as may be specified in the applicable prospectus supplement. As of December 31, 2014, Mr.&nbsp;Metcalf held
options under our 2008 Equity Incentive Plan to purchase up to 42,700&nbsp;shares of our common stock, and he was eligible to receive additional equity awards under such plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional legal matters may be passed upon for us, or any underwriters, dealers or agents, by counsel that we will name in the applicable
prospectus supplement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom825446_18"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Omeros Corporation appearing in Omeros Corporation&#146;s Annual Report (Form&nbsp;10-K) for the year
ended December&nbsp;31, 2013, and the effectiveness of Omeros Corporation&#146;s internal control over financial reporting as of December&nbsp;31, 2013, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as
set forth in their reports thereon (which contain an explanatory paragraph describing conditions that raise substantial doubt about the Company&#146;s ability to continue as a going concern as described in Note 1 to the consolidated financial
statements) included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein in reliance upon the reports of Ernst &amp;&nbsp;Young LLP pertaining to such consolidated financial statements and
the effectiveness of internal control over financial reporting as of the respective dates given on the authority of such firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;14.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Expenses of Issuance and Distribution </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the various
costs and expenses (other than the underwriting discounts and commissions) payable by the registrant in connection with the sale of the securities being registered. All amounts are estimates except the SEC registration fee. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NASDAQ Global Market listing fee</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and engraving costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent fees and expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee fees and expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of the registration fee associated with this registration statement. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top">These fees are calculated on the securities offered and the number of issuances and accordingly cannot be estimated at this time. The applicable prospectus supplement will set forth the estimated amount of expenses
incurred in connection with securities to be offered and sold pursuant to this registration statement. </TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;15.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Indemnification of Directors and Officers </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 23B.08.510 and 23B.08.570 of the
Washington Business Corporation Act, or WBCA, authorize Washington corporations to indemnify directors and officers under certain circumstances against expenses and liabilities incurred in legal proceedings in which they are involved by reason of
being director or officer. Section&nbsp;23B.08.560 of the WBCA authorizes a corporation by provision in its articles of incorporation or in a bylaw approved by its shareholders to indemnify or agree to indemnify a director made a party to a
proceeding, or obligate itself to advance or reimburse expenses incurred in a proceeding, without regard to the limitations imposed by Sections 23B.08.510 through 23B.08.550 of the WBCA; provided, however, that no such indemnity shall indemnify any
director from or on account of (a)&nbsp;acts or omissions of the director finally adjudged to be intentional misconduct or a knowing violation of law, (b)&nbsp;conduct of the director finally adjudged to be in violation of Section&nbsp;23B.08.310 of
the WBCA (relating to unlawful distributions) or (c)&nbsp;any transaction with respect to which it was finally adjudged that such director personally received a benefit in money, property or services to which the director was not legally entitled.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Article XI of our Articles of Incorporation and Article VII of our Bylaws require that we indemnify and hold harmless, to the fullest
extent permitted by the WBCA, any individual made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, and whether formal or informal, because that individual is or was
a director or officer or is or was serving at our request as a director, officer, partner, trustee, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, and that we will reimburse
the reasonable expenses incurred by that individual with respect to such proceeding without regard to the limitations of Sections 23B.08.510 through 23B.08.550 and 23B.08.560(2) of the WBCA, or any other limitation that may be enacted in the future
to the extent the limitation may be disregarded if authorized by our Articles of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our practice is to enter into separate
indemnification agreements with each of our directors and officers that provide the maximum indemnity allowed to directors and officers by the WBCA. We also maintain directors and officers insurance to insure such persons against certain liabilities
potentially arising from their service to us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The above discussion of the WBCA, our Articles of Incorporation and Bylaws is not intended to be
exhaustive and is qualified in its entirety by the actual provisions of that statute and those documents. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;16.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A list of exhibits filed herewith is contained in the exhibit index that
immediately precedes such exhibits and is incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;17.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Undertakings </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the
most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of
securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with
the Commission pursuant to Rule&nbsp;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the
effective registration statement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To include any material information with respect to the plan of distribution
not previously disclosed in the registration statement or any material change to such information in the registration statement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I>,<I>
however</I>, that paragraphs (l)(i), (l)(ii) and (l)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant
pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference into this registration statement, or that are contained in a form of prospectus filed pursuant to Rule&nbsp;424(b) that is
part of the registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. That, for the purpose of determining any liability under the Securities Act of 1933, each such
post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each prospectus filed by the registrant pursuant to Rule&nbsp;424(b)(3) shall be deemed to be part of the registration
statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each
prospectus required to be filed pursuant to Rule&nbsp;424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule&nbsp;430B relating to an offering made pursuant to Rule&nbsp;415(a)(l)(i), (vii)&nbsp;or (x)&nbsp;for the
purpose of providing the information required by Section&nbsp;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after
effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&nbsp;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date
shall be deemed to be a new effective date of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the
registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or
prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. That,
for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the
undersigned registrant pursuant to the registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed
pursuant to Rule&nbsp;424; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the
undersigned registrant or used or referred to by the undersigned registrant; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The portion of any other free writing
prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#146;s annual report
pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Securities Exchange Act of 1934)
that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. The undersigned registrant hereby undertakes to supplement the prospectus, after the expiration of the
subscription period, to set forth the results of the subscription offer, the transactions by the underwriters during the subscription period, the amount of unsubscribed securities to be purchased by the underwriters, and the terms of any subsequent
reoffering thereof. If any public offering by the underwriters is to be made on terms differing from those set forth on the cover page of the prospectus, a post-effective amendment will be filed to set forth the terms of such offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the indemnification provisions described herein, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a)&nbsp;of
Section&nbsp;310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section&nbsp;305(b)(2) of the Trust Indenture Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Seattle, State of Washington, on January 16, 2015. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>OMEROS CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Gregory A. Demopulos</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gregory A. Demopulos, M.D.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chairman of the Board of Directors</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and
appoints Gregory A. Demopulos, M.D., Michael A. Jacobsen and Marcia S. Kelbon, and each of them severally, as his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities
and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might
or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities and on the dates indicated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:15.95pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:16.00pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gregory A. Demopulos</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Gregory A. Demopulos, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President, Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January&nbsp;16,&nbsp;2015</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael A. Jacobsen</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Michael A. Jacobsen</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Finance,</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Accounting
Officer and Treasurer</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Financial and Accounting Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January 16, 2015</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ray Aspiri</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Ray Aspiri</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January 16, 2015</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas J. Cable</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Thomas J. Cable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January 16, 2015</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Peter A. Demopulos</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Peter A. Demopulos, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January 16, 2015</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Arnold C. Hanish</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Arnold C. Hanish</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January 16, 2015</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Leroy E. Hood</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Leroy E. Hood, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January&nbsp;16,&nbsp;2015</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="15" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incorporated by Reference</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Form</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>File No.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>No.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filing Date</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filed<BR>Herewith</B></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Underwriting Agreement*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Articles of Incorporation of Omeros Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">10-K</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">001-34475</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">3.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>March 31, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Bylaws of Omeros Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">10-K</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">001-34475</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">3.2</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>March&nbsp;31,&nbsp;2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Common Stock Certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-1/A</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-148572</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>October&nbsp;2,&nbsp;2009</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Senior Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-3</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-169856</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>October 8, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Subordinated Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-3</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-169856</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.2</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>October 8, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Senior Debt Security (included in Exhibit&nbsp;4.2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-3</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-169856</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.3</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>October 8, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Subordinated Debt Security (included in Exhibit&nbsp;4.3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-3</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-169856</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.4</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>October 8, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Articles of Amendment*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Preferred Stock Certificate*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Deposit Agreement*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Depositary Receipt*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Warrant Agreement*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Warrant*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Subscription Rights Agreement*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Subscription Rights Certificate*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Stock Purchase Warrant issued to Oxford Finance Corporation dated April&nbsp;26, 2005 (assumed by Omeros Corporation on August&nbsp;11, 2006)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-148572</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.2</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January 9, 2008</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Omeros Corporation Stock Purchase Warrant (as of September 30, 2014, warrants in this form were issued to purchase up to 167,885 shares of common stock)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-1/A</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-148572</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.4</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September&nbsp;16,&nbsp;2009</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Omeros Corporation Stock Purchase Warrant (as of September 30, 2014, warrants in this form were issued to purchase up to 24,904 shares of common stock)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-1/A</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-148572</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.5</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September 16, 2009</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Notice of Waiver of Warrant Termination (applicable to Stock Purchase Warrants filed as Exhibits 4.15 and 4.16)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">S-1/A</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">333-148572</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.6</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September&nbsp;16,&nbsp;2009</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="16" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incorporated by Reference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Form</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>File No.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit</B><br><B>No.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filing Date</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filed<BR>Herewith</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Notice Regarding the Extension of the Expiration Date of Certain Stock Purchase Warrants to March 29, 2013 (applicable to Stock Purchase Warrants filed as Exhibits&nbsp;4.15 and 4.16)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">8-K</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">001-34475</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>March 29, 2012</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Notice Regarding the Extension of the Expiration Date of Certain Stock Purchase Warrants to March 29, 2014 (applicable to Stock Purchase Warrants filed as Exhibits&nbsp;4.15 and 4.16)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">8-K</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">001-34475</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>March 29, 2013</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Notice Regarding the Extension of the Expiration Date of Certain Stock Purchase Warrants to September 29, 2014 (applicable to Stock Purchase Warrants filed as Exhibits&nbsp;4.15 and 4.16)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">8-K</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">001-34475</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>April 3, 2014</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Notice Regarding the Extension of the Expiration Date of Certain Stock Purchase Warrants to March 29, 2015 (applicable to Stock Purchase Warrants filed as Exhibits&nbsp;4.15 and 4.16)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">8-K</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">001-34475</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September 29, 2014</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.22</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Common Stock Warrant issued by Omeros Corporation to Cougar Investment Holdings LLC, which were subsequently assigned to its affiliate Vulcan Capital Venture Capital II LLC (as of September 30, 2014, warrants in this form
were issued to purchase up to 399,999 shares of common stock)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">8-K</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">001-34475</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">10.3</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>October 25, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Mark&nbsp;A. Metcalf</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Covington &amp; Burling LLP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>12.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Computation of Ratio of Earnings to Fixed Charges</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">10-Q</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">001-34475</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">12.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>November&nbsp;10, 2014</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Independent Registered Public Accounting Firm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Mark&nbsp;A. Metcalf (included in Exhibit&nbsp;5.1).</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Covington &amp; Burling LLP (included in Exhibit 5.2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">X</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Power of Attorney (included on signature page).</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incorporated by Reference</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Form</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>File No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filing Date</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filed<BR>Herewith</B></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>25.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form T-1 Statement of Eligibility of Trustee for Senior Indenture under the Trust Indenture Act of 1939.**</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>25.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form T-1 Statement of Eligibility of Trustee for Subordinated Indenture under the Trust Indenture Act of 1939.**</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">To be filed by amendment or as an exhibit to a report pursuant to Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934 and incorporated herein by reference. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top">To be filed separately pursuant to Section&nbsp;305(b)(2) of the Trust Indenture Act of 1939. </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d825446dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 | 16 | 2015</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Omeros Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Omeros Building</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">201 Elliott Avenue West</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Seattle, Washington 98119</P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen:</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g825446g80y50.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I am Associate General Counsel, Corporate
Finance and Governance and Assistant Secretary of Omeros Corporation, a Washington corporation (the &#147;Company&#148;) and have acted as counsel to the Company in connection with its filing of a Registration Statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (the &#147;Registration Statement&#148;) under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), with the United States Securities and Exchange Commission (the
&#147;Commission&#148;) on the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registration Statement relates to the registration by the Company under the Securities
Act of the offer and sale by the Company from time to time, pursuant to Rule&nbsp;415 under the Securities Act, of the following securities: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) shares of the Company&#146;s common stock, par value $0.01 per share (the &#147;Common Stock&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) shares of the Company&#146;s preferred stock, par value $0.01 per share (the &#147;Preferred Stock&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) debt securities, which may be either senior or subordinated and may be issued in one or more series (the &#147;Debt Securities&#148;);
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) depositary shares, representing a fractional interest in a share of Preferred Stock and evidenced by a depositary receipt (the
&#147;Depositary Shares&#148;); </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g825446g07b84.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 | 16 | 2015</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 2
</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g825446g96h31.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) warrants to purchase
Common Stock, Preferred Stock or Debt Securities (the &#147;Warrants&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) rights to subscribe for and to purchase Common Stock or
Preferred Stock (the &#147;Subscription Rights&#148;); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) units comprised of any combination of Common Stock, Preferred Stock,
Depositary Shares, Debt Securities, Warrants or Subscription Rights (the &#147;Units&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Common Stock, Preferred Stock,
Depositary Shares, Warrants, Subscription Rights and Units are collectively referred to herein as the &#147;Securities.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I have
reviewed such corporate records, certificates and other documents, and such questions of law, as I have considered necessary and relevant for the purposes of this opinion. I have assumed that all signatures are genuine, that all documents submitted
to me as originals are authentic and that all copies of documents submitted to me conform to the originals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I have assumed that, at the
time of the issuance, sale and delivery of each series of Debt Securities and each issue of Depositary Shares, Warrants, Subscription Rights or Units, as the case may be: (i)&nbsp;the execution, delivery and performance by the Company of the senior
indenture in the form of Exhibit 4.2 to the Registration Statement or the subordinated indenture in the form of Exhibit 4.3 to the Registration Statement, as applicable, and any indenture supplement thereto (any such indenture, together with any
indenture supplement, the &#147;Indenture&#148;), or any deposit agreement, warrant agreement, subscription agreement or unit agreement (collectively, the &#147;Opinion Documents&#148;), as applicable, and all actions necessary for the issuance of
the Securities, and the form and terms thereof, will comply with all requirements and restrictions, if any, applicable to the Company, whether imposed by any agreement or instrument to which the Company is a party or by which it is bound or any
court or other governmental or regulatory </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 | 16 | 2015</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 3
</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g825446g96h31.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
body having jurisdiction over the Company; and (ii)&nbsp;the authorization thereof by the Company will not have been modified or rescinded, and there will not have occurred any change in law
affecting the validity, legally binding character or enforceability thereof. With respect to any Opinion Document executed or to be executed by any party other than the Company, I have assumed that such party has, or will have, duly authorized,
executed and delivered the Opinion Documents to which it is a party and that each such Opinion Document is, or will be, the valid and binding obligation of such party, enforceable against it in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As to any facts material to my opinion, I have relied as to certain matters on information obtained from public officials, officers of the
Company and other sources I believe to be responsible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and assuming that (a)&nbsp;the Registration Statement and
any required post-effective amendments thereto have all become effective under the Securities Act, such effectiveness has not been terminated or rescinded, and comply with all applicable laws at the time the Securities are offered and sold as
contemplated by the Registration Statement, (b)&nbsp;a prospectus supplement will have been prepared, delivered and filed with the Commission describing the Securities offered thereby and will comply with all applicable laws, (c)&nbsp;all Securities
will be offered and sold in compliance with applicable federal and state securities laws and in the manner stated in the Registration Statement and the appropriate prospectus supplement, (d)&nbsp;any legally required consents, approvals,
authorizations and other orders of the Commission and any other governmental or regulatory authorities have been obtained, (e)&nbsp;the truth, accuracy and completeness of the information, representations and warranties contained in the instruments,
documents, certificates and records I have reviewed, (f)&nbsp;that a definitive purchase, underwriting, placement agency or similar agreement with respect to any Securities offered will have been duly authorized and validly executed and delivered by
the Company and the other parties thereto, and (g)&nbsp;with respect to shares of Common Stock or Preferred Stock offered, that there will </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 | 16 | 2015</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 4
</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g825446g96h31.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be sufficient shares of Common Stock or Preferred Stock authorized under the Company&#146;s organizational documents that are not otherwise reserved for issuance, and further subject to the
additional qualifications below, I am of the opinion that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The Company is duly organized and validly existing under the laws of the
State of Washington and possesses the requisite corporate power and authority to execute, deliver and perform the Debt Securities and the Indenture related thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. With respect to the Common Stock, assuming (a)&nbsp;the Company has taken all necessary corporate action to authorize and approve the
issuance of any Common Stock and to fix or otherwise determine the consideration to be received for the shares of Common Stock and the terms of the offer and sale thereof, (b)&nbsp;certificates representing shares of Common Stock shall have been
duly executed, countersigned and registered and duly delivered to purchasers against payment therefor, if issued in certificated form, and (c)&nbsp;the Common Stock is duly issued and delivered against payment of the consideration therefor in
accordance with such corporate action and applicable law and as contemplated in the Registration Statement and the prospectus supplement setting forth the terms of the Common Stock, or is duly issued and delivered upon the conversion, exercise or
exchange of any Preferred Stock, Debt Securities, Warrants, Subscription Rights or Units, the Common Stock will be validly issued, fully paid and non-assessable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. With respect to the Preferred Stock, assuming (a)&nbsp;the Company has taken all necessary corporate action to establish the rights,
preferences and privileges of, and limitations on, any series of Preferred Stock and to authorize and approve the issuance and sale of the Preferred Stock of such series and to fix or otherwise determine the consideration to be received for the
shares of Preferred Stock and the terms of the offer and sale thereof, (b)&nbsp;appropriate Articles of Amendment to the Company&#146;s Amended and Restated Articles of Incorporation with respect to such series of Preferred Stock have been duly
filed in accordance with applicable law, (c)&nbsp;certificates representing shares of Preferred Stock shall have been duly executed, countersigned and registered and duly </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 | 16 | 2015</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 5
</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g825446g96h31.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
delivered to purchasers against payment therefor, (d)&nbsp;any shares of Common Stock issuable upon conversion of such Preferred Stock, if applicable, have been duly and validly authorized and
reserved for issuance, and (e)&nbsp;the Preferred Stock with terms so fixed is duly issued and delivered against payment of the consideration therefor in accordance with such corporate action and applicable law and as contemplated in the
Registration Statement and the prospectus supplement setting forth the terms of such series of Preferred Stock, or is duly issued and delivered upon the conversion, exercise or exchange of Debt Securities, Depositary Shares, Warrants, Subscription
Rights or Units, the Preferred Stock will be validly issued, fully paid and non-assessable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. With respect to the Depositary Shares,
assuming (a)&nbsp;the Company has taken all necessary corporate action to authorize and approve the form, terms and issuance of the Depositary Shares and the terms of the offering thereof, (b)&nbsp;the depositary receipts evidencing the Depositary
Shares and any other agreements related thereto have been duly executed and delivered by the Company and the depositary in accordance with the applicable deposit agreement and in accordance with such corporate action and applicable law and as
contemplated in the Registration Statement and the prospectus supplement setting forth the terms of the Depositary Shares, and (c)&nbsp;any shares of Preferred Stock underlying the Depositary Shares have been duly and validly authorized and reserved
for issuance and have been deposited with a bank or trust company (which meets the requirements for the depositary set forth in the Registration Statement) under the applicable depositary agreement, then, upon the happening of such events, such
Depositary Shares will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. With respect to the Warrants, assuming (a)&nbsp;the Company has taken all necessary corporate action to authorize and approve the form,
terms and issuance of the Warrants and the terms of the offering thereof, (b)&nbsp;the applicable warrant agreement has been duly executed and delivered to the warrant agent and the Warrants have been duly executed, issued and delivered against
payment of the consideration therefor in accordance with such corporate action and </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 | 16 | 2015</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 6
</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g825446g96h31.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable law and as contemplated in the Registration Statement and the prospectus supplement setting forth the terms of the Warrants and the underlying Common Stock, Preferred Stock or Debt
Securities, as applicable, and (c)&nbsp;any shares of Common Stock, Preferred Stock or Debt Securities purchasable upon the exercise of the Warrants, as applicable, have been duly and validly issued and reserved for sale, then, upon the happening of
such events, the Warrants will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. With respect to the Subscription Rights, assuming (a)&nbsp;the Company has taken all necessary corporate action to authorize and approve the
form, terms and issuance of the Subscription Rights and the terms of the offering thereof, (b)&nbsp;the applicable subscription agreement has been duly executed and delivered to the rights agent and the Subscription Rights have been duly executed,
issued and delivered, against payment of the consideration therefor in accordance with such corporate action and applicable law and as contemplated in the Registration Statement and the prospectus supplement setting forth the terms of the
Subscription Rights and the underlying Common Stock or Preferred Stock, as applicable, and (c)&nbsp;any shares of Common Stock or Preferred Stock underlying the Subscription Rights, as applicable, have been duly and validly issued and reserved for
issuance, then, upon the happening of such events, the Subscription Rights will be validly issued and will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. With respect to the Units, assuming (a)&nbsp;the Company has taken all necessary corporate action to authorize and approve the form, terms
and issuance of the Units and the terms of the offering thereof, (b)&nbsp;the applicable unit agreement has been duly executed and delivered to the purchasers and the Units and the Securities or Debt Securities underlying the Units, as applicable,
have been duly executed, issued and delivered against payment of the consideration therefor in accordance with such corporate action and applicable law and as contemplated in the Registration Statement and the prospectus supplement setting forth the
terms of the Units and the underlying Securities or Debt Securities, as applicable, and (c)&nbsp;any Securities </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 | 16 | 2015</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 7
</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g825446g96h31.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or Debt Securities to be issued pursuant to such Units have been duly and validly authorized and reserved for issuance, then, upon the happening of such events, the Units will be validly issued
and will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">My
opinions above are qualified to the extent that the enforcement of any Security denominated in a currency other than United States dollars may be limited by requirements that a claim (or a foreign currency judgment in respect of such claim) be
converted into United States dollars at a rate of exchange prevailing on a date determined pursuant to applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">My opinion that
any document or any of the Securities is a legal, valid and binding obligation of the Company is qualified as to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">limitations imposed by bankruptcy, insolvency, reorganization, arrangement, fraudulent conveyance, moratorium or other laws relating to or affecting the rights of creditors generally; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">rights to indemnification and contribution, which may be limited by applicable law or equitable principles; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">general principles of equity, including without limitation concepts of materiality, reasonableness, good faith and fair dealing, and the possible unavailability of specific performance or injunctive relief and
limitation of rights of acceleration, regardless of whether such enforceability is considered in a proceeding in equity or at law. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I am a member of the bar of the State of Washington and my opinions above are limited to the laws of the State of Washington. I do not express
any opinion herein on any laws other than the law of the State of Washington. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I hereby consent to the filing of this opinion as
Exhibit&nbsp;5.1 to the Registration Statement and to the use of my name under the caption &#147;Legal Matters&#148; in the prospectus contained therein, and in </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1 | 16 | 2015</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"> Page
 8
</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g825446g96h31.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any supplement thereto or amendments thereof. In consenting to such reference, I do not thereby admit that I am in the category of persons whose consent is required under Section&nbsp;7 of the
Securities Act or under the rules and regulations of the Commission thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Mark A. Metcalf</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Mark A. Metcalf</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Associate General Counsel, Corporate Finance</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">and Governance and Assistant Secretary</P></TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>3
<FILENAME>d825446dex52.htm
<DESCRIPTION>EX-5.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g825446g66c71.gif" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">January&nbsp;16, 2015 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Omeros Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Omeros Building </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">201 Elliott Avenue West </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Seattle, Washington 98119 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as special
counsel to Omeros Corporation, a Washington corporation (the &#147;Company&#148;), in connection with the registration by the Company under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), of (i)&nbsp;shares of the
Company&#146;s common stock, par value $0.01 per share (the &#147;Common Stock&#148;), (ii)&nbsp;shares of the Company&#146;s preferred stock, par value $0.01 per share (the &#147;Preferred Stock&#148;), (iii)&nbsp;debt securities, which may be
either senior or subordinated and may be issued in one or more series (the &#147;Debt Securities&#148;), (iv)&nbsp;depositary shares, representing a fractional interest in a share of Preferred Stock and evidenced by a depositary receipt (the
&#147;Depositary Shares&#148;), (v)&nbsp;warrants to purchase Common Stock, Preferred Stock or Debt Securities (the &#147;Warrants&#148;), (vi)&nbsp;rights to subscribe for and to purchase Common Stock or Preferred Stock (the &#147;Subscription
Rights&#148;) and (vii)&nbsp;units comprised of any combination of Common Stock, Preferred Stock, Debt Securities, Depositary Shares, Warrants or Subscription Rights, pursuant to the Company&#146;s Registration Statement on Form S-3 the
(&#147;Registration Statement&#148;) filed with the Securities and Exchange Commission (the &#147;Commission&#148;) on the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have reviewed such corporate records, certificates and other documents, and such questions of law, as we have considered necessary or
appropriate for the purposes of this opinion. We have assumed that all signatures are genuine, that all documents submitted to us as originals are authentic and that all copies of documents submitted to us conform to the originals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed that, at the time of the issuance, sale and delivery of each series of Debt Securities: (i)&nbsp;the execution, delivery and
performance by the Company of the senior indenture in the form of Exhibit 4.2 to the Registration Statement or the subordinated indenture in the form of Exhibit 4.3 to the Registration Statement, as applicable, and any indenture supplement thereto
(any such indenture, together with any indenture supplement, the &#147;Indenture&#148;), and all actions necessary for the issuance of the Debt Securities, and the form and terms thereof, will comply with all requirements and restrictions, if any,
applicable to the Company, whether imposed by any agreement or instrument to which the Company is a party or by which it is bound or any court or other governmental or regulatory body having jurisdiction over the Company; and (ii)&nbsp;the
authorization thereof by the Company will not have been modified or rescinded, and there will not have occurred any change in law affecting the validity, </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g825446g60f17.gif" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Omeros Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January
16, 2015 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
legally binding character or enforceability thereof. We have also assumed that the Debt Securities will be offered and sold in compliance with applicable federal and state securities laws and in
the manner stated in the Registration Statement and the appropriate prospectus supplement. We have assumed further that the Indenture will be governed by and construed in accordance with the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed further that the Company is duly organized, validly existing and in good standing under the laws of the State of Washington
and has all requisite corporate power, authority and legal right to execute, deliver and perform its obligations under the applicable series of Debt Securities and the Indenture related thereto. With respect to all matters of Washington law, we note
that you are relying on an opinion of Mark A. Metcalf, Associate General Counsel, Corporate Finance and Governance and Assistant Secretary of the Company, dated as of the date hereof, which opinion is filed as Exhibit 5.1 to the Registration
Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we have relied as to certain matters on information obtained from public officials, officers of the Company and
other sources believed by us to be responsible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the qualifications set forth herein, we are of
the opinion that, when, as and if: (i)&nbsp;the Registration Statement and any required post-effective amendments thereto have all become effective under the Securities Act and all prospectus supplements required by applicable law have been
delivered and filed as required by applicable law; (ii)&nbsp;the Indenture has been duly executed and delivered on behalf of the Company and a trustee qualified to act as such under applicable law and such Indenture has been duly qualified under the
Trust Indenture Act of 1939, as amended; (iii)&nbsp;all necessary corporate action has been taken by the Company to authorize, execute and deliver the Indenture and to authorize the form, terms, execution and delivery of the Debt Securities;
(iv)&nbsp;any legally required consents, approvals, authorizations and other orders of the Commission and any other regulatory authorities have been obtained; (v)&nbsp;such Debt Securities have been duly executed by the Company and authenticated by
the trustee in accordance with the Indenture and have been duly issued and delivered against payment therefor in accordance with such corporate action and as contemplated in the Registration Statement and the prospectus supplement setting forth the
plan of distribution and the terms of the Debt Securities, respectively; and (vi)&nbsp;any shares of Common Stock or other securities issuable upon the conversion of the Debt Securities, if applicable, have been duly and validly authorized and
reserved for issuance, then, upon the happening of such events, such Debt Securities (including any Debt Securities to be issued by the Company upon the conversion, exercise or exchange of other securities issued by the Company pursuant to the
Registration Statement) will constitute the valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other
laws of general applicability relating to or affecting creditors&#146; rights and to general equity principles. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g825446g60f17.gif" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Omeros Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January
16, 2015 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinion above is
qualified to the extent that the enforcement of any Debt Securities denominated in a currency other than United States dollars may be limited by requirements that a claim (or a foreign currency judgment in respect of such claim) be converted into
United States dollars at a rate of exchange prevailing on a date determined pursuant to applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We express no opinion as to
(i)&nbsp;waivers of defenses, subrogation and related rights, rights to trial by jury, rights to object to venue, or other rights or benefits bestowed by operation of law, (ii)&nbsp;releases or waivers of unmatured claims or rights,
(iii)&nbsp;indemnification, contribution, exculpation or arbitration provisions, or provisions for the non-survival of representations, to the extent they purport to indemnify any party against, or release or limit any party&#146;s liability for,
its own breach or failure to comply with statutory obligations, or to the extent such provisions are contrary to public policy or (iv)&nbsp;provisions for liquidated damages and penalties, penalty interest and interest on interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are members of the bars of the District of Columbia and the State of New York. We do not express any opinion herein on any laws other than
the law of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as Exhibit 5.2 to the Registration Statement. We also
hereby consent to the reference to our firm under the heading &#147;Legal Matters&#148; in the prospectus constituting part of the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose
consent is required under Section&nbsp;7 of the Securities Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Covington&nbsp;&amp; Burling LLP </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>d825446dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Experts&#148; in this Registration Statement (Form&nbsp;S-3) and related Prospectus of Omeros
Corporation for the registration of common stock, preferred stock, debt securities, depositary shares, warrants, subscription rights, and units and to the incorporation by reference therein of our reports dated March&nbsp;13, 2014, with respect to
the consolidated financial statements of Omeros Corporation, and the effectiveness of internal control over financial reporting of Omeros Corporation, included in its Annual Report (Form 10-K) for the year ended December&nbsp;31, 2013, filed with
the Securities and Exchange Commission. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:78%; font-size:10pt; font-family:Times New Roman">/s/ Ernst&nbsp;&amp; Young, LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Seattle, Washington </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January 14, 2015 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g825446g07b84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g825446g07b84.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``@&!@<&!0@'!P<*"0@*#18.#0P,#1L3%!`6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`&\`;@,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/?Z`,/_`(2JR0S>?#<0)#<K;.\BJ%#GGKGIC!S[UK[)]#'V
MT5OWL:PNK=I4B6>,R.N]5##++Z@>E9V9KS*]C/C\1V$FJR6&9$9-P\UEQ&Q4
M`L`WJ,C-7[.2C<S56+ERER/4K&5':.\@=47<Q60$*/4U/*UT+4XO9BG4+($`
MW<(RGF#]X.5_O?3WHY7V#FCW'I=VTDB1I/&SR+O10P)9?4>U*S0^9=S/M/$=
MA=ZA<60,D4D)(+2`!6PVTX.?4@5;IR2N9QJQ<G$?>:Y:662XD=`$.Z,`@[G"
M`9SZFDH-CE4C$277[*/4)+$,TDT00N$P0NYMH!YZYH5-VN)U8J7*6QJ%F1,1
M=PXA_P!8=X^3Z^E3ROL7S1[DT4L<\2RQ2*\;#(93D&DU8::>J,+Q?J5UI>DI
M/9R>7(90N<9XKAQU6=*GS0?4]/+J,*U5QFKJQ7\#7D]_I^H7-R^^9[L[FQC.
M(HQ_2M\-4E4H0E+?7\V<V,IQI8F<(;*WY(ZBMSF.:N?#<US]J5VA9)M16[VL
M,C8%`P1ZY%;*HE;TL<[I-W];E;1?"D^G:I:7-R8YA#;QQAED(*,JE3@8Y!SZ
MBJG54HM(FG0<9)OL1WOA._NI+R(30"V(N'@/.XM*,$-[#G\Z:JQ5OE^`I4).
MZZ:_B1W'@F9OM/V8V\(E1N$&W<?-5P#@=,+BA5EI<3P[UM_6I+)X/D\F8P16
MZ.;>&.-'8M@I)O92V/NGI_2DJO<;H.VG9?F6-'\.7>FZI9W.Z%52!TN-A)WD
ML655!'`7)`.>1VI3J*46BJ=*4))E!_!U_P#:]3N8FMD:>3S%^9OWI$HD7?QQ
MC&./6K]M&R1G["5VU_6MRRGA>^.GQQ/)`)0J[MI.`1<"4XX].*GVJO\`UVL4
MJ,K6_K>Y%%X1ODOKN0M;!'F5T<9WN//,F6XZX./PI^U5E_72PE0DF_ZZW&ZC
MX:DM(+N\40$M(TSJ(V;S?WYD`8`$G@@41J7:7];!.CRIR_K>YO>%;::T\,6$
M-Q#Y,HCRT>,;<DG&/QK*JTYMHWHIQII,S?'_`/R`8_\`KLO]:\C,OX*]3W,H
M_COT(OAU_P`@2\_Z^S_Z+2NG!?[M#Y_FSES#_>ZGR_\`24=?74<1SNNZ_=Z-
M>I&L$$T<R'RQN(=6RJ@M_LY85M"FI(YZE65-V&Z5XBN[[48K::TBC5H96+*Y
M)WQR%&`'IQ1*FHJZ80JRE*S7](S8/%]_)HMM?%+5WGC9]J(ZA,%1CD\_>/-6
MZ45)HS5>7*I%]?&5K&CI-')).K2*?*3Y`0S!5))X)V'\JGV+Z%_6$MQ]CXM6
M\M=0G>PFMEL[5+@F4C#;D+8X^E*5*S2ON.-?F3=K65R+3_&UG)IEO-J"F"Y=
M-TB(,JI!8-@^@VG]*<J+3M$4<1'E3EN3+XUTQO(Q%=8ESD^5Q'A@OS<\<D?G
M2]C(?UB&@I\;:0KPJ3-NE",!LZ*X!!//3D4>QD'UB!G:EXVGT[5)[!K6,R1M
M*H.3_=4Q?]]%L?A5QHJ2O?\`KJ9SQ#C)QM_70N6_CG3;G$<,<\MP5+;%0`$!
M<Y!)Z'!QW]JET)+<M8F#T1MZ5??VGI5K?>2\/GQA_+?&5S]*RE'EDT;0ESQ4
MC!\?_P#(!C_Z[+_6O*S+^"O4]K*/X[]"+X=?\@2\_P"OL_\`HM*Z<%_NT/G^
M;.7,/][J?+_TE'7UU'$8E[X:M[^_N;J6ZN,SQK&4##"A3D;>..>?K6L:CBDD
MC&5%2;;9-9:!:V,L$D;R,\,;QY9L[M[;F)]R:3J-CC24;-%6/PG:K80V4ES<
M2Q0(8X]S#*KQQT_V13]J[W)5!64;C?\`A#M.^T^<7GP7:1TW_*[$L03]-[8^
MM/VTK6%]7C>X^/PI:1VUQ;FXG>.XACAD#,.0G3MZ<'VI>U=[C5!)-7&-X+TA
MIO,,3!0LRK&IVJJR`!@`.G3(],FG[:0?5X7^_P#$F7PQ:^2D<LTLNR,19.`2
MH<-S@>JBE[1]!^Q5K,J6?@JRLKF.YBNKDS1$!6<AL(!@)TZ8`]Z;K-JUB(X>
M,7=,M7WA33=0OI;N=7,LKPNV#QF,Y7_Z_P!*4:LHJR+E1C)W?E^!$O@^Q6&&
MW,\QMH9/,2+(&.N!G&>]/VSW)]A&UNAL:?9+IVGP6:2/(D*A%9^N!TK.3YG<
MVA'EBHG._$!@N@1EB`/.7K^->7F2_=+U/:R=7KNW8B^')!T.\(.1]K/_`*+2
MNC!Z8:'S_-G+F.F+J?+_`-)1V%=1PA0!SOB&>:SU32[EYY!8B01R112;6WLP
M"L1_$N>"/?-;4TFFNISU6XRB^ACR^-[^+3'O)+2!`TN(%.29$!.X'G@C'4\<
M]*T5&+=KF3Q$E'F:+8UG5SJD4/VFS\EM2:W*^6<B,)N`)SU]ZGDC:_D5[2?-
M:ZWL,\,:_J%W)I]CY*S0K:QO/,[_`#[F4D'W'&*=2G%784:LI6CY&3KFN:O8
MZ_=645S*(DE\L-Z>>%6+'^Z0Q%7"$7%/^M#*I4G&;BG_`$]C9\.ZW--X@UB&
MZN'-MPUN9.%"H?+;:>X+#/U-9U()131M2J-SDGM_2$U[4-3L?$]KLFD2UD`"
M!=ICVA7,A=?O9&%QVHA&+@Q5)SC47;^KF9IVJZI-X>6:74)TGBOH`X)5BR.$
MXW`=#DG`Y&<5<HQ4K6Z,SA.;A=OJC4U&?4X]1UN""]F=4CMY55653&A9@X0G
M@'"]ZB*C:+:[FDW-2DD^QL^&;JXO?#ME<7)<R2(2"_WBN3M)QW(Q6=1)3:1M
M1;E!-F)\2?\`D7(O^NZ_R->7F'\)>I]!DG^\/T&?#+_D7;K_`*^V_P#0$KHP
MO^[P^?YLY,S_`-]J?+_TE':5T'GA0!!+96L]Q%/-;1231?<=D!*_0]J:;2LB
M7%-W:('T;3)`P?3[8AG\P@Q#EO7ZT^>2ZB]G#L2MIUDTC.;2$NSB0G8,E@,!
MOK[T<S[CY(]@33[..:.9+6%98EV(X0`JOH#Z4<SVN')%.]A[V=M([.]O&SL5
M)8J"25^[^7:E=H?*GT(+C2;&YB2.2V38A!``QT;=CZ9`.*:FT2X1>C1.;6W-
MP;@P1F8KL+E1NV^F?2E=VL5RJ]R.+3;*"#R(;2%(M^_8J`#=ZX]:;DV[MB4(
MI62'S65K<"036\<@E`5PR@[@.@/K23:V!Q3W1,JA5"J``!@`=J11Q_Q)_P"1
M<B_Z[K_(UY^8?PEZGMY)_O#]!GPR_P"1=NO^OMO_`$!*Z,+_`+O#Y_FSDS/_
M`'VI\O\`TE':5T'GA0`4`%`!0`4`%`!0`4`%`!0`4`<A\18S)X>C"]?/7^M>
M=F#M27J>UDSMB'Z$?PU4Q^'[M3U%VW_H"5TX1WP\/G^;.3,G?&5'Z?\`I*.S
MKH.`*`"@`H`Q=)\11ZO<SVZ6TD#HK-&TF")%#E"1C_:6M)T^57,855-M6,*?
MQ1JENLJ*;>7R))2TVPA94CVY`&>#EB,^U:JE%F+K37RO^!J:+XE&I3W[3?NH
MX@TD,?ED%HU)4ONZ')!Z=*B=/E2L:4ZW,W<SH_$NHWNA?:X)$M[QID5;>2`]
M),;!R>>.<^QJ_9QC*SV,U6E*%UO_`)FIH>OOJNJWMO(/+6,L(4\LC>J-L9]W
M0_-QCM6<Z?+%,UIU>>31E2^)=62.6%?*2_$LA,4T141QJC.._.X`<_6M%3CO
MT,G6FM.I$OC'49Y$\F.!$O&,=L&4DQL&526]>I/X"G[&*WZ"]O)[==CJM#OI
M=1T>"YF51,=ROMZ;E8J2/;BL)QY961TTY.44V8OC_P#Y`,?_`%V7^M>3F7\%
M>I[>4?QWZ$7PZ_Y`EY_U]G_T6E=."_W:'S_-G+F'^]U/E_Z2CKZZCB"@`H`*
M`,/0_#D&D17!:1I;F<OODW'A2[,%7T'S?G6LZCD8TZ2@GW$3PEI:6EO;%9GB
MMV)C#2DX!ZK[J<<BCVLKW%["%DNQ+#X:TZ"XEFC656D<,0)#@#))4#LI))([
MTG4DU8I48IW0MIX:TVR,1BC<^5()4WR%L$+M4<]@#P.U#J281HPCL+%X<T^&
M[ENHA*DDK[CB4@+\VX@#L"W)'>AU)-6!4HIW1#+X3TR:"6*83R-+)YCRM,2Y
MXQC=Z8)&/0TU5DGH)T(-68Z7PKI,CW#&!E,X`.UR-G(.5_NG*@Y'I2562!T8
M.YIV5G#I]G%:6Z[8HEVJ,YJ&W)W9I&*BK(YSQ_\`\@&/_KLO]:\O,OX*]3V<
MH_COT(OAU_R!+S_K[/\`Z+2NG!?[M#Y_FSES#_>ZGR_])1U]=1Q!0`4`%`'/
M>%HW6#5+BXF,LDE[*&=ACA3@#Z`5M5Z)=CGHK23?=G)W=]G3'EM+Z>/3Y)YV
M@(F);<L7[O)ZC<X)"]^*W4=;-:Z'-*7NW3TU_+3\37T77)QXBNO[4D12P*<R
M$>0%V@`KT&XMD'KS6<X+D7*:TZCYWS_\,9T&H7-_I6IQ76Y[Z61?+:.5P8Y'
M=D5".VT#./:K<5&2ML9J3E%I[FEIFJ/:>*;N"^F'DP@PH7E.8414PS`\?,6Z
M]:B4;P31I"?+4:E_7_#F7J-V8KF]MI;]OLYN#)+=P3M@`ARD9[*00.G7BKBM
M$TC*4K-IO3O]^A%]KU&[N7BN-1:TNY4*3"60JD<8CC93Q]W+%AD>IIVBEHM/
M^'%S2D[-V?\`P$=[H%PMUH-E.L+0K)&&",Q8C\3R:Y9JTFCNI.\$S&\?_P#(
M!C_Z[+_6O)S+^"O4]O*/X[]"+X=?\@2\_P"OL_\`HM*Z<%_NT/G^;.7,/][J
M?+_TE'7UU'$%`!0`4`(%500%`!Y(`H`C%K;JNU8(PN=V`@Z^M.[%RH4P0EF8
MQ(6;&X[1DXZ9HNPLA1#$I)$:`EMQ(4<GU^M%V%D(8(69F:)"S``DJ,D#I1=A
M9""V@",@@C",=Q7:,$^M%V%D*]O#+N\R%'W``[E!R!1=H&DR0``8'`I#.1^(
MDAC\/1D#/[]?ZUYV8J])>I[.3*^(?H1_#9R^@7;$8)NV_P#0$KHPBMAX+U_-
MG+F2MC*B]/\`TE'95TG`%`!0`4`%`!0`4`%`!0`4`%`!0!ROC_\`Y`,?_79?
MZUYF9?P5ZGKY1_'?H1?#K_D"7G_7V?\`T6E=."_W:'S_`#9RYA_O=3Y?^DHZ
M^NHX@H`:Y98V*C+`<#U-`'%P?$%+GSEBTY]\">9*&?&U0H+GIS@DC\*Z7A[=
M3C6*OL@7XA1R6[W*:>Y@C.QCOY#,&,8QC^(`?]]"CZO9VN'UK2]OZZ&C;^+/
MMFA+J5O9Y\Z=8($9\;B<<DXXP21^%0Z5I<K9HJ_-#F2,Y_'EPR^9;:2KQ!-Q
M+3[2"(R[#H>@!%7[!=69_67NHEB3QG.7G^S:1))$KI%%(S%5=R5&"<8'WO?I
M25%=65]8>MHBR^,Y8VF!TW"HX"N9?E";RA=L#Y0"OOUH5%=P>(:Z?UL:&J>(
M6T^ZDBCM1,D%L;B9O,Q@9P`..22*B-/F6YI.KRNR6RN9<GC2[5TA32D:8$K,
M#<8"GS`@P=O/)!J_8KN9/$2VM_6QTFD:A_:FE6]Z8O*,JY*9SM(.",]^16,X
M\LK'13ESQ4C"\?\`_(!C_P"NR_UKRLR_@KU/:RC^._0B^'7_`"!+S_K[/_HM
M*Z<%_NT/G^;.7,/][J?+_P!)1U]=1Q!0`4`9\>AZ7$93'8Q*94>-\+]Y6)+#
M\235\\GU,U3@MD"Z%I:0O"MC"(W='9=O!9,;3^&T?E1SRWN'LX)6L,?P]I+V
MYMS9)Y14KM!(`!;=QCI\W.:/:2O>X>RA:UA?^$?TG;M^PQ;=NW&.VW9C_ODX
MH]I+N'LH=A5T'2TE>1;-`SE689."5QM.,XR,#GVHYY=P]G#L1MX;TAVG)L4S
M.XDDP2-QSGGGIDGCI1[27</90UT'OX?TJ1U=[)"RAUSD]&.6!YY!STH]I)=0
M]E!]!(O#VDPHB1V,8"``=2>&W=>_S<T.I)]05*"Z%ZVMH;.W6"WC$<2?=4=!
MSFI;;=V6DHJR,CQ5I-SK&EI;VNSS!(&^<X&*XL91E6I\L#T<!B(8>KS3VL5?
L!=A-IEEJ-G<;?-CN^=IR.8HS_6ML/3E2HPA+=7_-G/BJL:V(G4CL[?DC_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g825446g53m01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g825446g53m01.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0^Z4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````GP```.(````&`&<`-0`S
M`&T`,``Q`````0`````````````````````````!``````````````#B````
MGP`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````#1X````!````<````$\`
M``%0``!GL```#0(`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!/`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U5))))2DDDDE*5;J.:W!PK<EVI8/8WQ<?;6W_`#U97+_6C*=?F58%
M7N%4/>T=['^VIG^8[_P90\SE]O%*0^8^F/\`>DS<MB]S*(GY1ZI?W8M_ZL9M
MN3@NJN<7VX[RTV'4N#OTC?\`JMJV5R5%S^C]9IHMAM-3!58[LX6@669.O_=C
M_P`!I708?5\'-O?1C/-CF-W$[2&Q.W1S@U1\KF'`,<Y5D@?;J1]4N%DYK">,
MY(1O',>Y8^6/$W4DDE::JDDDDE*22224_P#_T/54DDDE*22224CR+F8]%E]G
MT*FE[HY@"5S'1*3DYEO5LO1E.ZYYY&]VYW_@-:T?K-E[,>K"9)?DN]S6_2+&
MD>QL?GW6>G4Q/DX3L3ZO6T$@V;0^XMT$ES76!O\`):S]&Q4\WKR]X\O$Y"/]
M9\T`W,/HQ=I<Q(8P?]7\LB\]U'.NZCDOR'-AK!#0!]%DPW<[^L__`#WJ[CWL
MZ9TVCJ6$T67WN-61ZNXAH:'.>P>F6[/>SZ;E>Z#@47X.8VP2;G&AQ_DAL^W^
MU:Y0^K%?4<2ZW&R:+&56#>'D>T6-]C]?^%;_`.>U6QXI\<)DGBS"7ZRN+VI]
MVSDRPX)P`%83']7?#[L*V;W1^NT]2FHM]+(:-Q9.YKF\;ZWZ+46%G].KQNKX
M&9B-]-UUWIVL;H#+'N=8&C_@VV>HMU7\$LE2CDUE`UQ#],?,)-#/''<98](S
M%\)_0-\)"DDDE,PJ22224__1]522224I))))3FX>,W*S;.IVC=#MF)Y5M&SU
M/^NO-CV?R%?>*WM=6^"'"'-/<'12````$`:`!4>J]'Q.IU1:`VYH_17@2YO_
M`).O]ZM1\)A`\($Y&Y&_3QR.[)Q"<QQ$PB*B"/5P1'RH\%IZ>^RFT_H'N!KN
MT+9B-KX_F_[:T@0X2#(/!"Y(?5'J(_.QQ\'/_P#22Z/I6)9A]/HQ;"TOJ;#B
MR=O)/MD-4/+3R682Q''$"XDGB_P67F88ZXXY!DD34@!7^$\\?K->_(;<[%8]
M]>YM0WGVS[7N^A]-W[WYC/\`C'K7Z=U'JF6^;<1M-7=VXDGX-AK?^DK`Z-TH
M<8E/?\P=U;:QK&AK`&M'`&@2Q8<XE>3+8WJ('J_O>E.7-@,:ABH[7(GT_P!W
MU,DDDE::JDDDDE/_TO3,_J.!TW'.3GY%>-2#&^QP:">=K?WGZ?0:@8?7NCYV
M0<7%RZWY`:U_HD[7EKV-O8]M=FQ[F^D]K_:N0Z/<?K+]><C+ROTN)TH/^Q5'
M5C2UXHILVG\^S;9D[_\`2>C_`*&M7?\`&3@#[!C=8Q_T6;A7,:V]FC@QY.WW
M?\'D>F^O_KO^D4WM`2C`D\4A](D[,/O'AE,`<,3]9".[U]ME=-;[;7!E=;2Y
M[CH`T#<YQ0L+/PNH8XR<&]F1020+*W!PD<MT_.6;3U+]J_5%V>0`Z_#L-@&@
M#PQS+FM_DMM:]<G_`(LLRS%S\GI=TM&317E5-)TD-89;_P`=CWTO_P"M)HQ7
M&9_2@=OS2<U3@/T9C?\`Z+WF?U3IW36-LS\FO%8\[6&UP;)`W0W=_)5I>8?X
MR\NS*ZKZ+9^S].8VIQ["[(:<DC_V'JJ7;_6SJMG2>@Y6700W(@5T$]GV.%37
M_P#6MWJ_V$3BTQUO/^04,P)R6*CCZ_FSS_K3]7^GY'V;+S:V7CZ53=UCF_\`
M&MI;9Z7_`%Q7Z\W$MQ!FU7,LQ2TV"]C@YA8-2_U&^W:N=_Q>],IQ>@5YL3E=
M0+KKK7:N(W.;4W?]+Z'Z3_C;;5N9M%-/2LJJFMM58IMAC`&MES7N=[6_O.=N
M391B)<(O0T2F,I&/$:U%@-4?6WZLDM`ZIB^[B;6@?>2M1CV6,;96X/8\!S'M
M,@@ZM<UP7!?4S#Q<WZB9]&6T.J-ESI/YI;54YMK?W7UN][5?_P`6%U]GU>L9
M82:Z<AS:0?S0656O8W^3ZMCW)\\0`D03Z#PZK<>4R,00/6#+3P>FZAU/I_3*
M#D]0R*\:D:;['!LGG:S]]W\EB%A]>Z/FY+L3&RZWY+`'&@G;9#FBUKA79M>Y
MOIO:[VKD.A6CZS?77*ZCE#U<7IC7#!K/T6G?Z5%FT_GO].W(_P"-]+_05JY_
MC(P0W"Q>M8WZ+.PKF-;>V`X,=.S7\[T\CT]G]>[_`$J7M#B$"3Q$?2).P5[I
MX)9`!PQ/UD!U>R6<_P"L'1F=09TS[4Q^:\[?0KFQS3_PWI->VC_KWIK+ZIUW
M(O\`J-9UC$/IWW8["7,F:W/<VG(],_2_0;K=COY"C_B[HP*_JW59BM:+['O^
MUN'TC8USH;9_5JV>G_P?O_PB;P5$RE>AX*'[R[W+F(1K6/'9_=?_T]+_`!8C
M9U'JE;_YUK*P1W]K[FO_`.DM[_&'8UGU7O:>;+*6M^/J,?\`]2Q9%=+NC?7'
M(ZCTHMZEA97J#.Q\5[;<B@N=NM+L9C_4VLRF?N_GVT?3]/U)_6^S)Z];B8+6
MNZ;TFNT/R.H9P^S-+RUS6,QZ\KTKK+&5&[V[/?9_P=2LGU98Y/T-)$_N\/Z+
M4'IPRQ?IZQC'K+B_2;WU::YG^+YH<(G&RG#X.=>]O_1<N=N'[)R/JEUYL,KM
MQ<>C)=&@#:V5/>[^MB9#_P#V'7=Y->-7]7+:L(M=BLPW-QRUP+36*BVK;9.U
MS=GY^Y<WU7`HS/\`%[TO'NNJQ[!5B&E]MC&,W;&LN_2/=Z;_`-5?D/\`IIL)
MBR3M.1ORFOGC/"(CYH1B1_>@X7UHQLJGZO596:PU9?4>I9&5?4X06>VS'IK$
M^[8RBIFQ=/\`XRVO=]76%O#,FHO^!#V?]6YBI?XS:0>D].KH@L98X-+GM'M%
M;MOOM>W>NH^L&+@YO1LK%S[FXV/:P--]A#6L=+?0LW/<QOLO]/\`.]Z)F/U4
MC^](_1'MD^[#O&(^OJ</ZO=.ZOE="Z?=A=9LPJ#CUM;CMHHL#2T>G9^DNK=;
M[WMW^Y;]U5]/1;:LBXY-S,=XLO+0PO<&&7FNOV,W?R5S?U.S\WI?3CT[/QK+
M\>I[SAYV$TY5%C"XN<QK\7U7_P`\;-CK6,_T=GIOJ7179%F5T2^]U%F,^RBT
MBB[:+&^U^WU-CWUM<YON_G$S()<5Z<)EZ94-?\)?CE$PJ_4(^J-_+_@OFV)9
MU.K_`!?668=A9C',=7G5M`W.JL90QOZ7Z5;/4VU6[/ILN7I/0&=-;T;$/2V"
MK"?6U]3`9(W^]V]TNW6[W?I=W^$7+_47&Q7_`%-S<?J+F5XMEMK;GE[-K6.J
MI:Y_JM<ZMFU'_P`7+NHT8>1T_*K+\6JQS\/+80^EXW.KR&4VL<YFWUV>LS_C
M;5)E]0G7Z$K_`+PDQX?287^G&O[LH_\`?.=_BJ&R[JE;M+&MH!!Y]IR&O_Z2
MW/\`&)8UGU8M:>;+:6M^.]K_`/J6+)HJ=T;ZWY.?TK;U/I^7N&;1B/9;=0YS
MM[R[&K?ZGLR6/V>SZ%EM/\YZ?J3^MMF1U^_$P2QW3>CU6A^1U#-C&#GEK@&8
M]>5Z=SK&4^ML]GOL_P"#J2/JRC)^AI(G]WA_10/3A.+]/6(C^]Q?I.O]3,1M
MOU-Q,;*KW57UVA];N'5VV6N']E]5BY:_&ZE]0^N5VX]ANZ3F/`(=J',!]]5W
M[N5CL=OHO_PO_;U:]%PVXS,2AF'M.*VMHHV'<WTP!Z6QVNYFSZ*Y#ZV/NZWD
M8>$YG[/Z11D!^3GYQ&.'N`<WT<6O(-=]CO2]?_!>_P#XI-QSN<B?DE9G?\OF
M7Y<=0@`?UD*$*\/^Y?_9.$))300A``````!5`````0$````/`$$`9`!O`&(`
M90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T
M`&\`<P!H`&\`<``@`#8`+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N
M``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!
M`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`__``!$(`)\`X@,!$0`"$0$#$0'_W0`$`!W_Q`#;``$`
M`@(#`0$!````````````"0H("P4&!P,$`@$!``(#`0$!`0````````````<(
M!08)!`,"`1````8!`P,"`P,$"@H3`````0(#!`4&!P`1"!(3"2$4,2(*0146
M48$R(W%28C.U5A=W.#FA0H*20S66)U<989&RPF,D-&34)28V=M:W&"A8>!$`
M`@$#`P("!04*"`H*`P```0(#`!$$$@4&(0<Q$T%182((<8&Q,A21H4)28G(C
M%74VP;)3LR1T%C>"DJ(S<Y-4U#47\-)CH].$I"55&(,T5O_:``P#`0`"$0,1
M`#\`O\:4II2FE*:4II2FE*:4II2FE*:4II2NLW2VPU"J-ENMA7]M"52#DY^4
M5#IZ_9Q;15VJF@4PE[KE8$NA(@>JBABE#U$-8K?-XPN/;-NF^[E)IP,3'>9S
MZ=,:EB!ZV-K*/22`.IK*;)L^;R#>-KV/;H]6=ESI$@]&J1@H)]2B]V/@`"3T
M%1J^/GE1+Y<MF7J=>7^\].6.0R746RJYE2MHJ25(UF:S'F4Z1!C7BI,S-B``
MF%-54P_HCJKGPX=W,SF>\<SV3?\`(_\`<)\I\['4F]HW.F2!+_@PVC*#QLSG
MT59[XBNT^'P_:.';UL./_0,?&3"R&`M>1`6BG>WX4UY`Y\+J@'C4J&K<54VF
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2O_]"_QI2FE*:4II2FE*:4
MII2FE*:4II2FE*B3\IF;30E0K6#X1ZF#ZXK%LES(BN07#>NP[E(T''.4BF$Z
M:4S-D%QN(`(A'@'J4XZIQ\6W/#@;+M?`L"<?:,UO.R0"+B&-AY2,/$"24:^O
M\CZB:N!\*'!AG;QNG.\Z`^1A#R<8D=#-(I\UP?`F.(Z.G\MZP*BGXP6>Q4_D
M#B6;JZ:[B6)=H:/%HAMUOXR9<!#S4><3*)))HO8A\NF=0X@1$![AA`"".JA=
MJ-VW/9>XW#L_:59LP9T2:1^&DK>7*AZ@`-&S`DFR_6/05;7NIM6V[SV[Y?@[
MJRKB'!D?4?P'C7S(G\"25D52`.K?5'C5K:,DX^:C8^8B7K:1BI5DUDHR09JD
M7:/H]\@FZ9O&JZ8F36;N6ZI3D.41`Q3`(:Z^XN5C9V+C9N'.LN)-&KHZFZNC
M`,K*1T(8$$$>(-<D<K%R<')R,+,@:++AD9'1A9D=2596!Z@J000?`BOW:^]?
M"FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K_T;_&E*:4II2FE*:4II2F
ME*:4II2FE*X^7EHV!BI.<F7B$=$0T>\E920<G[;9C'1S91V]>.#_`-HBV;(F
M.8?L*4=>;-S,7;L/*W#-G6+#@C:21VZ*J(I9F)]`502?8*].'AY.X9>+@84+
M29D\BQQHO5F=R%50/6S$`>TU4VS=D^3SIE^Z9'D]FQ;#**K,6X@8"Q=<BFQ&
M,,S[8JG`5FL*R2!3I$`6<=1@`!/MKCSSSE>5W`YIOG)LKW!DRDH/Y.&,:8EM
M<]5C5;V^L]SXM77C@O%<7@7#=DXUB^\<:(!C_*32$M(U[#HTC-:_U4L/!:]0
MH<;%XIP/9\PR9`+?,C*2N-</@83=Z.8G;$9Y,MR"0"045&E>E/NUJY`1,FX?
MB)0`Q.K6U\=QL7B';[=N;90MR#<S)@[;?Q1;!<[(`]!6&3R4>]P\IL`5O6J[
M_E97+>?[5PS%-]@VT1YNX^IV#%L'')](::/SG3P*1"]PUJEL\9V8/Q[@Y:@R
M;SOV#%$D$0FFH;=<]1E^^^KBPB)MSD:+INV10`-DT6J0#\0U<CX6.:_VAX"_
M'<J?5N6SR^6`?$X\EWA/M"D21#\540>D53[XH>&_V?YVG(<6#3MV[Q>82/`9
M$=DF'L+`QRG\9G<^@U([JSE5III2FE*:4II2FE*:4II2FE*:4II2FE*:4II2
MFE*__]*_QI2FE*:4II2FE*:4II2FE*:4II2HW?)EF4*#A5MCN,=&2L.6'JL:
ML5(2@=&H0QFSNPJ&'YC$!^X7:LP#8.XDLML/RB&JP?%/S<<=X+%QK%EMN6\2
M%#;Q&/%I:8^S6QCCM^$K/UZ$59GX7>%?V@YQ+R3*BOMVT('%_`Y$NI81[="B
M23V,J=.HJ$7#5#?9(NE8HT4V5?/+=.L8Y^@W.W(LE"H/6BCDAN](LC`W<KG(
MHNH395N@V,H3K`%":H;PCCV1R??-JV##B,D^;D(C`$7$8921U=3I8V+L.J(A
M9=0#"KU<TY!C\9V3=-^RY1'#AP,ZD@D&0JP7P1NH%PBGW7=PK:25-2'>1GCH
M&/*/A:QTU)R:E4:OGQO*,4A5]A%.UWR\VQGBMCK.!;K6:2?/"NCB8?UJ:!=Q
MW#:RGQ,]LO[-;!P7<]D5SL6WXWV*11?1&Q<RK-IN;&=WD\PW^L(Q<W%5P^&O
MN5_:3?><;;O3H-\S\@9L;&VN10@B:+4`+B!$C\L6^J9#86-8><.,^H<><S1]
MLF3/3TV8BY&NW%JP3!PY4C728.V#ILV.HFDHZ833-N<!$2CV14(!@ZQ'4*]D
MNXL?;7F^/O&<9#LD\3PY*H-3%&&I&5;@%DE5#Z/=U"XU&IG[T]O9.X_"<G:,
M((-ZAE2;&9S90ZG2ZLUB0KQLX\#[VDV.D5GO??+*7J<-L8XJ`"@)?:S-\F.K
MJW]![]<KHB)0#X[EE!]/38!U8;D/QB"\D7%.(C\F3+D^F&'P^:>J^<?^$,VC
MEY3RTW_"CQ(_HFF_A@K/_B/FBR9[PU'9!M;&'833B<G8MPC`MWK6+.G'.BE;
MJ-V\B[?.T_U2H%-U*GW,41W]=M6+[,\YW3N)P?%Y)O$$$>>^1+&1"&6.R-8$
M!V=AT-NK&]K^FJ\]XN$;9V^YKD\=V>>:3!7'BD!E*L]W7J"455/47%E'0VK)
MO4K5%M-*4TI32E-*4TI32E-*4TI32E-*4TI32E?_T[_&E*:4II2FE*:4II2F
ME*:4II2FE*K!<SLK&SIGN^V2,?H+U.D-T*G6%16'L.8:$D08G<,!*B07*DU/
MR3IXGN'5[<_J82);ARC[X\O//^X?(=SQ<A6V?`48\!OT:.)]!*=.IEF=Y!Z=
M!\;+75#LGQ$<"[?<?VS*QV7=\YCD3BW59)4U`/U]T11(D9]&L>%VK.7Q>852
M3<V+,LPU=^^:,_PW!%?1JS=-LM)%(Y=K,G#ML0RZB4(5`W=;J&2.C)=`_.F.
MI[^$[@J+-N7-\V)_/C3R8M2%0#)8L5+*+D1:?>0E2L]C[RU`_P`5?.':';>%
M84J>0[^=+I<$L$]U0P5C8&76-+@,&AN.C5ZCY!N2=-CZ;9\$M$HV;D9QB1&V
M/7!EUDJVNU7CY>)8QR"`$*]LAW"22P"*@)-.DO=`=S]K;OB/[H;)C;'NO;^%
M8I\F>,#(9KD0E2DD:(!]:>X5NK:8[#4#=M&J?#IVQWK)WK:^?SO+!BP.3CJ+
M`S!@\<CN3]6&Q9?#5)<Z2++K@*USLKH17ON&./-\S8Y0)4V#UXP!^+&2>1L<
MO*&C#=!#=3X$U&S)B"A%"]HSMPU2/N(@?8IMI"X3VXY%SJ6-=FQ))(/,TNR(
M7T>'UNH1+W%O,=%/7KT-1]S7N+Q_@\3MO&3&F1Y>I%=PFO\`-N"SVL;B-'8=
M.G47F9PEE;!?#6M(\?,H9%/#W*-D7$^[(\K=C<M44K.DV?LR*R4-$R44GU([
M&']>)4P,`&-N`CJ\/`>7\#[(;1%VXY=R7R-\BE:9@T,S*!.`Z@O'&\8Z=?K6
M%^I\:I/SOB//.]>Z/W%XIQL3;)+$(E*S0JQ,!9&LDDB2'KT^K<VZ"L^:;?*5
MD.)+.T6UU^W1!C`0S^ORK.4015$O5[=R+154S1T4/TDE0(H7[2AJQ>R<AV+D
MF&-PX_N^/F81_#AD60`^IM).EO6K6(](JO>]<?WSCF8<#?\`:,C#S!UT31M&
M2/6NH#4OJ9;@^@UVW68K#TTI32E-*4TI32E-*4TI32E-*4TI32E?_]2_QI2F
ME*:4II2FE*:4II2FE*:4K%GF7E9QB/C[?)N(7.C:)F-4K-8[`.!<I/IH/:OI
M1`[=%7VQX&&.Y>E54Z$@40(43`8Y0-$??#F$G#.W'(,[#D*[M/$8(+:M0>7W
M7D!4'3Y46N4,UE!4"]R`98[)\1CYCW%V#!S(PVU02B>>]M)2+WEC()&KS9-$
M147:S$VLI(KG8PQR[O,C`PD=%'?SEDLD9#LD'3E1@U.R<K-T-RK.8L629)21
MD&C,KLCA8[,51,9#YTC#S-XIQF;?\G;\'&PS)GY64D:AFT#2Q4>+1Z1YCO'&
M)`[&/428^JD]*>4\DAV'&W#.R<L1X&+C/(Q50[:E!/@KZCH1))#&442:;"3H
MP%C>[3,3Q3XV/5V;EJH^JU>%C&NW"2#8LU<Y,BIUI99F@F!5`5DU5I!=!(@F
M%!(Y2`(@`:Z:[]G879_M=/)!*IR,3&T(Q`'FY,@),A4#K=RTS(!?0I`\!7-3
M8L+,[N=SX$FB<8^7DZW4$MY6,E@(PQ/2R!859C;6RDGJ:K*76QOK;87LL\<N
MY!_*.W$@^=NS)G<2$O)KF=2+Y7M-VP&=.G*G0<QBB<W;#U``*4O*W?-SR-XW
M*?,GE>3(E<N[-:[R.=3N;!?>8FQ)%S;QM8#J+LFVX^T;=!AP1)'CQ($15N`D
M:#2B"Y;W547`!L+GTW)Y"SXTM55J-*O$K&*MJU?%+`WKLB<X&)(KUAVV:2RB
M:8)E%!L59Z0J(F$17`ASE^7T#T[KQ;=]HV;8]_R\5EVO<#,L+GP=H&59"!;H
MMV`4DG58D=.@\^U\GVG=MXWO8<3*5MSV\0F9!^`)U9HP3?JUE):P&FX4]?'.
MOQC9B-2,SOL:23D20.58X6S0JA]D6UOKZ+J0B%0$X]"?WA'"[:B!=C*KG0#U
MZ0#5@?A4YL=AYQD<6RI;;=N\=E!\!D0AGC/LUIYD?3JS&,>@5`?Q2\+&^\)@
MY1BQ7W#:)-36'5L>4JD@]NA_+DZ]%42'TFN$\CU0MBW)2WV1&KV)6NFK]0`L
M^G"29X4PMJZR2<`65*V%B(H*%$I_UGR&#8=AUX?B=V7>9.Z&\[I'M.2VV?9L
M;],(G,7NPJ#^D"Z.AZ'KT/C7N^&C>=H3MCLVV/NN,-R^T9'Z(RH)>LS$?H]6
MOJ.HZ=1X5A;C;*-]Q%9VEOQY9)&MS34Q.M1FJ(M)%L4X',PEX]3J9RL<J(?,
MBN0Y!'80`#``A!?%^6\AX9NL.\\;W23%SD(N5/NN/'1(A]V1#Z58$>GQ`-3=
MR?BG'^8[7-LW(]LCR<%P;!A[R'\>-Q[T;CT,A!]'@2*LF\1>3T7R:Q^O,+,V
ML+>*RX;QMU@&JASM$7#E-12/F8KO**N/N:8304[95#&416252$QP(553J'V:
M[KX?=3CDF:T*P;]BL$RH5-U!8$I)'<D^7(`=())5E9"6TAFYD]XNU>7VNY%'
MAI,\^PY2E\:9@-1"D!XY+`#S(R1<J`&5E<!;E5RPU,%1%32E-*4TI32E-*4T
MI32E-*4TI32E?__5O\:4II2FE*:4II2FE*:4II2FE*A*\D^5%K?D2K8+JCMP
MHK&M$AM7LUM@4=S[^.,Q@0256:(.5CK-6JJI3&Z"F!(.X4`6`M#?BAY<^]\G
MVG@&T3,7A0>?I/BTSH5BL2H8DK&S"]@0GO#WP+T?#'Q--FXUNW/-WA4)*Y\C
M4/!84?5+<!BH`:15(%R-?NGW+]@\=&.4[+;)W(Q".%*;05%:W3%G)"I"]<^V
M,A[Q(@"<Y"RAW3R4D&IS&32>+,3I"/:`0ROPS<97=-XW#DRACLFWDP8Q86U-
MIMJ'I&LM)/*A)"R-`5^H*QWQ*<E;:]GP.-,5&];@!-DA3?2M[Z3Z#HTQP0R`
M`M&LX:VLW]6\G$C(*U+$E/9NW;1*RW"267]L5<Q'!T$(NM@W>"W714(T597%
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MN)0(D0@JJ2M=%PB4@;`HZ%(P@(E#70/O3VUP]_[39&Q;-AA<C:(5FQ%4=?Z.
MA#1BUKF2'6H'X4A4GJ*H+V9[C9>P]UL;>]XRRV/NTS0Y;,3;^D."LAO>PCFT
M,3Z(]0'C5;6O3\K59^$L\$Z.QFJ[+1TY$O$_TVLE%.T7S)P4/3<4G*!3;?`=
MMM<O]LW'+VC<<#==OE,>=C3)+&P\5>-@RGYB!737<MOQ-VV_.VO/B$F#DPO%
M(I\&212K#YU)%6W<1Y&B<NXRI>1X?M@RML"SDE&Q#@J#"0$HMIB)4/\``ZL3
M+(+MCC]IDAUV1X;R;#YGQ78^385O(S,=7*^.A_"2,^V.0,A]JFN/G,>-9?#N
M4[YQK,OY^'D,@;PUI]:.0>R2,JX]C"L3.4O!#'.:824L%%AXJC95006=L)**
M;I1L):'9"F4".M$>V(1J*CXWRA()D*Y2.(&4%9,O;&'>[7P^\9YU@9>Y;!A0
MX'+U4LCQ@)%.PZZ)T4!;MX"8`.I(+%U&FI?[4=_N2\(SL3;M_P`V;/XDS!72
M0EY8%/37`[$M9?'R22C`$*$8ZJBWX$62RXFY;0M*F6SZ&5LA['CJWPCTAT%V
MK]!JZ>LD7+8_RE>,K%#H$ZOTBD.H!1V,.]3/AXW3=>'=X\'8LZ*2!\HS8>3$
MP(*N%9E#*?PEFC47]`+`=#5K?B"VS:^7]G\[>\*6.=,40YF/*IN&0LJL58?@
MM#(QMX$A2>HZ60M=/*YG4TI32E-*4TI32E-*4TI32E-*4TI7_]:_QI2FE*:4
MII2FE*:4II2FE*Z_;+/$4NL6"W3[DC.$K4/(3<HY.=,@),HUJHZ7$HJG33%0
MQ$^D@"8.HX@'VZQN\;KA;%M6X[SN,H3`Q87ED8V%E12Q\2!<VL!?J;"LCM&U
M9N^;KMVS[=$7SLJ9(HU%S=G8*/`$VZW)MT%S57]C)73/.7+#*,6;N6O^6[1*
MQT0`?K`@8F<<JJ3SD'0BL5)O#5Q4K%$I@.D@V54%/I.B0-<H,?*WSN!S'<LN
M"%YN1;SER)'Z?*CE8F8ZNH`CA/E)XA$9BMF1:ZISXNQ\`X?MV)D3)#Q[9\6-
MY/1YLD0`B73TN9)@96M9G=5#75VJRUB;&M>Q)0:Y1*VQ:M&D+&,6[M9LW(W/
M*22+)LU>2KT2B<[AZ\%N'4H<YSB4I0$P@4-=2N&\6VWAG'-LX_MD")%!$H8J
M`/,D"JK2-XDLUNI))L`+FU<P>7\HW'F/(=SW_<YW>:>5BH8DB-"S,L:^`"K?
MH``+DFW6L*/)#!=['E"MI4E5E*Y;O9)E3.D4A/?*1EE54<`J)`,D9"DG2*`'
M(/=5)ZB&Y1@CXH-O\SC7'=WT$G&S=/0@`:]$Q+7]%L8J.H]XKU]!G'X9=PT<
MCY#LY<*N3AZC<$GW-<(`MZ;Y08]#[JMT](P2XDL"-.6^/VASK.V+*:LRA'#H
MIE'":AL<ND6+EVZZ@*X76>E%+JZ0_6?DW`I:]]F,=8>\?'(&8O!'//U;JP/V
M1@A9K]26Z7MX_+83_P!X<@S=GN13*`D[P0"R]`1]L4L%7T`+[UK_`%?DN;!7
MQ]!]0'XAKI%7.FH'\S>,_++_`"?<I+$Z%0)CZ3ECR=<;2=A4CWD>A((I.W<:
M=H,>N":$=(++(H;'-N@0@^@B(!SXYQ\+/,<GEF]Y7#X\(<<EF+PJ\Q1D#@,R
M%=!L$<LJ]3=0I]E7^X3\4'$,?BNRXW+I,P\BBA"3,D(=7*$JKZM8N70*S=!9
MRP]M9]\%L.9GP/1K1C[*9((\06=2G:<M"S7WL+89-`Z4_'+$,U:F:MBN6B#A
M(`Z@,HX6$=A^-BNP'"><]O>/[MQSEPQSA_:!+C&*7S-.L6F0^ZNE=2JZVO=G
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M*;E07<!'2#1-E#)"W*<A7M@G5$^PD</^-$9+I$$%!*.JS_$?R&7]5;'P/`F0
M9>ZSJ9%(8ZH4=0L8M<:I92-*GZXB=%]XBK)?#KL$0W3?.=9T+G$VJ!A&05&F
M5T8M(;_@PQ`ZF'U#+&YNH-=RXB<5V&#F<K89%PC)3TX5F1FY3)T"SC$FR:CE
ML7=LBH1N]FSKO`3`YT]E$@_P1!UF>RW:+'X'#E;IE2+)GSA=!'X,8%V'U00&
MD+2`7(L4_$!K#=Y.[,_.YL3;<:)HMO@+%@>NIRQ"M]8@E8@L9-@>C?CD5G!J
M?Z@:O/LI4"-R=19^F2::9T99H)43*E,9,CI(>XB"H$.D<S5SL*#@@&+W6ZJA
M!'8PZUKE_',7EG'MRV/*4%9DZ7\`PZB]B#I;ZK@$:D9EO8UL?$^19/%=_P!N
MWO%)UPOUMXE3T-K@C4OUD-CI=5;Q%1!4",D\693JCV;8$AV%<L+6`?NY[>.?
M1;6$<=^O-I!PY,.RS!HNX1D'"BSE%1JY!\BJLV3-TTEX[BY?$>8;//G0"&'%
MREB=I?<9!$;Q*Y;P*J765RSJ8W$Z.\2DBYO(<K$Y9Q+=X,'(,T^3C-*BQ>^C
MM*+3,@7T,P1H4"HPD3R'1)6%YNTE`53(J4!`JA2G`#!L8`,&^Q@]=C!]NK^H
MP=%<>!%ZHBZE&9#X@U_>OU7YII2O);?GC#=&3F?Q+DRCL)""37%_`FM4"-B!
MP@`_]7I08R!9%2154`"$1[8&$X@`[?'6G;SW!X3L"YOZTY5@1Y..#KB^T0^=
M<?@"+7K+D]`MKW]5;ALW`.:[^V%^K.+Y\F/D$:)?(E\FQ_#,NC0$`ZEKVM6-
M^#)S$\1;LB9IR!E;$3?+&6WC,[F%;9-IDF6BTB);-FE8I;=\WEQ1>O4F+5%:
M2<(`#=P[`H$ZBI%44C'@.?P_"WGDO.>1<OV9>8;RZZHESL9_LN+&H6#&5A)9
MF"*K3.ON/);3<*&:3.>X'+\S9^-\(X[Q'>6XALZ-IE;!R4^U94A+3Y)0QW52
MS,L*-[Z1DZK%RJY)#GK!@&(0<SXH`Z@[$(.1*AU''81V*7[XW,.P:D__`)A\
M`!`_MQL]SX?TS&_\2HR_Y?<]()_L1N]AX_T/(_\`#KDHS,6(YIR#.'RECF6=
MB&X-8R[UE^X$-]AV1:R:J@[".WPUZ<;FW#,V7R</EVV2S?BIE0,?N+(37FR>
M%\QPH_.S.)[G##^,^+.H^ZR`5Z`@X0<D[C=9)=/<0[B)RJ$$0$0$`.01*(@(
M>NMCCEBF77%(K)ZP;C[HK79(I(FTRQE6]1%C]ROMKZ5\Z:4II2FE*:4II2FE
M*:4K_]"_QI2FE*:4II2FE*:4II2FE*P3H%#:9RY#6WD#.)@[J>/)MUC[%S9Z
MW.))%>MQB3&3M+$`4(C[-A9)67*T7'OE<'4*HF"0H$44KWQSCL/<#N5O/<?/
M77LVVSMAX"L.CF&,*\Z=;:5FDR/+?WPY8,N@QAFG[D7()N!=N-G[=8#:-XW&
M!<S.92+H)G+)`W2^IX8\<R)[I0*58N)"JYU@````````&P`'H``'P``^P`U8
M0``6'A4`^/4^-?@DI:*AFWO)B2CXIGW")>ZDGC9BV[JG4)$N^Z422[AP*.Q=
M]QV'7FRLS$P8O/S<J.&&]M3LJ+<^`NQ`N?57HQ</+S9?(PL62::U]**SM8>)
MLH)L/77`?R@T+^.]0_REAO\`INL=_:3CO_S^%_KXO^M61_LYR'_X+-_U$O\`
MU:QOS+CC%N2WY[9`9*IM5OOW:G%*RAI2N243/L6_?]BTLD<HY*X<A'^[5["S
M=9!8`.*:@J(_JM1;SKBO$>69#;QMW*,'$Y%Y0C,GF0O',JWT+,A;4=&IM#(R
MM8Z6UI[E2=PGD_+.+XZ[1N/&,W+X]YID$?ES))$QMJ:%PMAKTKJ5U9>FI0K^
M]7#X_P`_*T`J%'RNFP*WBRD8PUPJL@A9X)['-VRJK<3GCG3^0229LFHD4]P4
MC@A@(7I6ZA4+C^,]QYN-"/C_`#../RX1HBR<=A/$R*"5OH9WLJ+8ZP)![HL]
MRP]O(^W:<B,F_<0>0R2G7)C9"&"57+`&P=40EF:XT$H1<W2P4Y5UB]TVZD<G
MJ=GA;![/MB[)%OV[I9H"P"*0N4"'%=N"G2(!UE#<0$/B`ZF/:.0['ORRMLVZ
MP9.BVH1N&*W\-0\1?T7`]/JJ(MUX_O>QF)=XVJ?&UWTF1"H:WCI)Z&WL/I'K
MKMFLS6(JJGR__I.YOV_C_-?[LF_PUR([T?WK<]_:4OTUUI[-_P!UG!/V=%]%
M8^,8V0DU_;1S%X_7VZA18M5W:P$`Q2B?M($.?H`Q@#?;;<0#[=1OCXV1E2>5
MC0/))ZE4L;>NP!-2+/DX^*GF9,Z1Q^MF"B_JN2!65>/N)%[N4@T`B\*W8.V[
M=VV/-K2=;.X:.$R&]V*4ZPBA2;LA71,J)C@"A50(F(J;@66^.]G>0;UDP@28
MZX[J&4RL\%U('O6E5+!;J6N1<,%4EO")^1=W]@V7'F+).TZ,5(B"368$^[>)
MY+EK,%L#;268!;7F6XU<8'.(&#<T2JU@OO(5G,[(1$RC)JN':`I(-!CFK]M8
MVY$'+8BG<,#XAB`ML)5.DG:NWVM[39'#H8GQ'3&$EVE>.59"6%@NA669;,H.
MH^:"-5B&LNBE7<_NK#S&>1<M'R/*LL221E`%-RVME:$W#6TCRB#IO=;MKSH;
MHF02(F9=9R<I2@9=P*8JJF`H%%0X(IHHE,?;<0(0I=Q]`#5A8HS&BH9&=@/%
MK7/M-@!U]@`]0%0%(XD=F$:H"?`7L/8+DG[I)]M?;7TKYTTI32E-*4TI32E-
M*4TI7__1O\:4II2FE*:4II2FE*:4KYJI@LDJD)CD!5,Z8G3$"G*!RB43$$0$
M`.7?<!V'UU^736CH20""+CQZ^KVU^D;0ZN`"00>OAT]=?@AH:,KT3'0<,S1C
MXJ*9H,&#)N7H1;M6R94D4B!\1Z2%#<1W$1]1]=>;`P<3;,/&V_!@6+#A0(BC
MP55%@/\`IXUZ,[-RMRS,G/SIVDRYG+NQZDLQN3]VN3UZZ\M=?M54KEXKTK5+
M;#,+!79MJ=E*1,DB5=H[0/L8`,4=C)K)*%`Z2I!*HDH4IR&*<H"&.W?:-LW[
M;<O:-YP8\G;)T*R1N+JP/T$&Q5A9E(#*00#61VG=]SV+<<3=]GS9,?<H'#)(
MALRD?2".C*;JRDJP()%5[^9'!J9P&HM?*":1LN)G;DI'!ERBZFJ.X<&$$FLV
MH@D4KJ$64$"-W_27I.)45P!04U%^;W>[L%F]NV?D/'3+E</=O>O[TN*3X+*0
M/>B)Z)+86-DD]XJTG1?LMWYPNX2IQ_D(CQ>7HO2WNQ90'BT0)]V4#J\5S<7>
M.ZAECCSU6NK&TTI4OWB0_P"]6;/_``_2_P"$;!JZ7P;?\6YU_5L;^/+5-?C!
M_P"$\&_K&3_$AJ;[5]*HI6#5X\>V`,B9!L61K.>].9>TRKB8EHUM8VK.&.\=
M=D5>PDA#EDD4A%(1`H.AVZS>NW3TP#O_`,-W;GDO(]SY-NK;@V9ES&61%F58
MM36O8"/6!T\-?I/LM/.Q?$9W#XYQW;>-;6N`N'B0B.-VA9I-*WM<F303U\='
MH'MOP:'C1XQ-P6[;&\@94?E4"XNB'1+W"*`FGVVI"'(`IA^^`<?MWW`!#P)\
M+/:F,/I@W"Y]/VEKCJ#864#T>D'[O6O>_P`4'=.0IJGP+#T?9EZ]"+F['U^B
MWW*RGQIA''6)X]!A4H8X&;MVS4DA+NUY>3!)HD=%$"NGAC]@PIJ&ZQ2*F*@C
MN?<=2UQ7@'&.'8\<&SX)U*JJ'D8R264$"S-]7H3?2!JOUO43\HYWR7E^1)/O
M&:-+,S%(U$:78@GW5\>H%M1-O1:O6M;G6GTTI32E-*4TI32E-*4TI32E-*5_
M_]*_QI2FE*:4II2FE*:4II2FE*:4II2FE*_,]9,Y)FZCY%HV?L'S=9F]8O$$
MG31XT<IF1<-739<IT7#==(XE.0Y1*8HB`@(#KY3P094,V-DPK)CR*596`965
MA8JRFX((-B"+$=#7U@GFQIHLG&F:/(C8,K*2K*RFX96%B""+@@W!ZBL/G'C\
MXC.7"[E3$J1#N%E5SD;W*_M6Y#JG,H8J#9M:DF[=$HFV*FF4I"%V`H```&H6
MD^'/LW+))(W#E#,Q)MD9:CJ;]%$X`'J```'0`"IFC^(GO#%''$O+R550!?&Q
M&/06ZL8"2?6222>I-Z^/^KVXB?Z)Q_RYR-_YMU^/_KAV9_\`X_\`]5F?[Q7[
M_P#L9WC_`/Z[_P!+A_[O7L&(^.&&L%.YM[BRH#6'-B;LFLPH,_9IGW:$<HX6
M9DZ)^8E$T.RHZ4'=("";J]1'8-MTX;VRX1P";.GXELOV27)55D/FS2:@A)46
MED<"Q8_5M>_6M,YCW+YKSZ'!@Y9O/VJ+&9FC'E01Z2X`8_HHXR;A1]:]K=+5
M[AK?:T2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*__T[_&E*:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4K__4O\:4J([EYYK^#W$.QRE!F+58,OY.A5U64U1L-1\;9#UR12,*1X^S
M6F4EX.H1C]LN0R;EFD]=2+0Y1*JV*;8!DCC7:OE?)((\R/'3&P&%UDF)74/6
MJ`,Y!'4$J%/H8U#G,^^G`N&9,VW3YDF;NR$AHL90Y1O4\C,L:D'HRAF=?2@K
MQ"^^>C#&)J%QTR7DSCMGJ`JO(>LW&S1P,&U9>S540J61;+019RT?,RM9:/7<
MFE7BR:1470"#)TF(`?T$V7Q.S^Z;AE[W@X&]X;Y&%(B&^H*Y>))+@J&(`U:3
M<?6!K`[C\0FQ[/MW&=UW7C.XQ8>Y12N+!"T8CF>&S*S("6T>8+-]1AX^F3GB
MKS2XW<TJ8XNO'K)$9<6\8+9*RUU=)Q"W2H.W13B@UM%4E$V\M&E7,BH5!R!%
M&+L4CBW76*0PAH/(>+;YQ;*7%WK!:(M?2WUD<#THXZ'VCZPN+@7J5.(\XXQS
MC!;/XWNB3HEM:=5EC)\!)&UF6]C8V*M8Z6-JRGUKU;;7DV=\S5'COAW(N<+Z
MC,N*;C"L2%ML:%=9MY&<4BXTI3."QC%V]CFSIV(&^4AUTBC^V#62VC:\G>]S
MPMIPR@RLB0(I8D+<^L@$@?,:P_(-[P^-[+N>_;@KG"Q(FD<(`6TKXZ02H)^4
MCY:PAX:>7#AOSCNK_&F)K+:JUD9NQ<2D72<H0+*JS5JC6*9EY)S4U&$W/Q$V
MM%MB"LNT(Z!\1L4ZX("BDJHGM?*.V_)^)XJ9VXP1R8)(!DB8NJ$^`>ZJ5N>@
M-M-["]R`=#X/WDX3S[.DVO9\J:+<PI98IT$;R*.K&.S.KZ1U*AM0%VTZ02)-
M]:%4J4TI4*.6?/MP#P]DN_XLGGN7)Z>QS:IJFSDE4:)&R]<=S==>JQDN2%E7
M%JCAD&C61;JH@MVR)J&3$Q!,F)3FE3;NSO,=SP,/<(EQDAGC5U#R$,%87&H!
M#8D$&U[CT]>E09O'Q#]NMEW3<=HR)LR3)QIFC<QQ!D+(=+:6+BX#`B]K&W2X
ML:F<AI5M.P\3-LRK$9S$:QE6I'!"IN"MI!JD[0*NF4ZA2+%26`#`!C`!MPW'
MXZB^6-H9987MK1B#;PN#8U-T$R9$$.1'?RY$#"_C9A<7]O6N2U\Z^M1Z<R_*
M)P]X,*A!YEO[J2R*LP))LL2X]C2VO(*[)8I3-G$@R!W'P=70>IGZVYYE_'%=
M$`QD>X!1VW3B_`.3<M'G;9AA<$&QFD.B._I`-BSV].A6MZ;5&_-^Z_"N`$0;
MYN);<BNH8\*^9,1Z"1<*@/H,CIJ_!O:HQ8+ZBZHV<KFQ5S@QR=L&,V*ZI'UZ
M@DXR7*R;H"/?4<MF,>M7T'")0^=,\P4I1^)P^.M^E[)9$&F&?EN`F>1TC:XN
M?82=7SZ/FJ*L?XE\++#Y6+P#=I-J4]94"M8>L@`H#[#)\]2L\)?(SQDY]PUC
M>X'GK&2P4Q*.<7*AW:NK5ZVUIM,*.T8MV[*W<2M=DFCU5BL4JD?(/"IF)TJ=
M!A*`QWRKA&_<.E@7=X4,$I(22-M2,1:X%P&!%QT95]EZE[@O<OBO<2#)DX_D
MR?:(`IEBE0I)&&OI)ZLA!L>J.P%NMC6;4U*MH*'EIMZ58S.&C7\J[*W(51<S
M:/:JNURH)F.F4ZPI(CT@)B@)M@W#6JPQ--+%"EM;L%%_"Y-A6]3S)CP39$E_
M+C0L;>-E%S;YA4%3'ZC/QZ/U$T$6G('W*QBIHM0Q='+N%E#>A4TDV=Q<]PYA
M]``/B.I;;LCS1026PM/K\T_PH*@&/XF.VLA"J-QUGT?9P3]Z0U]6_P!1=X\Q
ME?NN4;Y^KPD5*DN\F<6-"MVW5L(G7;1UMD98I2`.X@#8Q]O@4=?QNR7-/+\R
M-L-_8LIO]TH!]^OZOQ+=MO.\F;]8Q=>I;'Z#Y0)"W^34LO'7E%@/EE1"Y(X^
M9,@,DU4CD&$@O%B\92T#)"F"P1=EKDPUCK#7)(R(@H1%ZU0.JD(*$`R9BF&.
M=[X_O'',O[#O.`\&1:XO8AAZU9258>U2;'H;&IAXUROCW,-O&Z<;W2/*P[V)
M6X9&_%=&"NC6ZV902.HN.M>^ZP];#32E1B<P_+SPGX5S+^EY$OLG=\I1I"B_
MQ9B>+0MUKBE#E`R:%B>N)"'J-7>"4Y#BTD)-N^[1RJ%0,00$=^XSVUY5RF),
MK"PUBV]O"68E$/M4`,[#VJI6_2]15S7O-P3@LTF#N>XM/NR^./CJ))%]CDE8
MXS^2[JUC<*16*%E\]N(:9@K#?(BS\;<[,\>YBOV4*2P*V"L*SL,EC=E07R4X
MY;R#^*A'K:UHW@_L4R2!0,,<OLH<-Q+L4'9_<LK=]TV6#?<0YN+#%(;ZM+>:
M9!I%@6&CR_>.G\(=/7J.7\0FS8'']CY-E\8W!=MS<B>(6T:T\D1$,02JD2"4
MZ`'_``&ZGT2#<.?(OQ1YTQCU7!&0?<6N':%?6'&5N9?AC(\"S$Z:0OG%?77<
M(2T6DJLF11]%N9!BDJH1,ZQ5#`36F<GX3R+B4BC=\*V.QLLJ'7$Q]0:PL?4K
MA6(!(%JD;A7<OA_/XG;CVY:LM%N\$@T3(/64).I?`%HRZ`D`M?I6<FM2K?::
M4K!?F#Y'N)/!QDB3.N246]P?L_?PN+J@T&TY)F&AA."+HE=:+)(PD<Z%,X(O
M99Q',5CIF(18QRB76V\9X/R/EC$[3@WQ0;-*YT1*?5J/UB/2J!F'I%JT'FG<
MWAW`HU_M!N@&:RW6",>9.P]>@?5!]#2%%-B`U^E88</O,LKS.S;7J+CCA3R*
M888GGLG%.>0KQ@XFJQ591LT76C4K@RK-;EJ["LW[Q,C99;\0*BS46*<Y#)`H
M<FT\F[8#B^U39>;RK".Z(`1C`A6<7ZZ"S!F('4#RQJM8&]@='X5WM/.=]QMO
MVS@NYKL<C,IS"-4<;`$J)`B,B@GW2?..DD$BUR)M]134[5__U9S_`#Q^3>S\
M5:=!<9,$3WW)FK+==>S-TMK$X?>V.<7O3/H1M]R+%$#1MONC]!R1J[*/?CFC
M)55,"++-5TYL[0\#@Y!DR[]N\.O:\9PJ(?"2468ZO6B"UQX,S`&X#`UI^(/N
MIE<0P<?BO'\C1ON;$6DD'UH8#=1I]4DI#!6\456(LQ1A@S].QX^J7D,EFYO9
MBKC2SEJMM5IV"H6=;$>1C:SPS=I(6G):K-P4Z$@_B7$@@PB%#@8C5XF\6`ON
M$FRJ6V=Z^9Y6%]GXIMDYC,D>N=E-CH:X2*X\`;%G'I&D>!8'0?AI[<X.Y#+Y
M[O>,)3%,8\57%U#J`9)['H64D)&3]5@[6U!2+5/('`&+.3V);?A7,E8:6FBW
M..49/FJQ2%?1CTH":-L,`^$AU8BQ0;OI<,W:?SHK$#XE$Q35[V;>=PV#<L;=
M=LG,>7$UP?01Z58>E6'1@?$>VK<\CX[M/*]GS=BWO$$VWSK8@^*G\%T/BKH>
MJL.H(^:M=8VM&??$ISSN,?2K`NVN^#+\_JTJDIWVD#E+':SME+,XZR1A#F[U
M9R%5%&3X$C"*K4RR*Z)B.$$E"77;'V?N-Q#&?*A!Q,N$./2T4EB"5/X\;ZEO
MX&Q!NI(KFDN7R+LWW#S8L'((SL#(,;#J$R(20P#KZ4FCTM;Q4D,I#*"-BOQ\
MS=3>26$L8YVQ^N=6I90J$5:HM)8Y#NXU1ZCT2<%(BEND$M79=%=@[*41*5RV
M4`!$`WU2?>MJRMCW7/VC,'])QY2A]1MX,/8RV8>PBNEW'-]PN3[%M7(-N:^'
MEPK(M_%;CWD/Y2-=&_*!K&3RH%`_CHYC@(".V";H;TW^)&93@/I]@"7?6?[>
M_OMQG^MI6K=VO[M>;?L^7Z*URN`<QV7CWFW%>;Z@J=.PXMO5<N;!(B@I$D"0
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MR5R?9VD=I'8EV-R3XDGJ2:VS=.1!O4:J@4.D$*Y!H@7X=()QC4@!\`^`%USJ
MRS?*R3ZY&^DUV&PE"8>(@\!$H^XHK"GR5\THW@CQ/O.:BI,9"]O%6U'Q)`R&
MYFLSDBR(/!B#O$2G3.YBJ['L7<N]2`R9EVK`Z)3D.H0=;3P7BS\NY%B;625P
MP#),P\5B6U[>HL2$4^@L#:P-:+W1YS%V_P"'[AOME;/)$6.A\&G<'3<>E4`:
M1ATNJ$`@D52M\8O$ZT>3[G)(36<96<N-,BG[_,G(NSO7ZB4I:O=R"AX^LJ/V
MYVZS5:\6(Y&QP:BB=M%IN1;BD9%/IM+SWD6/P+B:1;3&D64P$.,@'1+#JUO3
MY:]1>]VTWO<U1CM3P_+[K\^ER.02R3X*,<G,<GWI+M[L=Q8CS7]TZ;:8PVFU
MA6PNK%8KE*KL)4:A!1-8JU:C&<+7Z[`L&T7#0L1'($;,8V,CF::+5FR:-TRD
M(FF4I2E#T#5+\C(GRYY<G)F:3(D8LS,268GJ22>I)KI'BXN-@XT&'AP)%B1(
M%1$`554"P55%@`!T`%>95+COAB@Y:O6<*10(*IY*R?!P\!D.?@&_W66XMJ^[
M<NX9[.1K44XUU-LC/%2"_P"T5VNB8J:RBA4T@3]^3O>Z9FVXFTY>8\F#CN6C
M5C?06%B%)ZA38>[>P/4`7-\5A\;V3;]XW#?L';HX=TRHU29T&GS`A)4NH]TL
M+D:[:B.C$@"WH]P1]Q4;2@(;@O7)M$0]?7N1CHFWIZ_VVO#BG3E8S>J1?I%9
M/-77AY:>N)A]U36M5\6G]8EPW_GYHO\`"(:O1W`_<GD_]3D^BN7?:3^\SA7[
M0C^FKS?D_P#'[BSF_P`>+VV?U.*3SG3*C.SN&\AM&2*%GCK+$L59-C57DFB0
MKF0J5J<-"LG;1?O(I`N#A(A7"21RU,X#S+<.*;UAE,EOU3+*JS1DW4JQL7`\
M`Z7U`BQ-M).DD5?ONMVZVCGO&MP27#3]?00NV-,`!(KJ-0C+#J8Y"-+*;@7U
M`:@#5*3Q&\L[?Q0YMX=D8N9>M\?Y6N58Q/EBO=]0(B:J]SET8%E+OV8&[:CZ
MDRTJG*-%@`%B=E5$INVX6(>T_<?CF-R+BNYQR1`YF/$TT+>E712Q`/J<`H1X
M=0?$`BBO9GF.;P_GFRO%.PVW,GCQ\A+^ZR2,$#$>N)F#J?'H5'1B#LC=4<KI
MY4,7FH\BTAP6X^QU<QC(-V_(3.!Y:`Q^[$J+A2C5R-1;EMF1C-%2J)*/XP)!
MNTBB+%[9Y!R"XE53:+)&E'M;PE.6[R\^>A.RXEFD'AYC'ZD=_4;%GMUTBW0L
M#4(=\NYDG;_CD>-M4@'),_4D)Z'RD4#S)K'I=;A8P>A=M74(P,!7@7\?4#RZ
MRU>>56?V/XYQSB&SH-HJ`LP+2[3).9Y9(MC=2%J6>'6":CJ<R=MW[QJXZPD'
MTBU%83HD726F'N_S.;C6VXG'MF?RL[)C)++T,4`]T!+?5+D%5(^JJM:QL17?
MX>NW&/S/>-PY?R./[1MN',`J/=A-DM[Y:0GZPC!#LIOK=TU74,&NK9)QAC_+
M^/[-BS)=3A[ACZXPSB`L56EVI58U_&."`3M%*04U6;AJ8I5&RZ!DUVJZ9%43
MD4(4P59P=PS-MS8-PP<AHLV)M2N#U!_A!\"#<$7!!!J\^Z;5MV];=E[3NF(D
MVW3QE'C8>Z5/T$>*D6*D`J00#6NVY<XFR9XF/(?+L<-6B8@W>.9^*R7@ZVNC
M%<.I/'MH167C(Z<*)$4)UJDB9]7I@ATR(2(M'("F":O3JZO&]QP.XO"XWW/'
M5UG0Q3H/`2+T)7TJ?JR)UNMUZW%<UN9[/NG9SN5,FQY;QMC2+/BR'J6AD!(5
M_`.![T,@(`?2W2QJ^]PJY1U?F7QFQ7R&JZ"4<%X@MK+7TU^^:JW>&<+0]QK9
MCGV7.C&3[)8&JBA2'<LC(K](`J&J?\JX_D<7W[<-ER"6\I_=;\>-AJ1OG4BX
M'@UQZ*Z&<&Y9B<WXMM'),-0HR(_?2]_+E4Z9$]?NN#I)MJ72UNM=$\C?+3_V
M3\0,L9Z8MF<A;XB/8UO',6_+W&;[(%N?(P=<4>(`9,7<="*N3R;M$#D,NT8J
MIE,4Q@$/7PCCG]JN2[=M#L1C,2TI'B(T&IK>HM]4'T%@:Q_<SF/]A>%[QR%%
M5LQ%"0J?`S2$(EQZ54G6PZ752`;U3)\5?%]]Y2.=MMN7)^PS=_KE;CG^9\S/
M)!ZJWDLB3"\Q'1%>IR[R/]L>(B)1^\ZU4F96Y$8F.4:-O;]2)D[0=PM_3M_Q
M''QM@@2&=V$$``Z1C22SV-[D`=";W=@S:NMZ0=HN*2=VNX.;G\LR9,G&B4Y.
M26-C,Q8*D1(MI5B;D+8"-"BZ;J1?\K59KM,K\+4ZC!1-8J]<C6D-`5Z!CVL3
M"PL2P1(W91L7&L4D6C%DU0(!$TTR%(4H;`&J<SY$^5-+DY,S29#L69F)+,3U
M))/4DUT5Q<7&PL:##PX$BQ8E"HB`*JJ!8*JBP``\`*YS7QK[U__6P5\E.<)'
MD/SJY.9+>/#O&"^5;)4JL(J=:25+QZ[&BU`C<A1%)$B\!7D%S@3Y3+K*'$1,
M8QAOGP;:4V7B6PX"K9QCJ[_GR#S'_P`IB/D`%<K.Z6_2\D[@<JW1Y-4?VMXX
M_4(H3Y4=O0+H@)MZ23XF]7U/$YCAGBWQR\0ZXT0*W^]L/0.0W8`3H44?Y65=
MY,>*+;@!C*]ZV"7<?@4H%#T`-5![BYS;AS?DD[-?3DM&/DBM$/XE="^T&V)M
M';/AF*JVUX23'Y<B\YO[;R5(=K2JDBJ)?U)N.&=3YX5.[L&Y4BY5P+39N76`
M@%%U8JQ8;;2UU#F`/G,G6X2*)N/J`%`/@`:MSV-SFR>(9&*[?_KYCJ/8K*C_
M`,9GKG]\4.V)A]P,+/C6PR]NC9CZWC>2(_Y"QU+Y]-)F%]<N'N3\1R;H[D^%
M\P.EH),RG4#"IY)AV\^V8)IB(BF0;=&S;G<-@,9R/V@(ZC7OKMB8O)=OW*-;
M#*QK-[7B;23_`(A0?-4S_"WO4F=PG==FE>YP<TZ/9',H<#_6"4_X52@>4L!'
MQU\R0`-_\PE['\Q8TPB/Y@#6@]OOWVXS_6T^FI7[L_W:\V_9\O\`%K7/7S#L
MG3<18'R]NLK7LSL,C-FZRA!!-"SXUN[F"GHY`X$!,R2,'*PSC](3@HZ-N`%Z
M=[LX>YQY6Y;OMO038IC)_-E0,I_Q@X^:N9^X['+@[)QS>^IQ\]9Q\DD$I1P/
M9H:(^N['V5?$\#F?SYS\=N-(F2>>[LF"9F>PA,B=8#K?=U9%I,T@02$QE$FK
M6AV*-9)B/RF,S/T_`0"HG=[9AM/-<Z6-;09:+.ORM=9/G,BLQ_.%=!OA]Y&>
M0=M-JBE?5E;>[XK>NT=FB^80NBC\TUA)]2WFJ29X?X\<6:J+AY8,T9'=W.7B
MHX16?/8>AH-86N0JK0@BHJE8;=<TEFX`41.XB-@'<H@.U]BMJ1MRWKD&180X
ML`12?`-)=F:_Y*)8^QZT/XH]]E39>-<1P[MDY^49&4>)6*RHMORY)01ZS'50
M[D-BL^#,ZY>PNL]"2<8GR);,=/)$OZ#]_3IEW`/WB8=)>E-T\8*'*&WH4P!J
MR6S;@-VVG;=T5=*Y,"2`>H.H8#Y@:IER;9_[/\AWK8C)J;#R9(2WK,;%"?G(
M)K:FP9`2A8=,-MDXN/(&P;!L1HB4-@^P/37/B8WFE/Y1^FNN,`M#"/4H^BJ<
M'U/F8GTEF?C?@)NZ.6)I^-IW+$FT24_4N9B_65Y4XP[Q,#"!G$5'X]<"CN`"
M0C\^WH?5F^PFV)'M>^;PR_I)9UA!]2QJ'-O83(+_`)OLJDWQ6[W)+O?%^.J_
MZ&'%?(8>@M*YC6_M40M;U!SZZRU^E_Q\TC^/O)C*@(%!_;LQUV@'<B3YS,L=
MTII844BG$O[V#C)RHB`#ZC\?@&M<[^9C/O.P[??W(\9I+>V1]-_^ZK<OA1VY
M(N-<HW;3^DFSDAO[(8@X'W9S5G[4!5:RFE*XR;("D-+IC\#QC\@[_#8S54OK
MMZ_;KZPFTT1_*'TU\YA>&4>M3]%:T7Q:?UB?#?\`GYHO\(AJ]7<#]RN3_P!3
MD^BN6W:3^\SA/[0B^FME?:9^-J=8L=IFETVL/6H&7GY9RJ8I$F\;#1[B1?KJ
M'.)2$31:MCF$1$```]=46QH9,G(@QXA>61U4#UEB`/OFNHN7D18F+DY<[6AB
MC9V/J5023\P%:O7AW0)C,'+WCE08%JJ9_<<ZXX:=#8ISC'QQKA&/IF2-VBB<
MK6$AD'#I8X!\B*!C?`-7[Y+FQ;9QO>\V9O<BQ)#U])T$*/E9K`>TURAX5MTV
M]\TXUMV.GZ2?<(1T_!7S%+'Y%4%B?0!>MI1KG]76:M>+YW,WR&9/([EZ*,[.
MO7<+1]7P[5VXJ=2;5.OQ*4W:0[93"F592]V*4`Q@^<4R)@;]$`"Z?:/:4VOA
M&VR:;391:9CZ]1LG_=JGWZYL_$'OTN]]S=YA+DXV"L>-&/5H4/)\_FN_S`7\
M*M9>!S'#3'WC,P>]30*A)9(E\CY'FS%(!1<.Y.]SE?B5SCL`G,-3K,<7<?L*
M`?``U7GN]G-F<\W5";I`L42_((U8_P"6[5;WX?=L3;NU?'W"VER6FF;VEI71
M3_JT2IB-1E4TU3T^J+QTS:77B/EINW(#^P5;*..IAV!-CBTJ$M4[+7&YU`#U
M*5:[RAB@(^@B;;XCJS'8'.9L3D>VLWN))%(![7#JW\VM4L^+';$3-X;O*K^D
MDBGA8^R-HW0?=ED^_7I?TP.<5WE6Y,<<)%VJ=."F:MF6IM3GZR$2L+4]-N_:
M`QMT4TEX*#,!2ATB=<YO01'J\'?S:0L^Q;XBB[JT#G\TZX_XTGW!65^%'?VD
MPN4\8E<VCDCR8Q[''ER_)8I%\Y-9P_47U68L7CF>RT61<[.C9NQA:K"*)3F(
M2'=)V2EI'<=`"!4`G;@R#<WR]8E^W;6J=DLB*#FRQR$:IL25%_.!1^G^"C5O
MOQ+X<^3VREFA!T8^=!(]OQ3KBZ^S7(OSVJOQ]/?R?J^`^;3B@WA\UB:[R-II
M\:1DN]<(M&;#(+*69SU(1>.%SD(5*?4;/(E`@?,I(2#8H>@CJ9.\VP9&\<4&
M9B(6GP9?-*@7)C(*R6'Y-PY_)5JKC\-W*\3CW.WV[/D"8VYP>0K$V`F#!X@2
M?Q[-&/6[J*OS:I[70^FE*__7@_DG[F5D7\F]4,J\D7KI^[5,(B91R\7.X74,
M(^HF.JH(CKHZB+&B1H+*H`'R#I7'&65YY99I#>1V+'Y2;G[];3KBA&I0_%KC
M5$(E`B,5@'#D:D0`V`B3''=<;)E`/38"D2`-<^^1N9>0[[(3U;-G/W96-=;>
M(Q+#Q3C$*CW4V[&4?((4%>_:PU;#5,3ZH0K<,Y\6CE`/=&Q/=2K#Z=7MRW!H
M+8!^W8%#J[?GU:'L%J_5'(!^#]I3[N@W_@JC_P`6&C]?<1(_SGV26_R>8+??
MO7HGTM+]T6;YKQ8"862L5@!^8NX]!'2#O,3<@@'P`RJ3@V_VB!`_)KQ?$`B^
M3Q:3\,-D#YB(3_!63^$N1_-YU%?]'IQ#\]\D??O]ZK`?E&_J[>97\P.0/X(5
MU#G;[]]N,_UM/IJQ7=G^[7FW[/E^BJL$?QE'.GT]4!DF';]VW\:,ZY.R<S!-
M#NN'E)D+`C6\AQA%!$/;-FT:^;S2Q_7<L+T[?-N%@GW[]4]YYL"1K8V?AQ1'
MU"0*6C/M)(*#\^JEQ\5_M!\-N-N<*WS=KSYYQTN3$9-$R^P!2)3_`**N[?3.
M<AOP?R(S#QNEGW;BLRT1M=JNW64#H&[XP77,[9,4A'Y7$O3+`^<KF#]).')O
M^B&O)WWV7[3LFV;Y&GZ3%F*.?^SEM8GV!U4#\\U[OA8Y+]BY)O?%YI+0YN.)
M8P?Y6`FX'M:)V8^R,>JL@)15MY%/J%8QHS,,[B/A6@E[I02&48@O@=\H\>&[
M)@%JJ1?D7:"-!,(F!TQ0`P=10``PT8;A/9AV;W-RW0]/7_2!8>WIC)?V,;5L
MDK)W*^)")$/F;-L2]?5?%-S[.N9(%_*5;]1TJO%Y%!ZN??-,1_\`M1G@/S%R
M;92A_8#4T\)_<_BW[/Q_YI:K5W._O%YU^ULK^>>MG?'@`,&0````-&P``!L`
M`")````/0``-4*D_SC_*?IKJO']1/D%4#_J'I-R_\DML:KF$R4)B?%$6S`1$
M0(V5A74T8I=Q]`%Y+JC^R(ZN'V6C5.#8S#Q;(F)_QM/T`5SM^)25Y.Y^6C>$
M>'CJ/D*EOI8UF-XQ.;&:>%?CRJ#S"W$&]\KULG<H,^C:$*.M;D3T8:G0N/R,
M2M*?A3'60#&"QIS*I4?<`TV]B?H%3YNC6N>\5VKE/-,E=UY)%MP@V_'T:]'Z
M37)DWMKDC^KI%[7^L+V].\=J.=;[P?MKAR;'PS(WALK=LO6(C(/*\N'$TEO+
MAF^OJ-KZ?JFU_1F*X\YW.--,QP\0&=&Y2EW%5PYR^9,G[H__`,>$`Z?[H/V=
M:N.TW$R0/^9&*?FA_P!XK=F[^<]`)_Y+;@![3D?[F*DV\:O./-/-B#R[+9EX
MU3/&QYCV;J<9`PDZ6V@]L36?833MZ_ZK55ZLH9-@K&IIAV$3EW4'J$!V`=$Y
MWQ/:^*S;;'M>^+G+,CEF7192I4`>XS>-SXFI3[7\\WSG6-O$^^<7DVM\>2-4
M5_,NX<,2WZ1$\+`=`?;4ELD4#1T@4?@9DZ*/[`H*`.M$CZ21G\H?34HR?YN3
M\T_16M`\6O\`6*<./Y^J-_"0:O9W`_<KD_\`4Y/HKEIVC_O+X3^T(OIJ?'S1
M^927:1^;N!6(\9WK']I,]D<<9CR%??N:.<KU)V@DH^C,=P\%+SONX3(E>>I"
M65>KME#0[PQ2,RJ+E60A_M=VPB9]JY?N6?#-CV$L,<>HC6/`R,RK9HV!]Q01
MK`.JPL;$]\N]TT4>^]O=FVO(Q\S4T.3-+I4F,CJ(55FNLR$?I&*GRV("78,N
M8/A=\2%,XOPU9Y;9%MM5RQF"_P!,CYG&$C3E9!Y1,>T>[P2;L)&`D)-I&.YZ
MTVB`DRI.'QVJ";1HJHV;@8JBJRNL]T>X^5O\N1QO"QI,?;892LH>PDDDC:UF
M`)"HK"X6Y)(#&U@!NG8[LW@\2@Q>8;EFPYF]Y,`:!H[F*&*5+W0L%+O(C6+E
M0%4E5N"S&PUJ%JLC6KKYYR3J6YQ<QI!Z8QG#CE)GWKZOB4B.5+4@BD'QV*BB
MD4@!\``NK^\018^*<91?JC`Q_P":2N3W<25YN?\`-I'/O'=LO[T\@'W!6P<\
M6D<2+\=?#=LF0$RJX%HTD)2AL`GF8X)=4^VP>JBCX3"/VB.^J9]P7,G-N3,3
M?^EN/N&W\%='NTL8B[:<)0"W_M\1_P`8:OOWO6?&M.J0ZJU?5$`C_(UQ1,;;
MW`9-R$"7[;LC5845]O\`8ZRI[_FU8'L#?]9\B]7D1?QVJI?Q86_4?$/7]KF_
MFUJ/7Z9Q^Z;\[LH,$A$6LAQ9NYG1/7IZF>4<.*-U1`/3J(*AB@(_8<0^W6Z=
M]D5N(8#GZR[A';YXIKU&_P`+$CKW!W:('W&VB6_S9&-;Z?OU=0S5B"D9^Q-D
M+"^2(T96CY+JLK4[$T(8B;HC.4;F2(_CG!TU09R\2Z!-TS7`HF;ND4U"^I0U
M5K:MSR]FW'"W3!?3EP2!U/HN/0?6I%PP]()%7GWS9L#D6S[EL>Z1:\#*A:-Q
MZ;,+7!]#*;,I]#`'T5K>N?W`O+WCZS@]QY=D7DK391R\EL1959M%6D-?:RV<
M$%%RBHF=1.*M<("R2<K'"H*K)P)3D%1LLV<+7@X=R_;>9[2F;BD+E*`)HB;M
M&Q'A[4;J4:UF'3HP8#F+W&[>;UVXWY]NSE9\%R6QL@"RRH#T/Y,B]!(E[J;$
M75E8V//#AYLSY.=4CB-R[FA_E&<^WK.)LWRCHA4[ZX`$&T%2,A++;=%Y=>J#
M"6,;IF%`31<`#\X+/80[G=JA@+E\DXW%_0A=IH`/\WXEI(_^S'BR?@=2ON=%
MLYV2[[?K9L'AO,Y__=#9,?*8])CT"Q3'^5/@LGA(;*WZ0W>TQJOU6SK_T(?L
MTTAYC+,66,;R"!FK_'^2[U27C8Y1*9!U5;1*0:Z1BFV$!358B'YM=$-KRUS]
MLV[.0W2:"-P?8ZAOX:Y![]@/M6^;SMDBVDQLN6(CU&.1E_@K9S<,["WMO$+B
MQ9VBA54)_CIA66(8H@.POL;UM=0AMO@=)0XE,'Q`P"&J&<HA;&Y+R&!AU3.G
M'W)6KJKPK)7,X;Q/+0^[)MN,WW84-9)ZP5;/5&[ZF.YMYKFMBBG-5BJA2>.T
M`L_(40'VTM:+Y?7RC<X`(B4XQ#-BKZ[?*J&K9=B<5HN*[ADL+>;FM;VJL<8_
MC%A\U4'^*?.6?G.SX*-?R-M0GV-)+*;?XH4_/6?GTO6-WL7AWE1EM=J9-C=L
MCT"@1KDY3%!=7&];FY^3*B([`=,@Y.;@(AZ=0"'Q`=:=W]SEDW/CVVAO?B@D
MD(_TK*H_FC4B_"AM;P['RW>&2R9&5%"#Z_(1G-O]>/\`H*F?\I)NGQV<R1VW
MWP'?2_W\4<F_YNK47]OOWVXS_6T^FIP[L_W:\V_9\O\`%K`3P3T>!R7XF?Y.
M;4V*^K&0;)GRF6)D8`$KJ"M+QW`RS80,`E'O,'BA?7\NMP[N9<V!W&&=CM;(
M@CQW4^ID`8'[H%1[\/\`@8^Y]GDVW+35BY,F7&X]:2,R,/G!-5"L$6^T<`/(
M!2)RT'<,)CC;R%6K&0BM2*)JNJ_7[.]I626C4OS&,C-U-6012$.H#IK@(=0"
M&]D]WQL?F/#LN''LT6=A:H[^AF0/$3^:^D_**IAQ[-RNW/<?`GRR5FVO<C'-
M;I=$<Q3`>QHRX'K!]-7"/#-P;LG%^\\Z<AWY!=[/7;/TG1J!9I%3W;NTXGKI
ME[K#7UA(@90CJ.R.%]:N%#@8QCK1P=7J75:>Z'+(-_Q.)86&0(8L,22(.@25
MO<,9'H,7ED6]35=3LEP'*XGN'<#<MQ4MD9&Y-%#(>IDQTO*DH/I$WG`D^M.O
MA5.+R)_T^N:G_P"J,]?^I]FU9KA7[G<6_9^/_-)5)>YO]XO.OVME?SSULZX@
M_<BHQ3?JZX]D?J_;=39(V_Y]]4+E%I9!^4?IKJM$;Q1G\D?15%'ZDBC.ZWSZ
MKML,@8([(N`Z++MW8%$$U9"`GKA5)!H)Q'8SAJTB&AS`'P(N3\NK;]CLM9^'
M38^KWX,R12/8RHX/R$L?G!KG_P#$_M[XO</%S-/Z+)VZ)@?RD>2,CY0%4_(1
M4Q'TR]E;R'";+U7[A1?5ODQ9'ZB75N8D=8<:XP%BH)=O0JKR(=@'Y1(.HS[\
M0,G*=LR+>X^`H^=99;_>85-?PL92R<#WC%O^DBW1S\SP06^^K?<JQMJ$*LS3
M2E<=+FZ8F4,([`6.>FW_`";-E1W]/7TU](?\[%^</IKYR](I#^2?HK6A^+7^
ML3X;_P`_-%_A$-7K[@?N5R?^IR?17+;M)_>9PG]H1?34Z?U,'$<6<OB?FC4X
MD@-I=-'#>75VB(@8)5FD\E<;6-\"8&ZS/(Q*0BUW*@%`@,V".XB<@!$G8GDF
MN+<>+9,GO+^FAOZC82J/D.EP/RG/H-3_`/%-PW1+L_.<.'W7MC9!'XPNT#GY
M1KC+'\6-?2*SD^G3Y8$S'Q*F>/5CE1<WGC3._=\4BZ6`[IYBBYN'TO4UTC*"
M"S@D!.)R<:8I0,5HT29$$0!0A0U/O9QT[9R.+>H([8F<ES;P$R6#_)J72WM.
ML^@UOWPT<P&]\-FXYE37W#:Y-*@GJ<>4EHSZSH;6GY*A!Z15A;4+U9"M9?Y1
MJ,[QYY$.8M>>(&;*.\\7FY()&()-H_)$B.1(I0I1_P`&M&6E$Y1^`E,`_;J^
M'`,M<WA?&9E:X&'&GSQCRS]]#7+#NU@/MO<KFN,ZV+;A+*/DF/G+]T2`U?!\
M35B;6CQO\/9)JJ"R37#D)7#'`0,`.:>\D*D\2W*(AN@[A#D$/B`EV'UU43N-
M"V/SCDL;"Q.26^9P''W0U=!NSV2F5VQX7*AN!A*GSQDQG[A4BI#]:54DU45^
MJ0N;<[KAQCQ!<!=(-\T7.3;`8-R-W:F.(."7,3X[*J,I$I1_<#JR/8#%8+R;
M-(]TF!`?:/,9OI6J;?%GG+?A.VJWOC[3*P]A\E$/WGKS[Z7_`!+*/<O<F,ZJ
M(=N%K.-Z[B9HY4`P>\E;O9VEPD$6IMN@WW:SQ^V%?[2^[2^PPZ]O?S<8TVS8
MMH#?I9)VF(]0C0H+_*9#;Y#ZJQGPH[-*^\<JY`5M!%C)C@^MI7$C`?FB);_G
M"KE>JPU=RL<N5/%C#_,7#5EPGFFN(35<G$3KQ,HD1(E@I=E1062B+A4I(Q#*
MQ<_#J+B)#!NDX1,HW7(JW652/G./<AW/C&Z0;KM<Y6=#U'X+KZ4<>E3]T&S`
MA@"-9Y=Q+9>:[)E;%OF,),6075OPXG`.F2-OP76_R$75@58@ZU?E5QRR!PXY
M%Y&P'>'`?BG&=B2186&,!=FVGH9VW:SE2M\./<,NU0G(-ZV>$)W#*M5#BD<W
M<2-M>?CV]X?)MDPMXQ!_1YTZJ>I5@2KH?7I8%?4?'P-<N^7\8W'A')MSX]GO
M_2\64:76X#J0'CD7TC4I5K7NIN#U!J;C_7RYO_C3*?U>O\EWZ27]+'_3A^\_
MXZ_X+]X_<ZBO_E#M/^SK_P`9\[_RG\A^;]_VU/?_`-@]]_VMOW:\GT?\0_VG
M\[V>'LK_T>0^H#XCR^!>:4OFF)BEB8QY.(?CB-DD$3>P89'CFS..R/7UU@#8
ML@]?E1G/FV[A98P$ZNRITW#[-\DCWCBT6UR2#[?@'RR/28R28F^0"Z?X'M%<
M\/B-X;-Q[G,V^PPG]5;J/-#`=!,H"S(3ZR;2^WS#;ZIM8R\!')&)SAP#IE!6
MDDE[SQTE93%UGCS+%%Z2OK/WUAQY+>VW%1*,<5F0".14'Y5'$0X`/T!`(2[Q
M;')M7,<K-"$8F<HE4^C4`%D%_6&&H^H.*LS\._)X=^[=8&WF4'/VQV@D%^NB
MY>%K?BF,Z`?28V]537N7+9DV</'CA!HS:(*N73IRJF@V;-D$S*KN'"ZIB)(H
M(I$$QSF$"E*`B([:BI59V554EB;`#Q)]0J=&945G=@$`N2>@`'B2?0!6M$Y_
MYKE.='D`S!>\;L9*W(Y%R5&X\P]$1+=9T^L4!7TXS'=!)$1Y0%4'-M0BT7H(
M`'5[A\8!]1'5[.';5'Q+AVV8F<ZQF"`R3$FP5FO))<^I"2+^I:Y;]QM]F[@=
MQMYS]K1IER<I8<95%RZ)IABTCUR:0UO6QJ_?X].*C7A?Q$P_@0PM%[/`0:DW
MD229B51&3R-:W*D];U47(``O&,=)/18,U1`#&8,T-P#;8*=\TY"W*.2;GO`N
M,=WTQ@^B)!I3IZ"0-1'XS&NB/;?B*<'X9LO'NARHH]4S#P::0ZY#?T@,="G\
M15KK'E-'I\=7,@?C_F'NX?WS#I_L;Z]';[]]N,_UM/IKR]V?[M>;?L^7^+6'
M?T]1=O&I1!_;9-RT;]C_`+4J%_WNMF[T?OUE_P!7A_BUI7PW_P!UNV_UK(_G
M#5>;Z@SC2^QMY`4KQ6(9=:*Y/U.M6Z+;,&YA*ZR#$F1H-JAF*)"]2\B\5C(V
M16`NXJ+R^_Q$=31V9WU,[AOV2>4"3`D9"2?",_I$8^P791[$JMOQ'\6DVSN*
MF?B0$Q;M"DB@#QF6T,B@>ECI1SZS)5W/CM0)W%&`,'XOM$RO8;)CG$>.:-8)
MURH19:6FJI4(B"DWYUB%*"ON7K$Y@,.YC`("83&W,-5-[S(=QWG=MPQX@D$^
M3+(JCT*[E@/N&KX<;VZ?:..[#M.5,9,K&PX8G<]2S1QJC&_IN036MB\AI@'G
MMS5$/7;E7R`#\Y<J6D!_VA#5Y>&?N?Q;]G8_\RE<ONY?7N+SG]KY?\^];.2K
MJ=ZLUU7X]V"B%-_COUQ[<WQ_/JAF2+9&0/RV^DUU4Q3JQL=O7&OT"J_/U%W$
M.7S;QAJ?(:E12LG;.,TI,/K0U9(&5>.L27%..1M,CT(E,LY"H3,/'OC@(=#:
M..^7$2@4V\R]DN2Q[5OV3LN5(%Q\]5"$^`F2^D>S6I9?:P0>FJY_$OPR;?N)
MXG(\"$OF;4[,X`ZG'DL)#TZGRV5']2IYC>@U%O\`37\I(#&F?\I<:K7(`Q2Y
M"0T%,T%5RHFFS-?,;MK(\=PI#J*$!-W8ZM+N%">@]U2,32+\YR@;?^^?'YL_
M9MOWW'2YPF99+>/ERE1J^174?(&)\!42_"[RS'VOD6[\6S)=(W%$>&_AYL(<
ME?E>-B1ZS&!XFKM>JJU>VFE*X.SJ]BM6%;?;LP<LKOOMMVV#@^^X>H;;:^V,
M+Y$`];K](KX91TXV0WJ1OH-:TKQ<&Z?(APV'?;_/Y0"[[[?IRR90#^Z$=M7I
MY_\`N5R?^IR?17+GM*;=S.$_M"+Z:V'?,3CG`\L^,N9>/D^#9-/(U,D(V$D7
M1.XE!7%@*<Q2+$(`4QQ"!ML<S=&*7U.1(Q/@8=4MXSO<W'-^VO>8;_H)06`_
M"0^ZZ_X2%A\IO727FO&L?F'%M[XYDVME0,JD_@2#WHG_`,"0*WM`MZ:U]?CL
MY)6/Q^<\*-<+H1]7(>`M\OA[/<$XZB*LZA*ROX;NB,DW3$3+.:3,LT98B(#\
M[N*(3?81WN9S78X.9<1R\7%(>5XA-CMZW`U)8^IP2E_Q7-<X^VG)\KMQW"P,
MS/#10QS-C9:'T1LVB74/28F`D`]+1@5LI&[A!VW0=-5T7+5RBDX;.6ZA%D'"
M"Q"J(KH+)B9-5%5,P&*8HB!@$!#TU1=E9696!#`V(/B#74)65U5T8%"+@CJ"
M#X$&J9'U*G$>7K.7\?<QZU%*K5')D)&XSR4\;(F.G$Y"J;5P%4DI-4`_5DM5
M+2*S0'U*4T$8#"!E4P-:#L7R2.?;,SC$\@&3`YEB!],;GWP/S'ZG_2#U&J0_
M%'PV;%WG;>;XL).'E1K!.0/JS1@^6S?Z2/W1[8O:*D'^FYY+0E_XF6GC;(2S
M8EXP+=IN6B(-5RF5XZQED1\>Q-95DW4,5=P@PO3R70=BF4R;;OM>L2BX(`Z9
MWQV*7#Y%C[XD9^R9D2AFMT$L8TD$^B\80B_C9K?5-2/\,/*8-RX=E<8DF'V_
M;IV95OU,$QUA@/$@2F0-;HMTO]858VU"-69K7C><#DFSY3>0:Z,:,Z-9*IAZ
M,A<"TY6(ZGZ<Y+5V0DGUM7C$6@*E?*+Y`L,@R041[GNT&B)B")3$`+I]J-C;
MC_#,5LM=&1DLV0]^FD,`$O?PM&JD@VL2;^FN;7?ODZ<M[CYL6WOYN)A*N)'I
MZZV1F,FFWC>9W4$7U!5(]%7`_$=PW>\*.%M"Q]:F!6&4[PZ=Y5RT@(%%:/N%
MK:,$FU:6.43_`*ZH5>-CXQ<"G.D9ZV743'I4U6GN1R=.5<IS,S'>^WP@0PGU
MHA-W_P`-BS#TZ2H/A5TNSG"7X)P;;MLRX].[3DY&0/2)9`+)_P#C140]2-2L
M1T-2;:T*I3II2M>SYX<H53,ODER$SQXHE/\`X!K=&Q%)NX8OO2R]WK[=TO/,
M&H-@44=OX:7G!AU2``G!TQ.F`#TAO<_M%M^1MG!L)LT%/.>28!NED8^Z3?P#
M*NL>Q@:YO_$'NN)O?=#<8]M(D./%%CL5ZZI4!+J+>)5G\LCQU*1657^H/SU_
M%]S_`$!?Y2_B7^E5_H0_3_QQ_P`X_P"3_NM:]_S@VC^7'_&/*_\`*?R_YOWZ
MW+_Z\\@_V8_NYYW_`)__`&;\[V^'MK__TKB_D$Q7P]S3Q^?XYYI7?'N-\=6"
M:01J5YOE]J^-W%7R,2(F1@YBE66V2#",+;F,8+U1-L;OD=-"N$UD56XJE';.
M&;AR;:]Y3.XMB33YJ)[\<<;RAX[KJ5U0$Z"=/7I8V((-JT/N-M/"]\XY)MG.
M<[&QMLD<".6:6.$QS:6T-$\A"^8%U$#KJ74&4K<54^X[\=N;_`OD';LB>-3+
MO'SGI2FL>W97F'PEE+'N0QG:0Z?K'@FF5\20E[);Z]+%>-U#LGL0X>%;K`H5
M-X*:KA!2Q.];UQ3E^RXV%SK;<W:,HM=#/%)'ID`]XQ3-'H86\5<"XM=;@$5`
MXSQKGG;WDF;N7:W>=MY%MX4"5<7(AFU1$G0,C'67S$:X.EHV:QN`]BRG-CD[
MR4\V',3$=LQ!'<-6_$C&DU795',N2K;/-Z*@C0T6*ZEL"3OV49VM1%4HYX8B
MYI4S9NN\.R*<@+@D94BNJ[!L7:OC.Y8VY/R<[EG(X\F)%\S])?W+1Q*S/)JM
MHN0NJQM>Q&^<KY/WUYILV9LL7"%V;:Y(F&3/)((@(K'S+RSLBQQ:;^854MIN
M-5B0?5/$#P8X"\:+Q6KO:^87$[DGS#G068T.L8ZS3C>V0]`<K,7!Y!OC:!1L
M"EDM]Q7CR+=Z6,Q040:]:;9NB7O+KX_N5RWF&^XD^)C<9W'!XTG61Y()4:07
M%O-;3I1+VLFHW-BQ/0#*=E^`]N^+9V-G9?--GW3FLG2)(<F"1838W$"!]<DA
M%[R:00MPJJ-3-9VU`E6KK"CR.U)]?."G*6G1LK5X-]9,06:*;3%VM4%1ZE&G
M=))E%Y8;=9WT97Z_%($W,JY=N$D2%^)M;5P?)3#Y=Q_*DCD=$R5)5$:1S;T*
MB`LQ]0`)K1NYF&^X<!Y9A130QR2X4BAI9$BC6X\7D<JB*/2S$`5C-X1<8R>(
M>`=(I$O9\;6]^RON3G:LYBC(]-RM37!7]I<N$DV=QH<O.5YV[02,!5T2KBJW
M/\BA2F#;6>[K9\>Y<QRLN*">)##$-,T3PN++;JDBJP'J-K'Q%:KV(VJ79>W6
MWX$V7BSR+D3G7CS1Y$1O(3TDB9D)'I%[@]"`:[5Y",&\><N9CX`6/,^6L38T
MG\2\D`NU6ALDWNK5&5R3!LXEN]D*;2HBPR<>ZMTG(90BJ4DX;-2K"5NN8IBB
M95,I_/PO=MZVW;.8P;7MV3/#DX.AFBC=Q$Q)`=RH(0"(SD$VZCV&O9W'V#C>
M\[UV[R=\WC#Q<C#W3S8UFECC:=0H)BB5V!D8SKC`JM^AZBY`,HVH_J5ZUY7-
MO@Y?[AS%Y:V]MG#A;#(63DEG*>:P=KYH\;:I;&#>6R79G[=C8*S.Y%92M;FV
MZ2Y2.F+Y-!TT7`R2Q"*%,4+H\5Y9AXW&..8S;3NC%,&!2R8.2Z&T2BZNL9#+
MZF6X(Z@D5S=YYP#<,WF_,,U>0[%&LNZ93A)-SPXY`&F<@/&\P9'%[,C`,IN"
M`0:V!U)1<-Z946[L43.D*Q`(N3-ET73<SA**:$6%!TV.HW<HBH4>E1,QB'+L
M)1$!`=4VS"K9>4R7TF1K7%C;4?$'J/DKHO@*ZX.$LA&L1(#8@B^D7L1T(]HZ
M&OV64*Z-<GPM_P!S?A,825"T?B(61:_^'18KA-_?II(0C@AONWN^Z%Q^I['5
MU_+OK\0>?Y\/V77]IUC1IOJU7]W3;KJO:UNM_"OIE?9OLV1]MT?8_+;S-=M&
MBQU:]7NZ=-]5^EKWZ51XY4>-?#L#G>#RCXMN<7%:W3KR[PT[C;!3#E-B2.S#
M5L@C--75:A<03;BY&8W`"3?;^[&[QRSDT1!)`#OE![@VPX]SG<YMHEV_G_$]
MPBB$3++.<28PO'I(9IET73W?KD`J>I]P=*H7RWM?LD'(<?=NTO/MHFR6R%>'
M$7/QUR(YM0*+C-YEI/>MH5F5QT6\AZU*'0_(3YPH&`94.[>,I:_Y&9-R1@9#
M]G,U.O2CI$@(DE9U",DW-.4<N#AUN#L9.-9&,(BDFB38`T#,X9VHFF?+Q>=B
M'")OY=U=@/4I(U_)J5F]9-2SMW<;OUCXT>WY_:O[1N:C3YWO1HQ\-3@,8[GQ
M)5T4^@**D4\?M:\DTK=\I9E\@DY0ZR%PKM<K^+\!8^DVCF(QRC%24D_L$LY:
MPKV?A3O)D7K8GN5)J9D#E3[:BJ*1$DM:5S*?@T>)@;7PV*:3RI&:7(D!!DN`
M%`+!6LMCT"(OI`))-25VZQ>Y\V=NV]]QI\>+SHT2#$A8%80I8NQ"EENUU&HR
MR/TL2H`%2279%PXIEN;M!0!TO6)]%L+EPBU;`X5BG9$1<.G"B2#9`%#!UJ',
M4A"[B(@`".M&PRJY>*SWTB1;V%S;4/`>GY*DW/5VP<U8[>88G`N;"^DVN3T`
M]I\*H+^/;A+?:+S=XHW-YFKAK/M:]G"@2KR"I7,KCC<[>\;-9MLHNV@JI7,B
M/YJQ2IDP$$FC%)PX6/L5,AA';5PN9\JP\OBG(L5=JW1&?$D`9\+)1`2IZL[1
MA5'K+$`>DUSR[;<#W#;^>\1SWW[8Y%CSXF*1;EARRD!NH2-)BSMZE4$GT`UL
M#]4UKHQ5%;RU<&ZE>>=N8[W@GD/PV80MV>-YZ_5>\<M,!XYLE(S`0[F'R16Y
M>KVV\QD^UDG,Y$C*N>Z@7MNI)5$=C)&*6V_;GEF3B<1VS$W?9=S,L0TQO'AY
M$JR0]#$RND94C2=`L?!0?`U0+O%P#"W#N!O6X<?Y/L:0SD/-'-N&)"\63U69
M&CDE#ABR^8UQT9R/$6JUIXSV/(.!X:X>IG)6(A6U_H5?9T^(LM;N=8OD!D+'
M,2Q9CCFZQD_5I269.2.ZDX;-%3J*]UTNR.Z]4W!!&O'/'V:;E&YY6Q2L<.9R
M[*R/&T<I)\U"KA2+."PL+`-I\0:MYVNCY'C<)V3!Y1%&-QQXA&KI*DJ30J!Y
M,JNC,#>,JI)-V*E_!A7L_+6H<<[_`,?,C4KE?,4FO8)L\8SA[C.Y`M4-1Z_#
MK/)1DE7)-*VSKV/CX&>9646BD8X%8IRR!40(!C"!1Q?',G>\/><+*X[%*^[Q
ML618T:1FL#J&A02RE;AA;ZM_EK-\QPN,[CQS<\'E\\$?'Y4"R/-(L2+=AH;S
M'(".'TE#>^O3:YZ53.J/"KD+Q&Y4-<H^*GE-QSYBR%=:S$K%5G&&;L/63*3G
M'BJS5&>KN3<2)71`;57Q*NV0=.(99?K6!%TD1@Y*B"-G\GE.S<DX\VW]PN/Y
MNV(Y4%I8)EB$G72T4VCW&\2`X'2ZDN+WI%A<%Y)PWER[MVAY;MF]R1JS+'!E
M8SSF$D!TGQQ*/,3JH9HR>NEP(VTVDBR[R[\[7)#'$MA^C<%#<=I&RQ#J&NF6
M#+KU9Q'Q#EL=&:=5BQY)M,37Z4DJS,H!W?=D'K9(1.U627*14NC[;QOM'L>=
M'N>7RW[:D;!HX>CW(/NAEB0L_6WNV52?K`CI4H;SS+X@.3[9+LNW]O\`]62R
MH5ER"V@JI'O%'F=4BZ7]Z[LH^J0UC7EOB9\?7!G">3J%EWD)S6X=YDY#)ST.
M7#N%L=<@L76J`K%V>/$4J](?JK&23R%D9*162)%M&C3V;)]LHB+U?VRS?W]Q
MN9\LW7`S-MV7BVYXVRZ#YT\F/*C,@'O#ZMHX[7U$G4R]#I&H'#]G>W'`=AW;
M;]YY'SK9<[DPD7[-C0YD$B1RD^X?KZIIKV"*JZ5;JNMM++;OU6VKETTI4!?.
MSDAY<KOE&_\`%;A?Q$EJ'"H*I19>54A/,G,9.5J98(.TYVB6>RMJG2:=)H,G
M8HNR`K-RK%R10B`).2)*:F+B.Q]M\3;\+D/*.2+-*1?[(%(*LIMID12\CBXN
M.B(PM>ZDBJ\\_P"3=Y,_=MQXEP;AKX\`(7]8,X*LC`'7$[B.*-@#9NLLB$$+
M9@#6%OC(\>/`;`^6:5E/D5SEXI9]Y2H6QF-%Q74L]8VFJW6LF/)1!"'61:/K
M&2VY*R4UGC@#'K9MDD)$X&3;+N4T'!=IYYS3F&[[=E;?LG$]QP^/F,^9,^/*
MK-$!UZA=$417ZWO$E?%@I(K1>U?;;MYQ[><'=N3<^VC<>7B8>5!'EP,B3EK+
88%_,GG#_`%;JH#]0C,%86QM5TJX%?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g825446g60f17.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g825446g60f17.gif
M1TE&.#=A;``7`*4``/___]?7UV!@8#@X."`@(%!04*>GI^?GYWAX>$!`0!`0
M$)>7E_?W]Q@8&````-_?W[^_OZ^OKUA86"@H*$A(2,_/SW]_?^_O[Y^?GP@(
M"+>WMX^/CS`P,&AH:,?'QW!P<(>'AR`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("P`````;``7```&_D"`<$@L&H_(
MI'+);#J?T*AT2JU:K]BL=LOM>K]@*0.#$&P"1HVE8$$/%Q8#\6%I"S&6RQ!?
M&=(M11<+'0(6?4-UB8F'0FH2%AI%=!A$&X9*#P,.FYL(0P<4G)T,0A\.&0=#
MI@JD``D.#T.O!*D`$)M$&@VB#A]#O)R4`!>AHA1Z0K<."T,$#L)(F@,0$!T.
M($.:!!$0&QD.G@`'W]@`#`J]LK#J#@.DRD,5WPT=%@D$L4)UIKUUAZ\-N!E`
M)V&(L@P0A#B#9L2`@PFM`+@!@.%4+0`.UP$PU4"(0U3J\KGBU,$6+B&O"BQY
ML$DD@`B;&"GSD(R3@E@+DR!PL`&)_C651-#)`5!A4P0`F@J&5,</`SPAWR(!
MT)"@*D.6&DLYH%!D5T^3#@2T8Y`3B:FC1PJD(\*!YQ"U!8HZ8#12Y"L(.S.`
M.'EADYN*FP#Y:4G$FM(A;<LI8]!60-DC"\(BL?`P(M:$0F!NW5KDE5T'"5]]
M<]#,K3@(8@4+P>IR@P,"EHW6)!U@]+,D!]`A2*4A[FJ"L2"T=<>6$]JE*$$/
M<W82@.L,"QA<P(!.-0#61`[LHH`FP"N(L^\$4V+`]J;#&M")FN#2^28.1CRK
MPQQ`?6%>&118QTX$PBY1#=`4GA!BW:9$``(,0$`!0WV"0`(*)!"=$0SLPDQG
M6=TUA&9%-$`@P0034%!!(7,0%LB##22``#(#FJ,)0V'$*..,--9HXXTXYJCC
0CCSVZ../0`8IY)!/!`$`.S\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g825446g66c71.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g825446g66c71.gif
M1TE&.#=AOP)H`*4``/____?W]Y>7EX"`@+^_OZ^OK\_/SX>'A^?GY[>WM]_?
MWZ>GI^_O[Y^?G]?7UX^/C\?'QWEY>3$Q,0$!`6%A87%Q<0D)"4E)22$A(4%!
M05%141$1$3DY.5E961D9&2DI*6EI:6AH:$A(2&!@8']_?WAX>#@X."`@(%A8
M6'!P<%!04$!`0"@H*#`P,`@("!@8&````!`0$-G9V='1T3,S,S,S,S,S,S,S
M,S,S,S,S,S,S,S,S,S,S,S,S,S,S,S,S,RP`````OP)H```&_D"`<$@L&H_(
MI'+);#J?T*AT2JU:K]BL=LOM>K_@L'A,+IO/Z+1ZS6Z[W_"X?$ZOV^_XO'[/
M[_O_@(&"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=GI^@H:*CI*6FIZBI
MJJNLK:ZOL+&RL[2UMK>XN;J[O+V^O\#!PL/$Q<;'R,G*R\S-SL_0T=+3U-76
MU]C9VMO<W=[?X.'BX^3EYFL*``A.$'X*#>D![>?T]:X'*`0I+4T(,`Q-%!B8
MHF#!P"(01!1H$((`$P7Y`"CX]\0`B@?IA$!(42(C``<C'A1(X3"/`X#]4.H)
M<+"+@@#V8@HBH6+(BBT%`I`@(04!_@H`+-85.9&N@8LF)$HR"2!`Y0JE0G86
M&=$`@`$8#NP<R#"AJP4-\XPDR+"AJX<+"8H$\-#U@9$`92<4&$*@:X8B=2=<
M,-)U`I($%]B:C>!1"->^B/L.,-(@@X6N&,`>R;NA,``*7:O*W$PF@(NT&C4>
M()$@P((#"A@<@-!@!0(&(PH(>"KDP0(4!V:,&$$`)HD&*=9!6.&@!`J80PJT
M"*`".1&B`![<E`X@X<`4)$JD`)`4@(#M#E2<%G'P0`$5`H0"H$U$*A&J$F&T
MC..`0^*^$9P#"`#B?E<**@%P0%<2&/&`6<[E=1<1>4VP&!%]&<%`!_Y-8,%<
M0QQ6H8-$_B!P087YX=47!_IA-H%FG*7XQ566K2>$:PBX`%!-`$`W`D\DA"#1
M3=EQQQ,`"_!DD1`G9-4":$($T(((,"60U1`G+)""""C!(`1O`+3F@([=*7`3
M=R5$]]-(`)00IDU0^3A5"06$1`<#@MD5UP0>%&8B@1\@QD&'CTV0I@1='<"@
M72+VA20`$1;Q85\>D&56815D("D&7DDJ*8H!`#HBI7UU4&A7(!!A(HHJEJJ%
M/_,!D`"-);BEP@,(:&9C50V,4%U-),SEG@J@O0#0"5>2&@("(AQ`P(W/%14#
M0%8"@&6M0W3YY6\`$##==@>0REZT/PX!GQUW1C`$!!Q8,%\"_GU=@%(`$2@F
M:E>>TN65>M42.FA?E0V1Z!`-]*6!1P5(D"H1`T"&1,'_(<?`G:0VF-D0HYHJ
ML18MN"4$`@8XP(^S:1'0@@#(S9JEK0"$(%)4/Y90%0/`UACL$`F(```#+9!*
M9$8Q+```1<^2S)U#7D95E;5"B/!``_JQ5T`Z[@F0SK=T(-!7!48\.82F!191
M05\J&3#O$!K\5^B"\NJ)W+Y":+HG%`AC@$2?&A@1]@0;W-N7!4]&//'>54!P
M0EH."""$"1`8P*00+9P)P`M/"][`3Q"PL,(!61%`9>$H(/"`X#7"!+4!+BB`
M0`DF!$`OXP`48`)`+:20P`II/3Y$_@EI*6""$"4(_KI$DJ-&A`D.(=!".B7P
MY``+Z:#`.1T%<+U$`'UAV&'T1!QF,0)]IJI@H1+D.4&HB'9%!/1='=I$VT=X
MW=7`$/3E48/]3?`!0'KS;7\4"I`PPO)662T12A`@@`$80`"'%-`!"#`6"5@`
M$P*$!0)"<8``"0@5`2C/.REP3@`+V!()*D""U2)`5A100'D(D(2]"2#&'D``
M$MQ."`8HH`Q-*,/>2%"$=1B0_)C0OJ[0:PC>>Y`0FD<G(2!L;?<BFQ`4!($^
M"0YM/9P`O1)#@2.@SP@+\,K;NB*]!@7`>W&KW_W&B(82/&D%^M'#"C*BN$/H
M\`,\[,L/_H40Q")P*B>"D5[9E%BO"=SE0!:*(A&B&"`J6M%@6-3B$?K4Q0@Y
MH$\#$",9)SD&!BR@`4O[0ZP$4(`Y$H*($PC0$<@G%R-(C8M%`.0%B.B!R=AK
MCT*8&Z?\,@12'JJ`[9I`%8UPQ2*H;P+L<U_9:-FOKGC/9I1,9JE..0&J+0%K
M1MA:5T3)@#YQRF)CR^;,9BD^(F`MC<7<91%Z602XR:TK=1OF$.+7%V0J\YV;
M"=<0&!`!$A$!75U15Y)RR:%H(L8"GMQ>$L?5IV["K"\94`D$!"-.@B&2EWVA
M@,(89K=:VJ>=\,QHBN!TMPQX;P+Q&@*%1G31KMC3"+_\'A($_@K+(0#2H")%
MS`<<%=%#3L!MH]24770Z@;A5=`@*F),[-6J_S26@!&%Y0@,6<!N9+:X=`6C1
M$`R0JQ&$8*A5@P4$/HJ8#9AO816Z@">%L"A@KO252T0K`.9&2R*`U3\1V$!#
MAT#.(M2G0@#Z5!%`B56B2NP!.MH/"P:F!`$$%@`;>U(#NE4$!+S067T%ZI=>
MP2Z=?H`"8UV`ABR0`3T>@8A\'*AHY\FIE5Y@3AEH!P?F:L2'(N$`)=W`!=*4
M5I@*09J1]:N*7*`4$LA,?P;8GQ`8\`#2$(&WXQJ9`4;'&^)6A:H*N.H\!Z*`
MX@Z$(2`1E&E:T)O4/4!0"BC!:`2%_@H"B#()&>,#`I*Z!0A(5;?P)<)5U-.`
M&$B$<0&(03I"D`Y?P1`&<Z3-8FNC(P3HJ`4#DYD#@*6`%Q@@O^L(&I`$E:TL
MK<!P\<VPAK$P$8\(@,$M>TH`3E!`%0AE(OY[D4,&O)\3Q&H=A/,E\(BF@!"G
M0\(B:``!!.`6:&WXQT".0I2&$`);U5C%`%B6$4ZP/`2L0\#=>L#F<,=8`QP9
MJ#;>D1!0H$<?!_G+8#Y"`EH`$`.X^+Y(1I9Y87:"=C``-+"KUG&2A."+O2`M
M`4`:8N=2F@:_*"L,8*`$7<.`=L@NS(A.-`2L6@*4!,D!^0,-!!;P0Y#<J,RY
M$@(FA[`=_J`6N03J64!IJD,"2!]@`3!9`.<8T("!,(#'*4ZTK&>MA0=`P+.T
MSK6NZ<"<3N_ZU\`.MK"'3>QB&YL8#SZVLK],P"$@0(96LW(14(""%*@@!7%F
M@E`>$+K/%J`$7V+`>9=RWNBN8![@?@"V56``;(]``;/Q];+GG8P&E,``[,Y2
M"U8PN?VD('",12/1*KP$"=>H12RFT;:>L'`BK.`$*-G8",C+`IT!0-[TSG@Q
M3'!=GK2:03\J77*J=9,W,T4`64D`"0KR@``$H`3<3<<)#'``_HW@)^I(W0EL
M'0!C":`=!F@`R(:XZ0+LG+V:OOF+A+`JQ)$LMQJ/>BY"L',4_@!DL2&P>`DL
MC@+S$:UHKWEA"P[`G*H8_`0%8$",87B"&+P;R=S97W.6LY$).VL@#>=7`"KN
MHA97BP3`@J#4!Q^,XJ1@L.I@@`-,$"85E(0$V%SBEQJ\DYFOQR%2.?O3;)8`
M$[P`)NQQ3P-,L),7K"<$-.%)WC7]$<9-=@3MWCL)"4][7S1'0#H:8'18$!W.
MH4![D^>]PS'/$\U#EBY#0$%60O\CX#@\J:O/DJ;YS:\#;.<WYJN]]FLQ`M^X
MI<TEVX[A&*"`C3%HLL"K%D!H(Y5`0VGS-B$OR1R?%??0;!TZ,ZSIVD&5U"RW
MECXS`I,5(^W@`*BS?0A8"^V&>@U4_@(B,`(HT1H79E>+51*FT0!9056E(0!#
MATD!T$(00%P6!P`JL`(FH!`PA')YYC07(Q)"80`/`!K5U0X'8#&OUAW[<5@7
MYRV'8`"2<@%`9REI<0!(4@$#880`@(0)=#$"<`$#D$8=(H1682EN80#.=`#K
M0``4H`$Z@P`1D`'D92F"D@"'<@`74`%CI0XA-3,"4`$E@0`2E27KT`$9``)A
MH3E(:!57N`0:`!,'<(268@!6*!$9`!,=X&$Z$P!Y9848(01T6(=SN`X5,(()
MN!D)E(:10`!W(0!QHX6B@B(9X!"A"``9(`$*H`"[A`&]T5<*X#8,L">:J`X6
M0$`+0@'I_A"*$)`5`Q`!"``:#=4`*$(`)$*)1M"*SJ:*JB$X"F`!530`Z8`!
MJ5$!<Z$`'[!<&C`7!+`!B\%:1;`!822*2K$6L;(!`H13P_4!U>468X$`#C`_
M``"-`'`!;@&-(,`_E2@3#`"%E9"-&8`!0],H&9`6%`"*X$B*#2`!$%!%@)$E
MSI@$RY@!'+`8!(`!N]A*L7@9Z?``&("&5N$!&@`:`!D[F/(!',"*YB@`XN0I
MK;B+#0F/`>`I#P`^"[EC$G``W"@J(&"3HB@!DB($%,")#Q`!0HD7$K`7`-`!
M)1$!@K.1`U"-[T@!H76/4CD%!"`!!%``%CE;!+`.`YDA!1F*_@6``57D`&YC
M`!1`6T#E`06T`02$`7&U#@@`1VN%$@I0`;O$``6P-EJY#L"(%Q=`6$)@C$/4
M2NH@+L;8C\^8#@:P&`FP-@(@D?#@`>:(!!+5CZ+(0B71F!\0`!K@`4C'`:`Q
ME$>9%ALI`19#D34XE:I)!1,Y`!50(%4Y``,P%UU)`4T)$*,XBA2P2Q&@`0-P
M`;$&5-H8`1CP@7\$/@.@`2`0*ID2`4YX&2#PFVDCFW/1`+ZY&`W@A!F0AD$E
MFPX1*1'0`2/D-D'UC!50`?_BDQ<``A>0#@10%4VT!%7$`*I(BK;9D'`1*A4P
MF5YY,1FPF\X$C=0($/`XBJMYH$Y`_D%/0D$XA$`:@1*ZIWL!8#4L\3P<-%P'
MH13D-T\XM$1A`6WJ($,PU%U)\($%E!$36DOSX``P$4"6L:'#%4%+\"2O814R
M!*%P&9RZ!U0*!1,."@$PP0"`B:",T$*EIG(DP(X[D880H%^#9%].H(]-``%'
MHV,!D@`"T``$9TI%T")>FB0GB@1.UB%`)4.%@99$FJ9T,`(OM`*<$QM+`!WS
ME%ME-EE2(!7$HAD'<"9M8@3F,7I!VA#&I2H-$0('D:4)T'T,X$*,54LLH!G9
ML0"W=P#\QAX)@(5JFJEW0``NX(<X9RL!4``+D!'OD'8'QU1"X`!N@0"C"H-T
MF:4C(`,D_L!=/OIS,.06HH8$[@$!H=.DSF$SGN$6\-&7?5=GPV$5&Y,"D-JH
M0H`/5>$/`)$"<T%>+M5&FGJM<9!?:9$"I9,_9>(6#,0=)2-S.D9B'V$E"(`=
M^K"J-;$".O-U8\9JMW,59.BD1N`>`0`#!>!"3D`;(S`/(I`:S0(`,I(")*,_
M*,,8B_9<G:HF5S6H+X`/C8:M%/L&U08!WR%T6>%>Y?<2+Z!G!W=\.Z-I#N$`
M/%$`/Z&L)%<TV\$`6#&REW<$[K$S"8!M32`EB/,D7$8`,``3^6HY.#>K"9L_
M)&``5"JR;NHE@E-`];5<,%`5)$"M%3NU:-``B8.7(M!I&_$Z_NZI`@X6LM_2
M+#HF$3S!`"*P`!/[=:0G!##0#LVR>NX1(Y84`\Z1&F(A.``1`AAB`@C@&0/A
M``"V#T*0`H&5>3MA`/LZJRKP(P5D`EGQ)";#`*:7.C1"M99;!BYK*PS@`C_B
MK@A0)`H@**(*MIHAMD##$SZQE3"T'*]F9"WSML$3(%(1`"B@&2WP(SIA!+;Z
M<JEC*PCP)2O08S7!(NN!(3,[%:32*OOA`NN``NT@`NLP99<[O6-@`J!19ZIR
M$<4U.J01JB+@-"A@J.!6`,$EOOD0`")@@E]B,DNT5'RY`N1[;?F#30^``B'Q
M<<,5`B=8`FGTNY7::?N`O0;``BU@_G5,UP*M4QO4ADSGP5^JXCI#<``CT`*!
M90"5.FY:D``#@$T8.U48(D1&-``@"P\,*9L9L9@MQX2H5G`',`#S$``#H!YD
MESKS40"R^2`WK!0)@")C2US),0!IX</5(IM"H3DQ')BV\1!$G#HWG!$.8"S#
M93$D3,+42PQZ*P0A@,%)D`!(QPH.@)1"=`%.F27DB"A%,`&F(0%9D9M0`0)G
M^8>IPP$+L9E*,%L+4!(+\`'.!``6$"I="3&D4D4-8`%#P`$;(!09X`&0YC8!
M@`$"0`!/:(QP0@`'`!!YF0`+`22@V0#%6<<[EA5_W*QN^``D(IAL7,7$``'9
M8K118#JS_@`G%'`0"F"5/M4``R`!4G/&HDR*HFB;;@$G444`Z<"%0E"/2O"%
MH&@`'X#('=``H7P9OHDALR4`.%4`(%`!%@.&U>@V!6"4@8E3'-`!H'&-1,`!
M\_"12J`!&J`96RB;AG$U[H53IXS*].QL`O`!64&<7'%=#0`!7*'+`!`!;I&;
M+`15=8**VTA>2+D$!-`!XO)(B>Q,A5B*@1P!'=HH%E`2W2,!\DP`#\#1J2.7
MW\POQ/R31*`!G`.<2]#-;D$!%ET2'"`4Z`C,`,`!`V&@]8S*#7W/`V&4#Q`W
M?2D`;24$?O*;N'F9!000I+P`\F@5$N":WCQ*\GC-`3T0"'#(_J0H$1X0R($<
MT'M1`#X5@[R\5HS<`1W`B5'E-@YP`2@Y%P9@FA$@D:;)GDKPB@_0`2W]T@#!
MU'<M+O%(`0<@EQE0T#F-R@$$52@:/$+!7@<T565VHV`Z'[GX$$G]$5.U#K),
M+PXZ!%GQ@1,J%%%E%0!1:,XFS/NQH@4T2"1:'>]%!"CDHY"]'VLV+K,=0PY4
MV)BP$[K-K&B0*G;+!$.*V\+-"#0#&]VW1@]!`MW&+[;A&LV:`$?3K$(W9T2@
MI1X!W25!<PV@`BGV'0?1;D>5$;+Q;2X%W=DWW.A]!XCK++820V)**G(J!"R0
M%E$;'3_R>9Y1%2-P*")P*"3`/Q=Q_G$^0X)M-(&68Q4O!*?ON73IW>![L!L%
MQUCQ_1&>(S@O4!*TP:+K$18Q@P^NQ@+G@2$O<7HPXP+UBV='(1&=:K!1P24E
M\78.'N-V`.%(\($+P!L9,>$:(7(P`&?=<BQ$<`#(4V,!D``O\`!FJQ21XQ$'
MX`(0]#<\&YAMJP('RP_L`34RGN5P0.,.*>&6D:BN;`(6\P(80E4Y5QL_H@(0
MD``R$AWD154!H!(/T#+AZ[+I`+@FZU0LKK+K$=Q:_N=EP.7OG2SRA2%<4G(4
M08:X`U0X1V;YE1726BV@0:T*0+<`8`(ZTP)SH1Q6\7GK415]RC*`/NIKL"4A
M$)Q'\&8Y_J8>-Z(_8>)8)G`"@F*V.U%M1&!M*Q!8`L`"$QSG(E#K\K9NA\/F
M*(#<%_<"(G`XZ"L")P!UA@"#'SQ$+;'"M0%#`#/#S98E&;&$2X2FPZ7!(V1V
MI")$EA06EN01`U!F>H3MG),`(SC;(014-TPKZ_#$4HH`G+,`>_TDU%X=IP83
M)+S>ZRU`0V3/FO$`-PRATE,`&(+DI/X(?=L$#%!I$O]#<V09F*@("/"1X$-+
M?QR7V,0A8XL`'5``IR81#V*@%5#&`.#.2=`!(BPHL7B11,UTX@P"L7.-=DG4
M=^',HE*=SB0!'H`<#1G"=&&5!$\`<9,!]FA'?;L!@N..(`]#_A^0`+8XUC[O
M\P.P`0.Q2\E9`!30#@EYEB['`4<#A)=A`>T`CP\/;`SP`9B**+(I`9IAA!>`
M'!W``5GJ$+SX;.V@`!D@F_6)`!A0`/'B\DA0`6?=0'=!\V8<C_K1AW0T$,T4
M`3X_57NBTA!0DQ93]"TO1*TY`"4!`A%PDQ%\:A4`G$9I]S!QU0-P$/^9G(+<
MC"#``:BX'QB``"24$2XO&T*P`&%$G*W8VFV?:%;H`>O@(+?\K!1Y`>R,`!ZP
MT$9HA>09^`-0GTVY]>N`^$A@^+#9^$I$2R<E!"?EE&C,`1HP5QI``$9)`>LY
M]"V/[J!/D:*?)!(@I<Z&_@K0`17`_OR_J1E`H`!A%(`,9:"A`!K+P8#PT0`"
M%@2A,@``GMO&8[N84AH-CJ>X5:_9;?<;'I?/Z77['9_7[_E]_Q\P4'"0L-`0
M+B&"0,(`8&*+#*#B@6!!`A(`PH(`0.&B0`"C4\N((``C@>#A@(OT+:(@`2.`
M(`-@D8``P3%,@V!@`4#@(B%IZ]'!8FG-8".8@2.7`@R8`(*+(I=6(K<1<Z[C
M`B#!@D&2LA;`0)'"H91IJ:F52Q0@HD.5M(M*XF&!XUHD"A/2'#)X$&%"A0L9
M-G3X$&)$.`$$0-E"JD"C`P&V"-A58$N"-`$6>`3`@!,3!0Z">;F5\@V"`0_<
M*6@PZDDCTU<*#A3@"`"!`'<70X)D(X"C@VM`!=QZ`N;7$P8*G@RXN<6H'*54
MF@+8Z&77@@$)O!0Q`/+LRXYJ%/C[F6M-@@8_,U(98$YB7KU[^?;U^Q=P8,&#
M"1<V?!AQ8L6+&3=V_!AR9,F3*5>V?!ES9LV;.7?V_!ET:-&C29<V?1IU:M6K
M6;=V_1IV;-FS:=>V?1MW;MV[>??V_1MX<.'#B1<W?AQY<N7+F3=W_AQZ=.G3
HJ5>W?AU[=NW;N7?W_AU\>/'CR9<W?QY]>O7KV;=W_QY^?/FR@P``.S\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g825446g80y50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g825446g80y50.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``@&!@<&!0@'!P<*"0@*#18.#0P,#1L3%!`6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`0L`F`,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/?F98T9W8*JC)).`!2;45=[#2;=D5?[4T__`)_[;_OZO^-<
M_P!;P_\`.OO1K]7K?R/[F']J:?\`\_\`;?\`?U?\:/K>'_G7WH/J];^1_<P_
MM33_`/G_`+;_`+^K_C1];P_\Z^]!]7K?R/[F']J:?_S_`-M_W]7_`!H^MX?^
M=?>@^KUOY']S#^U-/_Y_[;_OZO\`C1];P_\`.OO0?5ZW\C^YA_:FG_\`/_;?
M]_5_QH^MX?\`G7WH/J];^1_<P_M33_\`G_MO^_J_XT?6\/\`SK[T'U>M_(_N
M8?VII_\`S_VW_?U?\:/K>'_G7WH/J];^1_<P_M33_P#G_MO^_J_XT?6\/_.O
MO0?5ZW\C^YA_:FG_`//_`&W_`']7_&CZWA_YU]Z#ZO6_D?W,7^T[#M?6_P#W
M]7_&G];P_P#.OO0>PJ_RO[F']IV'_/\`6_\`W]7_`!H^MX?^=?>@]A5_E?W,
M/[3L/^?ZW_[^K_C1];P_\Z^]!["K_*_N8G]J:?\`\_\`;?\`?U?\:7UO#_SK
M[T'U>M_(_N8?VII__/\`VW_?U?\`&CZWA_YU]Z#ZO6_D?W,/[5T[_G_MO^_J
M_P"-/ZUA_P"=?>@^KUOY']S#^U-._P"?^V_[^K_C1]:P_P#.OO0?5ZW\C^YE
MF.2.:,21.KH>C*<@UM&49KFB[HRE%Q=FK%;5/^01>_\`7!__`$$UCBO]WGZ/
M\C7#_P`:'JOS/,Z^$L?6!18`HL`46`*+`%%@"BP!18`HL`46`E3[HH(8Z@!#
MTH`AHL6%%@&4QBK28,]&\._\@&T_W3_,U]IEW^ZP_KJ?+XW^/(L:I_R"+W_K
M@_\`Z":WQ7\"?H_R,L/_`!H>J_,\SKX4^K"@`H`*`"@`H`*`"@`H`*`)4^Z*
M"6.H`0]*`(:"@H`93*'+2$ST7P]_R`;7_=/\S7V>7?[K#^NI\QC?X\BQJG_(
M)O?^N#_^@FM\5_`GZ/\`(RP_\:'JOS/-*^&/JPH`*`"@`H`*`"@`H`*`"@"5
M!\HH)>XX\`TQ$6\X[4BK$6XT[%V#<:+!84+QUH%<>D><\TA-V/0_#XVZ':CV
M/\S7V>7?[K#^NI\SC/X\B?5/^03>_P#7!_\`T$UMBOX$_1_D98?^-'U7YGFE
M?#GU84`%`!0`4`%`!0`4`(3CI3&A-QHL%B17(4"@EH4R'!H"Q#N-%BK#03FG
M88M("0=*"22(<&@F1Z#H/_($MOH?YFOL<O\`]VA_74^:QG\>1-JG_()O/^N#
M_P#H)K;%?P)^C_(SP_\`&CZK\SS6OB;'U846`*+`%%@"BP!18`HL`46`8W44
M)#0VF,D7[M*Q('I18".F4"J,T`/VBD*Y,(A@<T6(YARIMZ&@3=SOM!_Y`EM]
M#_,U]AE_^[0_KJ?-XS^/(FU3_D$WG_7!_P#T$UMB?X$_1_D9X?\`BQ]5^9YK
M7Q1]6%`!0`4`%`!0`4`%`#'ZBFAH;0,D7[M(D7'%`#=A]:8[BI&2P&:!-DOD
MGUI$\Q*!@`4$A0([O0O^0+;?0_S-?7Y?_NT/ZZGSN+_CR)M3_P"03>?]<'_]
M!-;XG^!/T?Y&>'_BQ]5^9YM7Q1]4%`!0`4`-+;3C%.P[";QZ46"P;QZ46"P;
MQZ46"PQWY'%-(:0W?3L.Q(KC;TI6%87>/2E85@WCTHL%AT<@#CBBUA-:$WFC
MT-!/*'FCT-`<H>:/0T!RG?:"=VB6I]C_`#-?78#_`':/]=3YO&:5Y$VI_P#(
M)O/^N+_^@FML3_`GZ/\`(SP_\6/JOS/-J^,/J@H`*`"@"-_O4T4AM,`H`*`&
MMU%-#0V@8]>E(3%H$%`"I]X4@9+2)"@`H`]!\/\`_("M?H?YFOK<!_NT?ZZG
MS6,_CR+.IC.E7@'_`#Q?_P!!-;8G^#/T?Y&5#^+'U7YGG'EO_=KXZQ]3=!Y;
M_P!VBP70>6_]VBP70>6_]VBP71"Z,&Z4%)H;M;TICN&UO2@+AM;TH"XQU.1Q
M30TQNT^E,=R1$.WI4LEL=L;TH%<-C>E`7%52#S2!L?0(*`"D!Z#X?_Y`5K]#
M_,U]9@/]WC_74^:QG\>1:U#_`)!EU_UQ?^1K;$?P9^C_`",:'\6/JC@<5\@?
M2!B@`Q0`8H`K3?ZS\*1K'8CH&%`!0`R3J*:*0RF,D3[M(ECJ0@H`*`"@`H`*
M`/0?#_\`R`K7Z'^9KZO`_P"[Q_KJ?-8S^/(M:B<:9=D]/)?^1K7$?P9^C_(R
MH?Q8^J//_-C_`+U?)'TMF'FQ_P!Z@+,/-C_O4!9AYL?]Z@+,K3.IDX/:E8TB
MG89N7UHL59AN7UHL%F&Y?6BP69&[`D<TTAI#<CUIV*L2(P"]:5B6AVY?6E85
MF&X=,T6"PM`@H`*`"@#T'P__`,@*U^A_F:^IP/\`N\?ZZGS6,_CR+&I_\@F\
M_P"N+_\`H)K;$?P9^C_(SH?Q8^J_,\VKY$^I"@`H`*`(G^]31:V&TQA0`4`-
M;@BFD"&YHL,>OW:0A:`%7[PI">Q-2("@`H`*`/0?#_\`R`K7Z'^9KZC!?[O$
M^:QG\>19U/\`Y!-Y_P!<7_\`036V(_@S]'^1G0_BQ]5^9YK7R1]2%`!0`4`,
M9"6R*92=A/+/M0.X>6?:@+AY9]J`N1NA!'2FAIC=IICN.'`Q2$+0`J_>%`GL
M35)`4`%`!0!Z#X?_`.0%:_0_S-?48+_=XGS6,_CR+&I_\@F\_P"N+_\`H)K7
M$?P9>C_(SH?Q8^J_,\VKY0^J"@`H`*`"@`H`*`"@"*7@BFBD,S3&!.!0`S>:
M=BK"JYW"E85B3S&I6)L'F-18+!YC46"Q-2)/0?#_`/R`K7Z'^9KZ;!?P(GS6
M,_CR+&I_\@F\_P"N#_\`H)K6O_"EZ/\`(RH?Q8^J_,\VKY4^J"@`H`*`"@`H
M`*`$R/6@"*4\BFBD,S3&(3P:!D>:90JGYA0(DS2)#-`!F@"QD>M20>A>'O\`
MD!6OT/\`,U]+@_X$3YK&?QY%C5/^03>?]<'_`/036M?^%+T?Y&6'_BQ]5^9Y
MKFOECZH,T`&:`#-`!F@`S0`9H`CIE$<@)(P*$-#-K>AIE`5.#P:`(\'TIC%4
M'(XH`?M;T-(0;6]#0`NUO0T`6/+?^Z:DSNCT3P\"-!M01@[3_,U]+@_X$3YG
M&_QY%C5/^01>_P#7!_\`T$UI7_A2]'^1EA_XL?5?F>:5\L?5!0!'*Q7&#BFD
M5%$?F-_>-.Q5D'F-_>-%@L@\QO[QHL%D'F-_>-%@LAGF-_>-.P[(?&Q).32:
M$U8DH)$;[IH&BOFF6.0_.*!/8GI$!0`#K0!?I&!W6A?\@6V^A_F:^DP?\")\
M[B_XTB;5/^01>_\`7!__`$$UI7_A2]'^1&'_`(L?5?F>95\N?5A0!%,?NTT5
M$BS3+#-`!F@`S0`S-,9)$>329,B7-(D1C\II@BO3-!R??%`GL3YJ2`S0``\T
M`:':@YSN]"_Y`MM]#_,U]'@_X$3Y[%_QI$VJ_P#((O?^N#_^@FM*_P#"EZ,S
MP_\`&AZK\SS'-?,'U@9H`AG/W::*B19IEAF@`S0`9H`9FF,DA/)I,F1+FD2!
MY&*`(_*]Z+E7'QQ`R*,]Z+B<K(M_91_?-(QYP^RC^^:`YP^S#^^:`YRQ09G=
MZ%_R!;;Z'^9KZ/!_P(GSV+_C2)M5_P"0/>_]<'_]!-:5_P"%+T9GA_XT/5?F
M>7YKY@^L#-`$,Y^[31<2+-,L1C\II@1[O>F58D!X%22:N@:/_:TEP7R(XT.#
M_MGI75AZ/M6[G'B\3]72MN_R,Y%:*62-QAE."/0BN:2L[,ZKII-#\U(@S0`9
MH`DA/[Y/K03+8OTC`*`"@!*`.]T'_D"6WT/\S7T>#_@1/G<7_'D2ZMQHU]_U
MP?\`]!-:5_X4O1D8?^-#U7YGEOF+_>'YU\P?6V8>8O\`>'YT!9D,[K\OS"J1
M<40[QZBF781G&T\B@$B/</44RK$BL"``<GTI6):/2M$L5TS28HFP'(WR'W->
MY0I^S@D?+8JK[:JVMNARGB*U,5_]M4`0W0W+['_Z_6O-Q<+2Y^C/8P53FI^S
MZQ,?</45QG;8-P]10%@W#U%`6)(743)\PZT"DG8O^8G]Y?SI&%F'F)_>7\Z`
MLP\Q/[R_G0%F'F)_>7\Z`LSO]`(.AVI'3!_F:^CP?\")\WC-*\B36?\`D!ZA
M_P!>\G_H)K6O_"EZ,C#?QX>J_,\@S7S1]H&:`&2'I312(\TQV$)XH'83=3"Q
MN>%;#[?K,99<Q0?O&_H/SKHPU/GJ:]#@Q];V5%VW>AUWB35XM-M8HGY:=P"!
M_<S\W^%>AB*J@DNYXV"P\JTFUT_/H6-:T\:OHYBA*[^'B/;_`#BG7I^UA9?(
MSPM;ZO6O+YG,S^$9K33IKJ>Z3=&F[8BY_6N&6#<8.39ZL,QC.HH1CN<SNKB/
M5L&Z@0Y&^=:3![%G-29!F@`S0`9H`]/\,?\`(N6?^Z?_`$(U]%@_X$3Y3'?[
MQ+^NA8UK_D!:A_U[2?\`H)K6O_"EZ,SPW\>'JOS/'=U?-'VH;J`&L`W6C8-A
M-B^].X[L0JH'>BX78W"T[E:GI'A+3A8Z,LC+B6X^=L]AVKU\+3Y(7?4^8S"M
M[6M9;+0PVM1XK\3S,6/V*WPI([@=A]37-;ZQ6?9'<I_4<,E]I_U^!W$<20PI
M%&NU$`50.P%>DDDK(\%R<G=[F!JVJ,^JIH;0%8[D;3+GL?0?A7+5JMS]E;<]
M'#T$J3Q">L>ADZAX)EBC:2PN/.*_\LW&"?H:YZF#:5X.YV4<T4G:HK>9R;!H
MW9'4JRG!!Z@UPZK0]A6:NA8S^\7ZU+V$UH6LU!F&:`#-`!F@#U'PO_R+=E_N
MG_T(U]'@_P"!$^3Q_P#O$OZZ%G6@3H6H`=?LTG_H)K6O_"EZ,RPO\>'JOS/'
M/*D_NU\Q='VMT'E2?W:+H+H/*D_NT7070>5)_=HN@NA&BD"GY:=T--%C2]/D
MO]3M[;:<.PW>R]ZUI1]I-1,J]94J3F>@^([W^SM%=8>))1Y<8';U/Y5ZN)J*
ME3TZGSF"I>VK)RV6K*_@RW$.@A\?/+(Q8_H*G!I*E<TS.?-7MV0RXUN6+Q0D
M)R+-?W1YXW'O^?%92Q-L1R]-BH86,L*Y?:W'>+;2;['%J-J2ES9MD,.H4]:U
MQ47RJ<=T++ZD>=TI[2,?2/%]Y'.D6I`2PL<>8!AE]SZUS4L8T[3V.W$9;3<;
MTM'V&>-K%8[^"[A`Q<+\V.Y'?\J,9%1DI+J5E=5NFX2Z',HCAP2.*X&T>JVK
M$^:DSL&:`L&:`L&:`L>J>%O^1:LO]T_^A&OH\'_`B?(X_P#WF7]="WK'_($O
M_P#KWD_]!-:5_P"%+T?Y&.&_C0]5^9Y'NKY4^R#=0`;J`#=0`C'Y33&CJ_!E
MB%2?4I<`#*(3V'<UZF!IV3J,\?,ZMVJ*]3)U[4_[2U-W1LPQ_)']/7\:X\35
M]K4NMD=N$H>QII/=[G0^#+M9=+DM\_/"Y./8UZ.!G>GR]CS,SIN-53[HP/$"
MM%?70;@^9D5YM=-597/2P;3IQMV'MXPOWMC!)%"ZE-C$CJ,8K?Z[4<>5I$++
M:2ES)LY_/8?E7$>D;?B"[W)861;+VL($A_VB.GX5UXF=U&'9'!@Z=G.I_,]/
M0Q-WO7(=]A=U`!NH`-U`";J`/5_"G_(LV7^Z?_0C7TF#_@1/D,P_WF?]="WK
M)QH6H'_IVD_]!-:5_P"%+T?Y&.&_CP]5^9X]YJ_WA7RMF?:<K#S5_O"BS#E8
M>:O]X468<K#S5_O"BS#E8;PY"*<LQP`/6FDV[!:VK-W6-7%G:)HEHX6.%=LS
M#JS=P/:NZM5<(^QALMS@PV&]I-XB:U>WH8L`>=UBA4R2'HJC)-<*C*3LD=T[
M05Y:(T],BU?2KU;F"RN?1E,1PP]*Z:7MJ4N:,6<E>6'KPY)27WF_K.E2:Y;B
M[M8Y(KC`WPRKM/X&NJM1=?\`>05GV9YV&Q"PTO9S=UW1QMU:R64Y@N5,4@&=
MK5YTHR@[21[E.I&I'FAJCKO!^G65SIS7$L"2RI*0KGJ.E>G@J<90YI+6YXN9
M5JD*G+%V5C=;0M*R6:PC)/))!)-=;H4NL3@6+K[*1@ZL^@6MO)'%:HMP.`/+
M.?UKCK2P\$TEJ>AAUBIR3<M/4Y"3$DC,!M![#M7F.5V>U'16&[!ZFE<=PV#U
M-%PN&P>IHN%SU?PH,>&+$?[)_P#0C7TF#_@1/D,P_P!YG_70M:YQX?U+_KVD
M_P#036M?^%+T?Y&.%_WB'JOS/$-U?,'WE@W4!8-U`6#=0%A1*T;!T8JRG(([
M&FG9W0<J>C(S(S,68DDG))[TRDK:(DBE>-E=&*.O(93@@TKM.Z)E%/1G>:'X
MV@>#RM5D\J5!Q+@D/]<=Z]2CC$U:IN?/8K*Y*7-05UV[&TWBG15C#&^4+Z[&
M_P`*V^MT?YCA6`Q+=N7\C@O%-_;:AK;3VDOFQ>6HW`$<CZUYN)G&=2\6?0X"
MC.E1Y9JSN5+#5;ZS4PVUU)%&<DJIXS6*JS@K1=C:KAZ53WIQNRVVMZDR%&OI
MBIZC=4^WJM6YF8K"T4[J**#2X;GD^M9'2HB>=[46'RAYWM18.4/.]J+!RAYW
MM18.4];\)G/A>Q/^R?\`T(U]-@OX$3XW,-,3/^NA9UW_`)%[4O\`KUD_]!-:
MU_X4O1_D983_`'B'JOS/#J^8/O1PC<IO",4SC=CC/I3L[7%=)VN(Z/&Y1U9&
M'4,,$4FFM&"::N@56=@JJ6)Z`#-`-I:L1U*Y5@01U!&*>PT[[#%5G.U5+'T`
MS3*;2W'E63Y64J?0C%)Z$W3V%1&D8(BEF/0`9)I)7T0FTE=FE>VES;V*&>WE
MB''+H12Y)Q?O*QS4JD)S?*TS-5'<D(K,0,G`S32;V.EM+<FABE5@QB<+CJ5.
M*4D[$2E':Y-69!$P)?`&3Z"J1:V%,,J[LQ.-GWOE/R_6JY6N@E*+ZC*DH4`D
M@`$D]`*!;$D]K<6I47$$D1897>I&1[9JI0E'XE8F%2$_A=SUSPE_R*UA_NG_
M`-"-?1X+^!$^-S'_`'J?]="UKO\`R+VI?]>LG_H)K6O_``I>C_(RPG^\0]5^
M9Y3X5T0:YK*P29%O&-\N.X]/QKP<+1]M4L]CZ['XKZM1YEN]$:/C/5R+_P#L
M>R5(+*S*X1%`RX[_`(5MC*OO>RAHD<V68?W/;U-92_(V_(C\:>#_`+4\:C4[
M<$;U&"6';Z$5U<JQ=#F?Q(X.=Y=B^1/W'^O^1R/A+_D:]._ZZ?T->?A/XT3V
M<P_W6?H=)\2=,5&M=2C0`L?*D('7N":[<QII-31YF25V^:D_5$/PUTX27EUJ
M+KD1*(T/N>3^E++Z=Y.;Z%YW6Y81I+KJ8WC1MWBV^X^Z5'_CHKDQC_?R.[+%
M;"P_KJ=-;VT?@[P>=2$:MJ5PH`9AG:6Z#\!7=&*PM#G^TSRIS>88OV5_<7Z'
M-W/B'5)-/D2:[:9)EVNL@!'/IZ5Y:Q-5W3E=,]2&#H*HG&-K=B[\.F*^(I%'
M0P'/YBNS+_XOR.?.5_LZ?F:VG^(;X>.;G3+B4S6<LSQB-P#L],5O#$36)=.3
MNF[')6P=+ZE&M!6DDF8_B_3X=.UYTMU"12H)`HZ`GK_*N#'4HTJUH[,[<MK2
MK4$Y;K0VM(L(/#WAF77IXEDO'3=$&'W0?NX_G79AZ<</0]M):]#AQ-:6+Q*P
MT7:*W_4P_#OB"XB\1>9=N)8[YPD^X#G/`/X5S8;$25:\OM;G=C,'"6'M#1QV
M)/&NAQ:3J236R;+:X!(4=%8=13QU!4IWCLQ99BG7IN,]T:NC6T6@^#9-<6%9
M;V1249AG8,X'^-=-"*H8=UDO>./$SEBL8L,W:*.,O=0N]1F\V\N'F?MN/`^@
M[5Y<ZDZCO-W/<I4:=%<M-6/6/"7_`"*UA_NG_P!"-?0X+^!$^/S'_>I_UT+6
MN_\`(O:E_P!>LG_H)K6O_"EZ/\C+"?[Q#U7YG(?#*)?*U&7^+<J_A@FO/RU:
M29[.>2=X1]3B]:<R:[J#-U^T./\`QXUYM9WJ2]6>YAE:A!+LCNOAF2=-OU)X
M$PX_X#7J9;\$O4\#/-*D'Y?J<MHH$/CJ!4X"W;*/IDBN&CIB5;N>MBO>P+;_
M`)3L[S_BH?"6JVY^:>UFE`]<JQ(_3BO2E^_HRCU3?X'ATO\`9,73ETDE^**_
MAEO[,@T+35.);M7NI1[8X_I4X?\`=J$.^IKCE[:56L]HVBCEO%""3QQ=1MT:
M9`?^^5KS\2KXAKS1ZV`?+@HM=G^IV/CR`7-CI]J9X[=))\%Y#A5PIZUZ6.CS
M1C&]M3Q,IGR3G.U[+IZG):CH<%MH[S+K%G,T8!$<;9+?2O)EAXQ3DII^1[-'
M%2G5473:OU)_AW_R,K?]<&_F*Z,O_C?(SSG_`';YFQI6C9\4ZEKLLBFWM9Y,
M1IRY8>WTKHIT?WTJSV39Q5\3;"PPT5K)+T.9US53K.JRWA4HAPJ*>RBO*Q%;
MV]1S/5PF'6'I*F=KXY'E>$HHTX421KCV%>SC],.DO(\+*O>Q;;[,\UA)6>,C
M@A@1^=>%'1H^HDKQ9Z-\0D#:#:R'[RRC'X@U[F8J])/S/F<G=J\EY$'@W4[3
M4M'?0;W;N`(53_&AYX]Q48*K"I3]A,TS*A4HUEB:?_#,Y?Q'X>FT&["DE[60
MGRI/Z'WKS\3AI4)>70];!8R.*A?9K='H_A+_`)%:P_W3_P"A&O;P7\")\QF/
M^]3_`*Z%K7?^1>U+_KUD_P#036M?^%+T?Y&6$_WB'JOS.%^&]\D6HW5D[8,R
M!T'J1U_2O+RZ:4G!]3W\ZI.5.-1=#G?$UHUEXDOXF&,REU]PW.?UKCQ,.2K)
M'I8&HJF'@UVM]QVW@W;HW@VYU*X^57+2#/<#@?F:]/!_NL.YR/"S*^(QD:,>
MFAQ_A=S+XOL9'Y9YBQ^I!KSL*[UXM]SVL>N7"32['3>$;\1>+]9L'/R7$LC*
M/]H,?Z5W82=J\X/JV>5F-*^$I55T2_(HZ"__`!<00++YD5MYD,1]%&<#\,UG
M0?\`M5NBNCIQ:_X3^:UF[-^IE>+V:/QA?.."'5A_WR*YL7I7DSKRY)X2"]?S
M9UWC'&L>#+?4+<;U0K*<=@1@_E7HXO\`>X=3B>-EO^SXQTI^://Y\?8D_"O`
M7Q'T<?C9T'P[_P"1E;_K@W\Q7IY?_&^1YN<_[M\S5T+4S9>/=4L)3B*ZE;`/
M9AT_,5O1J\F)E![-G)BJ'M,#3J+>*7W&#XDTPZ5K<\"KB)COC_W3_ATKS<51
M]C5<>G0]'!5_;T5+KLSK?$#_`-L>`8[J+YB@21@.Q'#5ZN(?ML(I+R/&P:^K
MX]PEYK_(X+1[1K[6;.W09+RKGZ`Y/Z5Y%&#G4C%'T&)J*E1E-]CK_B+?H3::
M<ARRYE<#MV']:]+,JB]VFO4\;)J+7-5?H<+'(\,BR1N4=#E6!P0:\E-IW1]`
MXJ2L]CT3Q1<FY\!6LUV`+F7RV`Q@[N_Z5[6*ES85.6[L?-8"')CI1ALKFWX2
M_P"16L/]T_\`H1KJP7\")P9C_O4_ZZ&K=6\=W:36TN?+F0HV#@X(P:Z914HN
M+ZG)3FZ<U..ZU.>MO`FCV=S'<0-<QRQG<K"8\&N2.!I1?,KW]3TIYKB)Q<96
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M$O$9A6Q,.2=K$<W@_2YM5;4F\\7+/YF5D(`/TJ98.E*?.[W*CF5>-+V2M;;8
MMZMH%AK1B-XCEHL[2C;3SVJZ^&IU[<_0QP^+JX:_L^HNEZ%::3#+#;&5H9?O
M1R/N7WXIT</"BG&.PJ^+J8AJ4[77833O#VF:5<27%G;!)'XSG.!Z#THIX:E2
M;E!#K8RM7BHS>B*%SX(TF\N9+BX:YDED.68S'FL98&E-\TKW]3HAFE>G%0C9
M)>06W@?0[:=91!)(5Y"R.67\J(X"C%WL$\UQ,X\M[>A;U;PU8ZU*CWC3D1C"
MHLFU5_"M:V%A6=YW,</C:N&35.VOD7["QATVQBM+?<(HAA=QR>N:UITXTHJ$
M=D<]6K*M-SENRS6AD%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`?
"_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g825446g96h31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g825446g96h31.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``@&!@<&!0@'!P<*"0@*#18.#0P,#1L3%!`6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`08`10,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/=-3OO[.L)+KR_,V?PYQG\:YL37^KTG4M>QM0I>VJ*%['._
M\)O_`-0__P`C?_8UXW]N?]._Q_X!ZG]E?W_P_P""'_";_P#4/_\`(W_V-']N
M?]._Q_X`?V5_?_#_`((?\)O_`-0__P`C?_8T?VY_T[_'_@!_97]_\/\`@CO^
M$T_ZA_\`Y&_^QI?VY_T[_'_@"_LO^_\`A_P1I\;8./[/_P#(W_V-/^W/^G?X
M_P#`'_97]_\`#_@@/&W_`%#_`/R-_P#8T?VY_P!._P`?^`']E?W_`,/^"3V_
MB[S[B.'[#MWL!GS<X_2KIYUSS4.3?S_X!G/+>2+ES;>7_!.FKWSR3(\2_P#(
M!N/I7G9G_NLCMP/\>)YY7QA].%`!0!)4D#&^]312$'6F!=T__D(V_P#OC^=:
MX;^-'U,*W\.7H>FU]^?)F1XF_P"0#<?2O.S/_=9';@?X\3SNOC#Z<*`"@"6I
M)(V^]5(:`=10,NZ?_P`A&W_WQ_.M<-_&CZF%;^'+T/3:^_/DC(\3?\@&X^E>
M=F?^ZR.W`_QXGG5?&GTX4`%`$PZ5))&WWJ:&A!U%,9>T_P#Y"-O_`+X_G6N&
M_C1]3GK?PY>AZ;7WQ\F9'B;_`)`-Q]*\[,O]UD=N`_CQ/.J^-/IPI@%("8=*
MDDC;[QJD4A!U%`%[3_\`D(V_^^/YUKAOXT?4PK?PY>AZ;7WQ\D9'B;_D`7/T
MKS\R_P!VD=N`_CQ/.:^-/J`H`*`)QTJ"")_O&J6Q2&!B#3L58NZ<Y_M*V_WQ
M_.ML,OWT?4PK+]W+T/4:^\/D#(\3?\@"Y^E>?F7^[2.W`?[Q$\YKXT^H"@`H
M`F'2H((G^\:I;%(C_BJBRYIW_(2MO^N@_G6V'_C1]3"O_"EZ'JE?=GQYD>)_
M^0!<_2O/S+_=I';@/]XB><5\<?4!0`4`3$[5S4$H@9SNJTBTA`,D4]@V+^G(
M1J5MS_&/YUIAW^^CZF%=_NI>AZC7WA\@8_B?_D`7/TKS\R_W:1VX#_>(GG%?
M''U(4`-W$&G8=A[.=M2D2D19R:LLD3M4LEFCI_\`R$;?_?'\ZTPW\:/J<U;^
M'+T/3J^]/DC'\3_\B_<_2O/S+_=I';@/]XB><5\<?4A0!&>M44.;[M)"0U1S
M38V6$4;0<5#9FV7-/_Y"-O\`[X_G6N'_`(T?4PK?PY>AZ?7WI\D8_BC_`)%^
MY^E>?F7^[2.[`?[Q$\WKX\^I"@",]:H8_J*D0Z-06/TI-B;)P,#`J""SI_\`
MR$;?_?'\ZWPW\:/J8UOX<O0]/K[T^2,;Q5QX=N?I7!F/^[2.[+_]XB>9;C7R
M%CZL7<:+`1ECNZU=AC]Q]:FPK#T8YX-2T)H?N/J:5B;%K36/]IVW)_U@_G6V
M'7[Z/J95U^ZEZ'JU?='QQB^*_P#D7;KZ"N#,?]VD=V7_`.\1/,J^1/K`H`C/
M6K&25`AR=:3$Q](DM:;_`,A.V_ZZ#^=;8?\`BQ]3*O\`PI>AZQ7W)\:8WBG_
M`)%ZY^E>?F/^[2.[+_\`>(GFG%?(GU0<4`1G[U442CI4DA0`4`6M-_Y"=M_U
MT'\ZVP_\6/J8U_X4O0]9K[@^-,;Q5QX>N?I7!F/^[2.[+_\`>(GF>X>M?(6/
MJ[!N'K18+$98;NM6D58D##'6IL387-(04`6],_Y"EM_UT'\ZVP_\6/J95_X4
MO0]9K[@^,,3Q9_R+EU]!7!F'^[R._+O]XB>7U\F?6!0`PGFJ*'TB29?NBH9+
M%I`6M,_Y"EK_`-=!_.M\/_%CZF-?^%+T/6J^W/C#%\5C/AVZ'L*X,Q_W:1WY
M?IB(GF/ECUKY*Y]9</+'K3N%R(KACS5)E7%I")E^Z*EDL6D(M:9_R%+7_KH/
MYUMA_P"+'U,:_P#"EZ'K=?;GQAB^*O\`D7;GZ"N#,?\`=I'=E_\`O$3S.ODC
MZP*`(6^\:I%HC;K5(8X'BD(?&?FI,3+^F?\`(4M?^N@_G6F'_BQ]3GK_`,*7
MH>N5]L?%F'XNX\-77T%<./\`]WD=^7?[S$\LR?6OE3Z\0L1WIV"Q"S'<:M(N
MPQFYII#L.#'%*P6)8&/F5,EH1):&II;?\36U_P"N@_G3H+]['U.6NOW4O0]>
MK[4^*,/Q?_R+5U]!7#C_`/=Y'H9;_O,3RJOECZ\0TT`W:*8[D;`;JI%(>JC`
MI"N36R`R].U9S>A$WH:VF1J-4MN/^6@_G3P[?M8^IR5V_92]#UFOMSXPP_%_
M_(M77T%<./\`]WD>AEO^\Q/*J^6/KQK=*:&)3`B<_-5(I#U/RBDQ,L6O^M_"
MLY[&<]C7TW_D)VW_`%T'\Z,/_%CZG)7_`(4O0]7K[@^-,+Q?_P`BS=_05Q8_
M_=Y'H9;_`+S$\IKY8^P$;I30#:8QC*2<TTQIDR1-M'2I<D2VB:WC*29/I43=
MT1)W1JZ;_P`A.V_ZZ#^=/#_Q8^IR5_X4O0]8K[<^-,+QA_R+-W]!7%C_`/=Y
M'H9;_O,3RFOES[`:W2F@0W-,89H`M1_<%9/<S>Y)']^H>Q+V-#3?^0G;?]=!
M_.M,/_%CZG/7_A2]#UFOMSXPP?&)V^%[L^PKBQW\"1Z&6_[S$\E\T5\SRGV7
M*(\J@=Z:BQJ(SSE]Z?*Q\K'>8M*PK%A)D"`<UFXNYFXNY+'.F[O4N+L2XNQH
M:9,AU2U`S_K!_.KH1?M8^ISUXOV4O0]=K[4^*,#QI_R*MY]!7'C?X$CT<L_W
MJ)Y!FOFS[09(?E%4AHCS5%$F:DDG0_**S9#'H?FI/8EFAI1_XFUI_P!=!_.J
MH?Q8^ISXC^%+T/9Z^Q/ACG_&O'A6\^@KCQO\"1Z65_[U$\?S7SA]H-D/`IH:
M&8.,XXZ9JACLTA$Z'Y16;(9(A^:I9+-#23_Q-[3_`*Z#^=70_BQ]3FQ'\*7H
M>T5]@?#&#XR`/A>[!]!7'COX$CT<L_WJ)Y'L3TKYF[/LKLCF1=HP.<U465%E
MW[(HLO+Q\W7\:P]H^>YCSOGN4P@QTK>YM<4#'`I"')]ZDQ,T=)_Y"]I_UT7^
M=70_B1]3FQ'\&7H>TU]>?"F#XR_Y%>[^@KBQW\"1Z&6?[S$\EKYD^R)(8?-D
M4G[JG)J92Y4*4K(L><#=B'N!67+[G,9\ONW)'TLO(SAP%/.*E8BRM8E5K*QF
MLA5B/0UU)Z'0F*BG=0V#9HZ2I&KVG_71?YU=!_O(^IS8C^#+T/:*^O/A3!\9
M?\BO=_05QX[^!(]'+/\`>HGD>:^9/LC151;:=YC<$G)KE;YZED<[?-.R(;10
MJ&9_O-R3Z"M*CN^5&DWKRHT)W9K020MP,'CN*YH)*=I'/%)2LR(PVMVG[L@/
M[52E.F]=BN:<'J9NTQRE&ZBNN]U='1>ZN7])_P"0O:?]=!_.M*'\6/J88C^%
M+T/9Z^P/A3`\9_\`(K7?T%<>._@2/1RS_>HGD\$9EF1!W-?+SERQN?8R?*KE
MG6)@(T@3H.M98:.O,S/#QUYF1%]VG97^[BK2M4U+M:9-:7J0V_E2`D=L5%2D
MY2NC.I3;E=%:)RERIBX^;BM9*\;,T:O'4DN'#WCD'BIIJT$A05HHM:3_`,A>
MT_ZZ+_.MZ'\6/J8XC^%+T/:*^O/A3`\9_P#(K7?T%<>._@2/1RS_`'J)Y7;R
MBWC>0<N>%KY6<>9I=#Z^<>9V*DVZ3&3\Q/4UM&T36.A+;QS191@"A]^E1-Q>
MJW)DXO5$UQ9M;H'#`I40J*3L1&HI.Q/IZQ>6S/MW`\$UG6<KV1%5RO9%H"RC
M.YE0^U8_O7HC+]X]$-L)(Y-:M/*C"+YH_G7=A8N-2/,PK)JC*[Z'LE?9'PY@
M>,P3X6NP`2<#H*X\;_`D>CEG^]1/(MK_`//-_P#ODU\W9GV=UW(IU?8/W;]?
M[IJXIW+BU?<6.YN(U"^6YQZH:3I)@XQ?4N2W4\\01HF`]E-8QI*+NC&,(Q=T
MROM?^X__`'R:TLR[KN.17W?<?_ODTFF)M=S1TE6&KVGR,/WB_P`)]:NBG[2/
MJ<^(:]C+7H>TU]<?""$`C!`(H#8;Y4?]Q?RI60^9]P\J/^XOY460<S[AY4?_
M`#S7\J+(.9]P\J/^XOY460<S[AY4?]Q?RHL@YGW%\J/^XOY460<S[AY:#HB_
)E19!=CJ8C__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
